"antidiabetic agents and hyperglycemic agents. this classification denotes agents which lower the blood glucose level.. . "
"antidiabetic agents and hyperglycemic agents. this classification denotes agents which lower the blood glucose level.. epalrestat. this classification denotes an aldose reductase inhibitor with the molecular formula c15h13no3s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 424dv0807x, chemically known as 5-((z,e)-beta-methylcinnamylidene)-4-oxo-2-thioxo-3-thiazolidineacetic acid but generally known as epalrestat, which bears us nih compound identifier 1549120. european medicines agency schedules epalrestat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06557mig. the term epalrestat is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). epalrestat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule epalrestat under hs 29341000 and sitc 51579. as of q4 2014, epalrestat remains the us fda preferred term for this commodity. epalrestat bears us nlm identifiers umls id c0095278 and nci concept code c72762. smiles: s1/c(=c\\c(=c\\c2ccccc2)c)c(=o)n(cc(=o)o)c1=s.. "
"antidiabetic agents and hyperglycemic agents. this classification denotes agents which lower the blood glucose level.. fidarestat. this classification denotes a cyp11b2 gene with the molecular formula c12h10fn3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8sh8t1164u, chemically known as spiro(4h-1-benzopyran-4,4-imidazolidine)-2-carboxamide, 6-fluoro-2,3-dihydro-2,5-dioxo-, (2s-cis)- but generally known as fidarestat, which bears us nih compound identifier 160024. european medicines agency schedules fidarestat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07624mig. the term fidarestat is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). fidarestat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fidarestat under hs 29349990 and sitc 51579. as of q4 2014, fidarestat remains the us fda preferred term for this commodity. fidarestat bears us nlm identifiers umls id c0905478 and nci concept code c81355. smiles: c1[c@h](oc2=c([c@]13c(=o)nc(=o)n3)c=c(c=c2)f)c(=o)n.. "
"antidiabetic agents and hyperglycemic agents. this classification denotes agents which lower the blood glucose level.. gliamilide. this classification denotes an anti-diabetic agent with the molecular formula c23h33n5o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier oty52em5b2, chemically known as 3-pyridinecarboxamide, n-(2-(1-(((((bicyclo(2.2.1)-hept-5-en-2-ylmethyl)amino)carbonyl)amino)sulfonyl)-4-piperidinyl)ethyl)-2-methoxy-, endo but generally known as gliamilide, which bears us nih compound identifier 3037231. european medicines agency schedules gliamilide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07915mig. the term gliamilide is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). gliamilide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule gliamilide under hs 29350090 and sitc 51580. as of q4 2014, gliamilide remains the us fda preferred term for this commodity. gliamilide bears us nlm identifiers umls id c2983990 and nci concept code c91020. smiles: s(=o)(=o)(n1ccc(cc1)ccnc(=o)c1c(oc)nccc1)nc(=o)ncc1c2cc(c1)c=c2.. "
"antidiabetic agents and hyperglycemic agents. this classification denotes agents which lower the blood glucose level.. glisamuride. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t4c1ie36l0. european medicines agency schedules glisamuride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07929mig. glisamuride generally arises in the molecular formula c23h31n5o4s. the term glisamuride is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21.) glisamuride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule glisamuride under hs 29350090 and sitc 51580. as of q4 2014, glisamuride remains the us fda preferred term for this commodity. glisamuride bears us nlm identifiers umls id c2348865 and nci concept code c72948. smiles: s(=o)(=o)(nc(=o)nc1ccc(cc1)c)c1ccc(ccnc(=o)n(c2ncccc2)c)cc1.. "
"antidiabetic agents and hyperglycemic agents. this classification denotes agents which lower the blood glucose level.. imirestat. this classification denotes an aldose reductase inhibitor with the molecular formula c15h8f2n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0pm69s95uq, chemically known as 2,7-difluorospiro(fluorene-9,4-imidazolidine)-2,5-dione but generally known as imirestat, which bears us nih compound identifier 65673. european medicines agency schedules imirestat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08154mig. the term imirestat is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). imirestat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule imirestat under hs 29332100 and sitc 51572. as of q4 2014, imirestat remains the us fda preferred term for this commodity. imirestat bears us nlm identifiers umls id c0063406 and nci concept code c96290. smiles: fc1cc2c3(nc(=o)nc3=o)c3c(c2cc1)ccc(f)c3.. "
"antidiabetic agents and hyperglycemic agents. this classification denotes agents which lower the blood glucose level.. minalrestat. this classification denotes an aldose reductase inhibitor with the molecular formula c19h11brf2n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g44pe6qb31, chemically known as 2-((4-bromo-2-fluorophenyl)methyl)-6-fluorospiro(isoquinoline-4(1h),3-pyrrolidine)-1,2,3,5(2h)-tetrone but generally known as minalrestat, which bears us nih compound identifier 190816. european medicines agency schedules minalrestat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08972mig. the term minalrestat is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 3 1997, list 38). minalrestat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule minalrestat under hs 29251995 and sitc 51482. as of q4 2014, minalrestat remains the us fda preferred term for this commodity. minalrestat bears us nlm identifiers umls id c1175807 and nci concept code c72820. smiles: brc1cc(f)c(cn2c(=o)c3(cc(=o)nc3=o)c3c(c2=o)ccc(f)c3)cc1.. "
"antidiabetic agents and hyperglycemic agents. this classification denotes agents which lower the blood glucose level.. ponalrestat. this classification denotes an aldose reductase inhibitor with the molecular formula c17h12brfn2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2cv0a5g64e, chemically known as 3-(4-bromo-2-fluorobenzyl)-3,4-dihydro-4-oxo-1-phthalazineacetic acid but generally known as ponalrestat, which bears us nih compound identifier 5278. european medicines agency schedules ponalrestat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09978mig. the term ponalrestat is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). ponalrestat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ponalrestat under hs 29339990 and sitc 51577. as of q4 2014, ponalrestat remains the us fda preferred term for this commodity. ponalrestat bears us nlm identifiers umls id c0071716 and nci concept code c82173. smiles: brc1cc(f)c(cn2nc(c3c(c2=o)cccc3)cc(=o)o)cc1.. "
"antidiabetic agents and hyperglycemic agents. this classification denotes agents which lower the blood glucose level.. zenarestat. this classification denotes an aldose reductase inhibitor with the molecular formula c17h11brclfn2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 180c9pj8jt, chemically known as 3-(4-bromo-2-fluorobenzyl)-7-chloro-3,4-dihydro-2,4-dioxo-1(2h)-quinazolineacetic acid but generally known as zenarestat, which bears us nih compound identifier 5724. european medicines agency schedules zenarestat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00145mig. the term zenarestat is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). zenarestat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zenarestat under hs 29335995 and sitc 51576. as of q4 2014, zenarestat remains the us fda preferred term for this commodity. zenarestat bears us nlm identifiers umls id c0149322 and nci concept code c72879. smiles: brc1cc(f)c(cn2c(=o)n(c3c(c2=o)ccc(cl)c3)cc(=o)o)cc1.. "
"antidiabetic agents and hyperglycemic agents. this classification denotes agents which lower the blood glucose level.. zopolrestat. this classification denotes an aldose reductase inhibitor with the molecular formula c19h12f3n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1pv3s9wp3d, chemically known as 3,4-dihydro-4-oxo-3-((5-trifluoromethyl-2-benzothiazolyl)methyl)-1-phthalazine acetic acid but generally known as zopolrestat, which bears us nih compound identifier 1613. european medicines agency schedules zopolrestat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00189mig. the term zopolrestat is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). zopolrestat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zopolrestat under hs 29341000 and sitc 51579. as of q4 2014, zopolrestat remains the us fda preferred term for this commodity. zopolrestat bears us nlm identifiers umls id c0085066 and nci concept code c82174. smiles: s1c(nc2c1ccc(c2)c(f)(f)f)cn1nc(c2c(c1=o)cccc2)cc(=o)o.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. . "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. liothyronine. this classification denotes a generic primary tumor tnm finding with the molecular formula c15h12i3no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 06lu7c9h1v, chemically known as 3,5,3-triiodothyronine but generally known as liothyronine, which bears us nih compound identifier 861. european medicines agency schedules liothyronine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08527mig. the term liothyronine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). liothyronine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, liothyronine remains the us fda preferred term for this commodity. liothyronine bears us nlm identifiers umls id cl414313 and nci concept code c907. smiles: ic1cc(cc(n)c(=o)o)cc(i)c1oc1cc(i)c(o)cc1.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. liotrix. this classification denotes a thyroid hormone and thyroxine-triiodothyronine drug combination with the molecular formula c30h23i7n2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yw8hj0n26x, more generally known as liotrix, chemically known as (2s)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid;(2s)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3, 5-diiodophenyl]propanoic acid, but generally known as liotrix. as of q4 2014, liotrix remains the us fda preferred term for this commodity. liotrix bears us nlm identifiers umls id c0936106 and nci concept code c87251. smiles: c1=cc(=c(c=c1oc2=c(c=c(c=c2i)cc(c(=o)o)n)i)i)o.c1=c(c=c(c(=c1i)oc2=cc(=c(c(=c2)i)o)i)i)cc(c(=o)o)n.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. thyroid-stimulating hormone or thyrotropin or thyrotropin alfa. this classification denotes a pituitary agent with the molecular formula c975h1513n267o304s26, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier avx3d5a4lm, more generally known as thyrotropin alfa. european medicines agency schedules thyrotropin alfa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12610mig. the term thyrotropin alfa is an international non-proprietary name or inn. see who inn reference publication, volume 12 no. 2 1999, list 40.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. methimazole. this classification denotes an antithyroid agent with the molecular formula c4h6n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 554z48xn5e, chemically known as 1,3-dihydro-1-methyl-2h-imidazole-2-thione but generally known as methimazole, which bears us nih compound identifier 1349907. european medicines agency schedules thiamazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10967mig. the term thiamazole is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules methimazole in its anatomical therapeutic chemical (atc) classification. as of q4 2014, methimazole remains the us fda preferred term for this commodity. methimazole bears us nlm identifiers umls id c0025644 and nci concept code c641. smiles: s=c1n(cc[nh]1)c.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. propylthiouracil. this classification denotes an antithyroid agent with the molecular formula c7h10n2os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 721m9407iy, chemically known as 2,3-dihydro-6-propyl-2-thioxo-4(1h)-pyrimidinone but generally known as propylthiouracil, which bears us nih compound identifier 657298. european medicines agency schedules propylthiouracil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10123mig. the term propylthiouracil is an international non-proprietary name. world health organization schedules propylthiouracil in its anatomical therapeutic chemical (atc) classification. propylthiouracil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule propylthiouracil under hs 29335995 and sitc 51576. as of q4 2014, propylthiouracil remains the us fda preferred term for this commodity. propylthiouracil bears us nlm identifiers umls id c0033511 and nci concept code c781. smiles: s=c1[nh]c(ccc)cc(=o)[nh]1.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. potassium iodide. this classification denotes a radioprotective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1c4qk22f9j. european medicines agency schedules potassium iodide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14985mig. potassium iodide generally arises in the molecular formula ik. the term potassium iodide is a united states homeopathic pharmacopoeia name designation. most nations schedule potassium iodide under hs 28276000 and sitc 52329. as of q4 2014, potassium iodide remains the us fda preferred term for this commodity. potassium iodide bears us nlm identifiers umls id c0032831 and nci concept code c47680. smiles: [k+].[i-].. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. levothyroxine or thyroxine or triiodothyronine. this classification denotes a generic primary tumor tnm finding with the molecular formula c15h11i4no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q51bo43mg4, chemically known as 3,5,3,5-tetraiodothyronine but generally known as levothyroxine, which bears us nih compound identifier 853. european medicines agency schedules levothyroxine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02917mig. smiles: c1=c(c=c(c(=c1i)oc2=cc(=c(c(=c2)i)o)i)i)cc(c(=o)o)n.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. montirelin. this classification denotes a thyrotropin-releasing hormone analogue with the molecular formula c17h24n6o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 30muj6yyuy, chemically known as (-)-n-(((3r,6s)-6-methyl-5-oxo-3-thiomorpholinyl)carbonyl)-l-histidyl-l-prolinamide but generally known as montirelin, which bears us nih compound identifier 65815. european medicines agency schedules montirelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09056mig. the term montirelin is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). montirelin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule montirelin under hs 29371900 and sitc 54154. as of q4 2014, montirelin remains the us fda preferred term for this commodity. montirelin bears us nlm identifiers umls id c0377440 and nci concept code c77010. smiles: s1cc(nc(=o)c1c)c(=o)nc(c(=o)n1c(ccc1)c(=o)n)cc1[nh]cnc1.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. azetirelin. this classification denotes a thyrotropin-releasing hormone analogue with the molecular formula c15h20n6o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 70j5awg54q, chemically known as l-prolinamide, n-((4-oxo-2-azetidinyl)carbonyl)-l-histidyl-, (s)- but generally known as azetirelin, which bears us nih compound identifier 65841. azetirelin most often comes in base and dihydrate forms. european medicines agency schedules azetirelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05653mig. the term azetirelin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). azetirelin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azetirelin under hs 29371900 and sitc 54154. as of q4 2014, azetirelin remains the us fda preferred term for this commodity. azetirelin bears us nlm identifiers umls id c0285719 and nci concept code c74408. smiles: o=c(n1c(ccc1)c(=o)n)c(nc(=o)c1nc(=o)c1)cc1[nh]cnc1.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. benzylthiouracil. this classification denotes a uridine phosphorylase antagonist and inhibitor with the molecular formula c11h10n2os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pz35lum333, chemically known as uracil, benzylthio- but generally known as benzylthiouracil, which bears us nih compound identifier 198125. european medicines agency schedules benzylthiouracil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13040mig. world health organization schedules benzylthiouracil in its anatomical therapeutic chemical (atc) classification. as of q4 2014, benzylthiouracil remains the us fda preferred term for this commodity. smiles: c1c=cc=cc1cc23c(=nc=nc2=o)s3.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. calcitonin. this classification denotes a peptide hormone with the molecular formula c145h240n44o48s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier df35i47hcm, more generally known as calcitonin. european medicines agency schedules calcitonin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00948mig. the term calcitonin is an international non-proprietary name or inn. see who inn reference publication, volume 13 no. 1, 1999, list 41. calcitonin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule calcitonin under hs 29371900 and sitc 54154. as of q4 2014, calcitonin remains the us fda preferred term for this commodity. calcitonin bears us nlm identifiers umls id c0006668 and nci concept code c2281. smiles: ccc(c)c(c(=o)ncc(=o)nc(c(c)c)c(=o)ncc(=o)nc(c)c(=o)n1cccc1c(=o)n)nc(=o)c(c)nc(=o)c(c(c)o)nc(=o)c(ccc(=o)n)nc(=o)c2cccn2c(=o)c(cc3=cc=cc=c3)nc(=o)c(c(c)o)nc(=o)c(cc4=cn=cn4)nc(=o)c(cc5=cc=cc=c5)nc(=o)c(ccccn)nc(=o)c(cc(=o)n)nc(=o)c(cc6=cc=cc=c6)nc(=o)c(cc(=o)o)nc(=o)c(ccc(=o)n)nc(=o)c(c(c)o)nc(=o)c(cc7=cc=c(c=c7)o)nc(=o)c(c(c)o)nc(=o)cnc(=o)c(cc(c)c)nc(=o)c(ccsc)nc(=o)c(cs)nc(=o)c(c(c)o)nc(=o)c(co)nc(=o)c(cc(c)c)nc(=o)c(cc(=o)n)nc(=o)cnc(=o)c(cs)n.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. carbimazole. this classification denotes an antithyroid agent with the molecular formula c7h10n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8kq660g60g, chemically known as 4-imidazoline-1-carboxylic acid, 3-methyl-2-thioxo-, ethyl ester but generally known as carbimazole, which bears us nih compound identifier 31072. european medicines agency schedules carbimazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06127mig. the term carbimazole is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules carbimazole in its anatomical therapeutic chemical (atc) classification. carbimazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carbimazole under hs 29332990 and sitc 51573. as of q4 2014, carbimazole remains the us fda preferred term for this commodity. carbimazole bears us nlm identifiers umls id c0006983 and nci concept code c83590. smiles: s=c1n(ccn1c(=o)occ)c.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. dibromotyrosine. this classification denotes a tyrosine analog and non-essential amino acid with the molecular formula c9h9br2no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qd49lep46e, chemically known as 3,5-dibromotyrosine but generally known as dibromotyrosine, which bears us nih compound identifier 10833. european medicines agency schedules dibromotyrosine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13561mig. world health organization schedules dibromotyrosine in its anatomical therapeutic chemical (atc) classification. as of q4 2014, dibromotyrosine remains the us fda preferred term for this commodity. smiles: brc1cc(cc(n)c(=o)o)cc(br)c1o.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. diiodotyrosine. this classification denotes a thyroid hormone with the molecular formula c9h9i2no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6l57q44zww, chemically known as 3,5-l-diiodotyrosine but generally known as diiodotyrosine, which bears us nih compound identifier 6181. european medicines agency schedules diiodotyrosine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13599mig. world health organization schedules diiodotyrosine in its anatomical therapeutic chemical (atc) classification. as of q4 2014, diiodotyrosine remains the us fda preferred term for this commodity. smiles: ic1cc(cc(n)c(=o)o)cc(i)c1o.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. methylthiouracil. this classification denotes an antithyroid agent with the molecular formula c5h6n2os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qw24888u5f, chemically known as 2,3-dihydro-6-methyl-2-thioxo-4(1h)-pyrimidinone but generally known as methylthiouracil, which bears us nih compound identifier 667493. european medicines agency schedules methylthiouracil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08878mig. the term methylthiouracil is an international non-proprietary name. world health organization schedules methylthiouracil in its anatomical therapeutic chemical (atc) classification. methylthiouracil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methylthiouracil under hs 29335995 and sitc 51576. as of q4 2014, methylthiouracil remains the us fda preferred term for this commodity. methylthiouracil bears us nlm identifiers umls id c0025830 and nci concept code c81590. smiles: s=c1[nh]c(cc(=o)[nh]1)c.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. potassium perchlorate. this classification denotes an antithyroid agent with the molecular formula clo4.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 42255p5x4d, chemically known as perchloric acid, potassium salt but generally known as potassium perchlorate, which bears us nih compound identifier 24505. european medicines agency schedules potassium perchlorate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14990mig. world health organization schedules potassium perchlorate in its anatomical therapeutic chemical (atc) classification. most nations schedule potassium perchlorate under hs 28299000 and sitc 52339. as of q4 2014, potassium perchlorate remains the us fda preferred term for this commodity. potassium perchlorate bears us nlm identifiers umls id c0071774 and nci concept code c47681. smiles: [k].[cl](=o)(=o)(=o)o.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. thiouracil. this classification denotes a nitric oxide synthetase inhibitor with the molecular formula c4h4n2os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 59x161scyl, chemically known as 2,3-dihydro-2-thioxo-4(1h)-pyrimidinone but generally known as 2-thiouracil, which bears us nih compound identifier 1269845. european medicines agency schedules thiouracil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15541mig. most nations schedule thiouracil under hs 29335990 and sitc 51576. as of q4 2014, thiouracil remains the us fda preferred term for this commodity. thiouracil bears us nlm identifiers umls id c0039957 and nci concept code c29856. smiles: s=c1[nh]c(=o)cc[nh]1.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. thyromedan or tyromedan. this classification denotes a thyroid agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9mu67i9k5i. european medicines agency schedules tyromedan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11370mig. tyromedan generally arises in the molecular formula c21h24i3no4. the term tyromedan is an international non-proprietary name or inn. tyromedan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. thyromedan or tyromedan bears us nlm identifiers umls id c2825356 and nci concept code c80844. smiles: ccn(cc)ccoc(=o)cc1=cc(=c(c(=c1)i)oc2=cc(=c(c=c2)oc)i)i.cl.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. thyrotropin-releasing hormone (trh) or thyrotropin-releasing factor (trf) or thyroliberin or protirelin. this classification denotes a hypothalmic hormone with the molecular formula c16h22n6o4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 5y5f15120w, chemically known as l-prolinamide, 5-oxo-l-prolyl-l-histidyl- but more generally known as protirelin, which bears u.s. national institutes of health compound identifier 32281. the european medicines agency schedules protirelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10142mig. the term protirelin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14). the world health organization schedules protirelin in its anatomical therapeutic chemical (atc) classification. protirelin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: c1cc(n(c1)c(=o)c(cc2=cn=cn2)nc(=o)c3ccc(=o)n3)c(=o)o.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. tiratricol. this classification denotes a thyroid agent with the molecular formula c14h9i3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 29oq9eu4r1, chemically known as 3,3\u2032,5-triiodothyroacetic acid but generally known as tiratricol, which bears us nih compound identifier 5803. european medicines agency schedules tiratricol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11116mig. the term tiratricol is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules tiratricol in its anatomical therapeutic chemical (atc) classification. tiratricol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tiratricol under hs 29189900 and sitc 51396. as of q4 2014, tiratricol remains the us fda preferred term for this commodity. tiratricol bears us nlm identifiers umls id c0046882 and nci concept code c66605. smiles: ic1c(oc2cc(i)c(o)cc2)c(i)cc(cc(=o)o)c1.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. elcatonin. this classification denotes an antithyroid agent with the molecular formula c148h244n42o47, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w0cms474jk, chemically known as1,7-dicarbacalcitonin, 1-butanoic acid-26-l-aspartic acid-27-l-valine-29-l-alanine- but generally known as elcatonin, which bears us nih compound identifier 16129700. european medicines agency schedules methylthiouracil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06479mig. elcatonin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule elcatonin under hs 29371900 and sitc 54154. as of q4 2014, elcatonin remains the us fda preferred term for this commodity. elcatonin bears us nlm identifiers umls id c0115656 and nci concept code c96281. smiles: cc(c)cc1c(=o)nc(c(=o)nc(c(=o)nc(cccccc(=o)occ(c(=o)nc(c(=o)n1)cc(=o)n)n)c(=o)nc(c(c)c)c(=o)nc(cc(c)c)c(=o)ncc(=o)nc(ccccn)c(=o)nc(cc(c)c)c(=o)nc(co)c(=o)nc(ccc(=o)n)c(=o)nc(ccc(=o)o)c(=o)nc(cc(c)c)c(=o)nc(cc2=cn=cn2)c(=o)nc(ccccn)c(=o)nc(cc(c)c)c(=o)nc(ccc(=o)n)c(=o)nc(c(c)o)c(=o)nc(cc3=cc=c(c=c3)o)c(=o)n4cccc4c(=o)nc(cccnc(=n)n)c(=o)nc(c(c)o)c(=o)nc(cc(=o)o)c(=o)nc(c(c)c)c(=o)ncc(=o)nc(c)c(=o)ncc(=o)nc(c(c)o)c(=o)n5cccc5c(=o)n)c(c)o)co.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. calcitonin human. this classification denotes a peptide hormone with the molecular formula c151h226n40o45s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i0io929019, chemically known as calcitonin (human) [mart.], but more generally known as calcitonin human, which bears us nih compound identifier 16132288. european medicines agency schedules calcitonin human or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00948mig. most nations, for tariff purposes, schedule calcitonin human under hs 29371900. smiles:. calcitonin human bears us nlm identifiers umls id c0770558 and nci concept code c77142.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. calcitonin salmon. this classification denotes a peptide hormone with the molecular formula c145h240n44o48s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7sfc6u2vi5, chemically known as calcitonin (salmon) [ep], but more generally known as calcitonin salmon, which bears us nih compound identifier 16129616. european medicines agency schedules calcitonin salmon or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00948mig. most nations, for tariff purposes, schedule calcitonin salmon under hs 29371900. smiles:. calcitonin salmon bears us nlm identifiers umls id c0073994 and nci concept code c329.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. liothyronine hydrochloride. this classification denotes a generic primary tumor tnm finding with the molecular formula c15h12i3no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t66dho0set, chemically known as alanine, 3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, hydrochloride, l-, but more generally known as liothyronine hydrochloride, which bears us nih compound identifier 71283. european medicines agency schedules liothyronine hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08527mig. most nations, for tariff purposes, schedule liothyronine hydrochloride under hs 29374000. smiles: c1cc(c(cc1oc2c(cc(cc2i)c[c@@h](c(=o)o)n)i)i)o.cl.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. liothyronine sodium. this classification denotes a generic primary tumor tnm finding with the molecular formula c15h11i3no4.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gca9vv7d2n, chemically known as l-tyrosine, o-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, monosodium salt, but more generally known as liothyronine sodium, which bears us nih compound identifier 5919. european medicines agency schedules liothyronine sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08527mig. most nations, for tariff purposes, schedule liothyronine sodium under hs 29374000. liothyronine sodium bears us nlm identifiers umls id c0546882 and nci concept code c2581. smiles: c1cc(c(cc1oc2c(cc(cc2i)c[c@@h](c(=o)[o-])n)i)i)o.[na+].. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. protirelin tartrate. this classification denotes a hypothalmic hormone with the molecular structure c16h22n6o4.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, syw8t997eq chemically known as l-prolinamide, 5-oxo-l-prolyl-l-histidyl-, (2r,3r)-2,3-dihydroxybutanedioate (1:1), but more commonly known as protirelin tartrate, which bears us nih compound identifier 176174. european medicines agency schedules protirelin tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04112mig. most nations, for tariff and trade purposes, schedule protirelin tartrate under hs 29371900. as of q4 2014, protirelin tartrate remains us fdas preferred term for this commodity. smiles: c1c([nh]cn1)c[c@@h](c(=o)n2ccc[c@h]2c(=o)n)nc(=o)[c@@h]3ccc(=o)n3.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. levothyroxine sodium. this classification denotes a thyroid hormone with the molecular formula c15h10i4no4.na.h2o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 9j765s329g, chemically known as 3,5,3,5-tetraiodothyronine but more generally known as levothyroxine sodium, which bears u.s. national institutes of health compound identifier 853. european medicines agency schedules levothyroxine sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08495mig. world health organization schedules levothyroxine sodium in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. thiamazole. this classification denotes an antithyroid agent with the molecular formula c4h6n2s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 554z48xn5e, chemically known as 1,3-dihydro-1-methyl-2h-imidazole-2-thione but more generally known as methimazole, which bears u.s. national institutes of health compound identifier 1349907. european medicines agency schedules thiamazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10967mig. the term thiamazole is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules methimazole in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary.. "
"thyroid and antithyroid drugs. this classification denotes preparations that treat diseases and disorders of a highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. it secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively.. dextrothyroxine sodium. this classification denotes a thyroid agent with the molecular formula c15h10i4no4.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0h00n2ahsp, chemically known as 3,3,5,5-tetraiodo-d-thyronine, sodium salt but more generally known as dextrothyroxine sodium, which bears us nih compound identifier 8729. european medicines agency schedules dextrothyroxine sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07055mig. most nations, for tariff and trade purposes, schedule dextrothyroxine sodium under hs 29225000 and sitc 51467. as of q4 2014, dextrothyroxine sodium remains us fdas preferred term for this commodity. dextrothyroxine sodium bears us nlm identifiers umls nci c65373. smiles: c1c(cc(c(c1i)oc2cc(c(c(c2)i)o)i)i)c[c@h](c(=o)[o-])n.o.[na+].. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. . "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. choriogonadotropin alfa or chorionic gonadotropin. this classification denotes a therapeutic gonadotropin with the molecular formula c1105h1770n318o336s26, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6413w06wr3, more generally known as chorionic gonadotropin. european medicines agency schedules chorionic gonadotropin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12481mig. the term choriogonadotropin alfa is an international non-proprietary name or inn. see who inn reference publication, volume 11, no. 11997, list 37. smiles: none.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. menotropin. this classification denotes extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, follicle stimulating hormone and luteinizing hormone, and which are used to treat infertility, preparations that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5y9qqm372q, and generally arise in the molecular formula c42h65n11o12s2, chemically known as 1-[19-amino-7-(2-amino-2-oxoethyl)-13-butan-2-yl-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-n-[1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide, but generally known as menotropins, and sometimes also called urofollitropin, and which bear us nih compound identifier 62819. the term urofollitropin, the synonym for this commodity, is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27.) smiles: ccc(c)c1c(=o)nc(c(=o)nc(c(=o)nc(csscc(c(=o)nc(c(=o)n1)cc2=cc=c(c=c2)o)n)c(=o)n3cccc3c(=o)nc(cc(c)c)c(=o)ncc(=o)n)cc(=o)n)c(c)o.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. urofollitropin. this classification denotes a therapeutic follicle stimulating hormone with the molecular formula c975h1513n267o304s26, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w9bb98u6hp, more generally known as urofollitropin. european medicines agency schedules urofollitropin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05053mig. the term urofollitropin is an international non-proprietary name or inn. see who inn reference publication, volume 1, no. 4, 1987, list 27. most nations schedule urofollitropin under hs 29371900 and sitc 54154. as of q4 2014, urofollitropin remains the us fda preferred term for this commodity. urofollitropin bears us nlm identifiers umls id c0383405 and nci concept code c80805. smiles: ccc(c)c1c(=o)nc(c(=o)nc(c(=o)nc(csscc(c(=o)nc(c(=o)n1)cc2=cc=c(c=c2)o)n)c(=o)n3cccc3c(=o)nc(cc(c)c)c(=o)ncc(=o)n)cc(=o)n)c(c)o.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. follitropin or follitropin alfa and follitropin beta. this classification denotes a major gonadotropin secreted by the adenohypophysis (pituitary gland, anterior), sometimes also called follicle-stimulating hormone, and which stimulates gametogenesis and the supporting cells such as the ovarian granulosa cells, the testicular sertoli cells, and leydig cells, and which consists of two noncovalently linked subunits, alpha and beta, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 076whw89tw. european medicines agency schedules follitropin in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub12426mig, sub12503mig, and sub25237. follitropin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, follitropin remains the us fda preferred term for this commodity. this classification encompasses follitropin alfa and follitropin beta.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. lynestrenol or lynoestrenol. this classification denotes an a synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive which the molecular formula c20h28o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n2z8alg4u5, chemically known as (8r,9s,10r,13s,14s,17r)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-17-ol but more commonly known as lynoestrenol, which bears us nih compound identifier 5857. smiles: cc12ccc3c(c1ccc2(c#c)o)ccc4=ccccc34.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. epimestrol. this classification denotes a steroidal estrogen with the molecular formula c19h26o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7ive3sdz38, chemically known as 3-methoxyestra-1,3,5(10)-triene-16alpha,17alpha-diol but generally known as epimestrol, which bears us nih compound identifier 23434. european medicines agency schedules epimestrol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06566mig. the term epimestrol is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules epimestrol in its anatomical therapeutic chemical (atc) classification. epimestrol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule epimestrol under hs 29372300 and sitc 54153. as of q4 2014, epimestrol remains the us fda preferred term for this commodity. epimestrol bears us nlm identifiers umls id c0014561 and nci concept code c80783. smiles: oc1c2(c(c3c(cc2)c2c(cc3)cc(oc)cc2)cc1o)c.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. acefluranol. this classification denotes an antiestrogen with the molecular formula c25h26f2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3k0bn50qxd, chemically known as 4,4-((1rs,2sr)-1-ethyl-2-methylethylene)bis(6-fluoropyrocatechol)tetraacetate but generally known as acefluranol, which bears us nih compound identifier 170368. european medicines agency schedules acefluranol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05204mig. the term acefluranol is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). acefluranol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acefluranol under hs 29153980 and sitc 51372. as of q4 2014, acefluranol remains the us fda preferred term for this commodity. acefluranol bears us nlm identifiers umls id c2699522 and nci concept code c78029. smiles: fc1cc(c(c(c2cc(oc(=o)c)c(oc(=o)c)c(f)c2)c)cc)cc(oc(=o)c)c1oc(=o)c.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. buserelin. this classification denotes a gonadotropin-releasing hormone analog with the molecular formula c60h86n16o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pxw8u3yxdv, chemically known as luteinizing hormone-releasing hormone (pig), 6-(o-(1,1-dimethylethyl)-d-serine)-9-(n-ethyl-l-prolinamide)-10-deglycinamide- but generally known as buserelin, which bears us nih compound identifier 42615. buserelin most often comes in base and acetate forms. european medicines agency schedules buserelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05991mig. the term buserelin is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules buserelin in its anatomical therapeutic chemical (atc) classification. buserelin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule buserelin under hs 29371900 and sitc 54154. as of q4 2014, buserelin remains the us fda preferred term for this commodity. buserelin bears us nlm identifiers umls id c0006456 and nci concept code c320. smiles: o=c(n1c(ccc1)c(=o)ncc)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c1nc(=o)cc1)cc1[nh]cnc1)cc1c2c([nh]c1)cccc2)co)cc1ccc(o)cc1)coc(c)(c)c)cc(c)c)ccc/n=c(/n)n.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. clometerone or clometherone. this classification denotes an antiestrogen, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 01l3e93t4c. european medicines agency schedules clometerone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06719mig. clometerone generally arises in the molecular formula c22h31clo2. the term clometerone is an international non-proprietary name or inn. clometerone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. clometerone or clometherone bears us nlm identifiers umls id c2347808 and nci concept code c74147. smiles: clc1cc2c3c(c(c(c3)c)c(=o)c)(ccc2c2(c1=cc(=o)cc2)c)c.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. clomifene or clomiphene. this classification denotes an antiestrogen and angiogenesis activator inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1hrs458qu2. european medicines agency schedules clomifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06722mig. clomifene generally arises in the molecular formula c26h28clno. the term clomifene is a hazardous substances data bank designation. clomifene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. clomifene or clomiphene bears us nlm identifiers umls id c0009008 and nci concept code c61607. smiles: ccn(cc)ccoc1=cc=c(c=c1)/c(=c(\\c2=cc=cc=c2)/cl)/c3=cc=cc=c3.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. cyclofenil. this classification denotes an antiestrogen with the molecular formula c23h24o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j468v64wz1, chemically known as 4,4-(cyclohexylidenemethylene)diphenol diacetate ester but generally known as cyclofenil, which bears us nih compound identifier 2898. european medicines agency schedules cyclofenil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06852mig. the term cyclofenil is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules cyclofenil in its anatomical therapeutic chemical (atc) classification. cyclofenil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cyclofenil under hs 29153980 and sitc 51372. as of q4 2014, cyclofenil remains the us fda preferred term for this commodity. cyclofenil bears us nlm identifiers umls id c0010560 and nci concept code c78030. smiles: o(c1ccc(c(=c2\\ccccc2)/c2ccc(oc(=o)c)cc2)cc1)c(=o)c.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. enclomifene. this classification denotes an antiestrogen, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r6d2ui4fls. european medicines agency schedules enclomifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06521mig. enclomifene generally arises in the molecular formula c26h28clno. the term enclomifene is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15.) enclomifene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule enclomifene under hs 29221980 and sitc 51461. smiles: cl/c(=c(/c1ccc(occn(cc)cc)cc1)c1ccccc1)c1ccccc1.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. ganirelix. this classification denotes a gonadotropin releasing hormone inhibitor with the molecular formula c80h113cln18o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ix503l9wn0, chemically known as d-alaninamide, n-acetyl-3-(1-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-l-tyrosyl-n6-(bis(ethylamino)methylene)-d-lysyl-l-leucyl-n6-(bis(ethylamino)methylene)-l-lysyl-l-prolyl- but generally known as ganirelix, which bears us nih compound identifier 16130966. european medicines agency schedules ganirelix in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07883mig. the term ganirelix is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules ganirelix in its anatomical therapeutic chemical (atc) classification. ganirelix is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ganirelix under hs 29371900 and sitc 54154. as of q4 2014, ganirelix remains the us fda preferred term for this commodity. ganirelix bears us nlm identifiers umls id c0073629 and nci concept code c77423. smiles: clc1ccc(cc(nc(=o)c(nc(=o)c)cc2cc3c(cc2)cccc3)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n2c(ccc2)c(=o)nc(c)c(=o)n)cccc/n=c(/ncc)ncc)cc(c)c)cccc/n=c(/ncc)ncc)cc2ccc(o)cc2)co)cc2cccnc2)cc1.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. nitromifene. this classification denotes an antiestrogen with the molecular formula c27h28n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 5fs1nj6q8n chemically known as pyrrolidine, 1-(2-(4-(1-(4-methoxyphenyl)-2-nitro-2-phenylethenyl)phenoxy)ethyl)- but generally known as nitromifene, which bears us nih compound identifier 3032557. european medicines agency schedules nitromifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09327mig. the term nitromifene is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). most nations schedule nitromifene under hs 29339990 and sitc 51577. as of q4 2014, nitromifene remains the us fda preferred term for this commodity. nitromifene bears us nlm identifiers umls id c0028183 and nci concept code c90720. smiles: o(ccn1cccc1)c1ccc(/c(=c(\\[n](=o)o)c2ccccc2)c2ccc(oc)cc2)cc1.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. panomifene. this classification denotes an antiestrogen with the molecular formula c25h24f3no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gcw5e728oc, chemically known as ethanol, 2-((2-(4-(3,3,3-trifluoro-1,2-diphenyl-1-propenyl)phenoxy)ethyl)amino)-, (e)- but generally known as panomifene, which bears us nih compound identifier 3033654. european medicines agency schedules panomifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09606mig. the term panomifene is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). panomifene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule panomifene under hs 29221980 and sitc 51461. as of q4 2014, panomifene remains the us fda preferred term for this commodity. panomifene bears us nlm identifiers umls id c0244902 and nci concept code c66304. smiles: fc(f)(f)c(=c(\\c1ccc(occncco)cc1)c1ccccc1)\\c1ccccc1.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. zuclomifene or zuclomiphene. this classification denotes an antiestrogen with the molecular formula c26h28clno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3ju1du3652, chemically known as 2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)triethylamine but generally known as zuclomifene, which bears us nih compound identifier 1548955. european medicines agency schedules zuclomifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00194mig. the term zuclomifene is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). zuclomifene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. zuclomifene or zuclomiphene bears us nlm identifiers umls id c0087182 and nci concept code c66870. smiles: cl/c(=c(\\c1ccc(occn(cc)cc)cc1)c1ccccc1)c1ccccc1.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. buserelin acetate. this classification denotes the acetate form of a gonadotropin-releasing hormone analog with the molecular formula c60h86n16o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pxw8u3yxdv, chemically known as luteinizing hormone-releasing hormone (pig), 6-(o-(1,1-dimethylethyl)-d-serine)-9-(n-ethyl-l-prolinamide)-10-deglycinamide- but more generally known as buserelin, which bears us nih compound identifier 42615. buserelin most often comes in base and acetate forms. european medicines agency schedules buserelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05991mig. the term buserelin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules buserelin in its anatomical therapeutic chemical (atc) classification. buserelin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule buserelin acetate under hs 29371900 and sitc 54154. as of q4 2014, buserelin acetate remains us fdas preferred term for this commodity. buserelin acetate bears us nlm identifiers umls id c0600174 and nci concept code c84460. smiles: ccnc(=o)[c@@h]1cccn1c(=o)[c@h](cccnc(=n)n)nc(=o)[c@h](cc(c)c)nc(=o)[c@@h](coc(c)(c)c)nc(=o)[c@h](cc2ccc(cc2)o)nc(=o)[c@h](co)nc(=o)[c@h](cc3c[nh]c4c3cccc4)nc(=o)[c@h](cc5cnc[nh]5)nc(=o)[c@@h]6ccc(=o)n6.cc(=o)o.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. clomifene citrate. this classification denotes an antiestrogen and angiogenesis activator inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1b8447e7yi. european medicines agency schedules clomifene citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01360mig. clomiphene citrate generally arises in the molecular formula c32h36clno8. the term clomiphene citrate is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule clomifene citrate under hs 29221980. smiles:.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. cyclofenil diphenol. this classification denotes an antiestrogen with the molecular formula c19h20o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 00w4083oml, chemically known as .alpha.-cyclohexylidene-.alpha.-(p-hydroxyphenyl)-p-cresol, but more generally known as cyclofenil diphenol, which bears us nih compound identifier 21260. european medicines agency schedules cyclofenil diphenol or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06852mig. most nations, for tariff purposes, schedule cyclofenil diphenol under hs 29153980. smiles: c1cc(ccc1c(=c2ccccc2)c3ccc(cc3)o)o.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. ganirelix acetate. this classification denotes a gonadotropin releasing hormone inhibitor with the molecular formula c80h113cln18o13.2c2h4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 56u7906fqw. european medicines agency schedules ganirelix acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25637. the term ganirelix acetate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule ganirelix acetate under hs 29371900 and sitc 54154. ganirelix acetate bears us nlm identifiers umls id c0872894 and nci concept code c61774. smiles: as of q4 2014, ganirelix acetate remains us fdas preferred term for this commodity.. "
"gonadotropic hormones and ovarian stimulants and inhibitors. this classification denotes preparations that depress or increase reproductive activity, typically by altering or supplementing biochemical substances having a specific regulatory effect on the activity of a certain organ or organs, in this case, gonads and ovaries.. nitromifene citrate. this classification denotes an antiestrogen with the molecular formula c27h28n2o4.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tn5uq266ra, chemically known as 1-(2-(p-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)phenoxy)ethyl)pyrrolidine, monocitrate but more generally known as nitromifene citrate, which bears us nih compound identifier 3032492. most nations, for tariff and trade purposes, schedule nitromifene citrate under hs 29339990 and sitc 51577. as of q4 2014, nitromifene citrate remains us fdas preferred term for this commodity. nitromifene citrate bears us nlm identifiers umls id c0919387 and nci concept code c90721. smiles: coc1ccc(cc1)c(=c(c2ccccc2)[n+](=o)[o-])c3ccc(cc3)occn4cccc4.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. . "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. finasteride. this classification denotes a 5 alpha-reductase inhibitor and anti-androgen with the molecular formula c23h36n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 57gno57u7g, chemically known as 4-azaandrost-1-ene-17-carboxamide, n-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)- but generally known as finasteride, which bears us nih compound identifier 57363. european medicines agency schedules finasteride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07629mig. the term finasteride is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules finasteride in its anatomical therapeutic chemical (atc) classification. finasteride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule finasteride under hs 29372900 and sitc 54153. as of q4 2014, finasteride remains the us fda preferred term for this commodity. finasteride bears us nlm identifiers umls id c0060389 and nci concept code c1099. smiles: o=c(nc(c)(c)c)c1c2(c(c3c(c4(c(nc(=o)c=c4)cc3)c)cc2)cc1)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone. this classification denotes an androgen with the molecular formula c19h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3xmk78s47o, chemically known as 10.alpha.-androst-4-en-3-one, 17.beta.-hydroxy- but generally known as testosterone, which bears us nih compound identifier 5408. european medicines agency schedules testosterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10937mig. the term testosterone is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules testosterone in its anatomical therapeutic chemical (atc) classification. testosterone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule testosterone under hs 29372900 and sitc 54153. as of q4 2014, testosterone remains the us fda preferred term for this commodity. testosterone bears us nlm identifiers umls id cl026906 and nci concept code c2299. smiles: oc1c2(c(c3c(c4(c(=cc(=o)cc4)cc3)c)cc2)cc1)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. trenbolone. this classification denotes an anabolic steroid with the molecular formula c18h22o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, p53r4420tr chemically known as estra-4,9,11-trien-3-one, 17-hydroxy-, (17.beta.)- but generally known as trenbolone, which bears us nih compound identifier 25015. european medicines agency schedules trenbolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11232mig. the term trenbolone is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11. ). most nations schedule trenbolone under hs 29372900 and sitc 54153. as of q4 2014, trenbolone remains the us fda preferred term for this commodity. trenbolone bears us nlm identifiers umls id c0040829 and nci concept code c95072. smiles: oc1c2(c(c3c(=c4c(=cc(=o)cc4)cc3)c=c2)cc1)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. methandriol. this classification denotes an anabolic steroid with the molecular formula c20h32o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5730z864kg, chemically known as 17-methylandrost-5-ene-3-beta,17-beta-diol but generally known as methandriol, which bears us nih compound identifier 10632. european medicines agency schedules methandriol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08835mig. the term methandriol is an international non-proprietary name. methandriol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methandriol under hs 29372900 and sitc 54153. as of q4 2014, methandriol remains the us fda preferred term for this commodity. methandriol bears us nlm identifiers umls id c0025615 and nci concept code c83950. smiles: oc1(c2(c(c3c(c4(c(=cc3)cc(o)cc4)c)cc2)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. fluoxymesterone. this classification denotes a therapeutic androgen and anabolic steroid with the molecular formula c20h29fo3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9ju12s4yfy, chemically known as 11-beta,17-beta-dihydroxy-9-alpha-fluoro-17-alpha-methyl-4-androster-3-one but generally known as fluoxymesterone, which bears us nih compound identifier 6446. european medicines agency schedules fluoxymesterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07724mig. the term fluoxymesterone is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules fluoxymesterone in its anatomical therapeutic chemical (atc) classification. fluoxymesterone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fluoxymesterone under hs 29372900 and sitc 54153. as of q4 2014, fluoxymesterone remains the us fda preferred term for this commodity. fluoxymesterone bears us nlm identifiers umls id c0016366 and nci concept code c507. smiles: fc12c(c3c(c(o)(cc3)c)(cc2o)c)ccc2=cc(=o)ccc12c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. methyltestosterone. this classification denotes a therapeutic androgen with the molecular formula c20h30o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v9efu16zif, chemically known as testosterone, 17-methyl- but generally known as 17-methyltestosterone, which bears us nih compound identifier 6010. european medicines agency schedules methyltestosterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08876mig. the term methyltestosterone is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules 17-methyltestosterone in its anatomical therapeutic chemical (atc) classification. most nations schedule methyltestosterone under hs 29372900 and sitc 54153. as of q4 2014, methyltestosterone remains the us fda preferred term for this commodity. methyltestosterone bears us nlm identifiers umls id c0718532 and nci concept code c648. smiles: oc1(c2(c(c3c(c4(c(=cc(=o)cc4)cc3)c)cc2)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. nandrolone. this classification denotes a therapeutic androgen and anabolic steroid with the molecular formula c18h26o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6pg9vr430d, chemically known as estr-4-en-3-one, 17-hydroxy-, (17beta)- (9ci) but generally known as nandrolone, which bears us nih compound identifier 9904. european medicines agency schedules nandrolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09148mig. the term nandrolone is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules nandrolone in its anatomical therapeutic chemical (atc) classification. nandrolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nandrolone under hs 29372900 and sitc 54153. as of q4 2014, nandrolone remains the us fda preferred term for this commodity. nandrolone bears us nlm identifiers umls id c0027368 and nci concept code c29279. smiles: oc1c2(c(c3c(cc2)c2c(=cc(=o)cc2)cc3)cc1)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. androstenolone or dehydroepiandrosterone or dhea or prasterone. this classification denotes a therapeutic androgen, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 459ag36t1b. european medicines agency schedules dehydroepiandrosterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10002mig. prasterone generally arises in the molecular formula c19h28o2. the term prasterone is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18.) prasterone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o=c1c2(c(c3c(c4(c(=cc3)cc(o)cc4)c)cc2)cc1)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. stanozolol. this classification denotes a therapeutic androgen and anabolic steroid with the molecular formula c21h32n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4r1vb9p8v3, chemically known as 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethylcyclopenta(7,8)-phenanthro(2,3-c)pyrazol-1-ol but generally known as stanozolol, which bears us nih compound identifier 25249. european medicines agency schedules stanozolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10641mig. the term stanozolol is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules stanozolol in its anatomical therapeutic chemical (atc) classification. stanozolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule stanozolol under hs 29372900 and sitc 54153. as of q4 2014, stanozolol remains the us fda preferred term for this commodity. stanozolol bears us nlm identifiers umls id c0592142 and nci concept code c842. smiles: oc1(c2(c(c3c(c4(c(cc3)cc3[nh]ncc3c4)c)cc2)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. dutasteride. this classification denotes a 5 alpha-reductase inhibitor and anti-androgen with the molecular formula c27h30f6n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o0j6xjn02i, chemically known as alpha,alpha,alpha,alpha,alpha,alpha-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2,5-xylidide but generally known as dutasteride, which bears us nih compound identifier 152945. european medicines agency schedules dutasteride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06430mig. the term dutasteride is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). world health organization schedules dutasteride in its anatomical therapeutic chemical (atc) classification. most nations schedule dutasteride under hs 29372900 and sitc 54153. as of q4 2014, dutasteride remains the us fda preferred term for this commodity. dutasteride bears us nlm identifiers umls id c0754659 and nci concept code c47503. smiles: fc(f)(f)c1c(nc(=o)c2c3(c(c4c(c5(c(nc(=o)c=c5)cc4)c)cc3)cc2)c)cc(cc1)c(f)(f)f.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. cloxotestosterone. this classification denotes an anabolic steroid with the molecular formula c21h29cl3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8422dh508n, chemically known as 17 beta-(2,2,2-tirchloro-1-hydroxyethoxy)androst-4-en-3-one. but generally known as cloxotestosterone, which bears us nih compound identifier 194706. european medicines agency schedules cloxotestosterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06785mig. the term cloxotestosterone is an international non-proprietary name. cloxotestosterone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cloxotestosterone under hs 29372900 and sitc 54153. as of q4 2014, cloxotestosterone remains the us fda preferred term for this commodity. cloxotestosterone bears us nlm identifiers umls id c2699389 and nci concept code c79526. smiles: clc(cl)(cl)c(oc1c2(c(c3c(c4(c(=cc(=o)cc4)cc3)c)cc2)cc1)c)o.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. alfatradiol. this classification denotes an aromatase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3vq38d63m7. european medicines agency schedules alfatradiol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12672mig. alfatradiol generally arises in the molecular formula c18h24o2. the term alfatradiol is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46.) most nations schedule alfatradiol under hs 29072900 and sitc 51243. as of q4 2014, alfatradiol remains the us fda preferred term for this commodity. alfatradiol bears us nlm identifiers umls id c1957081 and nci concept code c81622. smiles: cc12ccc3c(c1ccc2o)ccc4=c3c=cc(=c4)o.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. androstanolone or dht or dihydrotestosterone. this classification denotes an anabolic steroid with the molecular formula c19h30o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 08j2k08a3y, chemically known as 4,5alpha-dihydrotestosterone but generally known as androstanolone, which bears us nih compound identifier 10635. european medicines agency schedules androstanolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05509mig. the term androstanolone is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules androstanolone in its anatomical therapeutic chemical (atc) classification. androstanolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: oc1c2(c(c3c(c4(c(cc3)cc(=o)cc4)c)cc2)cc1)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. androstenediol. this classification denotes an anabolic steroid with the molecular formula c19h30o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 95ps51emxy, chemically known as 3beta,17beta-dihydroxyandrost-5-ene but generally known as androstenediol, which bears us nih compound identifier 10634. european medicines agency schedules androstenediol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12899mig. as of q4 2014, androstenediol remains the us fda preferred term for this commodity. androstenediol bears us nlm identifiers umls id c0524764 and nci concept code c95979. smiles: oc1c2(c(c3c(c4(c(=cc3)cc(o)cc4)c)cc2)cc1)c. .. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. androstenedione. this classification denotes an anabolic steroid with the molecular formula c19h26o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 409j2j96vr, chemically known as 3,17-dioxoandrost-4-ene but generally known as androstenedione, which bears us nih compound identifier 6128. european medicines agency schedules androstenedione in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12900mig. as of q4 2014, androstenedione remains the us fda preferred term for this commodity. androstenedione bears us nlm identifiers umls id cl026907 and nci concept code c2300. smiles: o=c1c2(c(c3c(c4(c(=cc(=o)cc4)cc3)c)cc2)cc1)c. .. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. bolandiol. this classification denotes an anabolic steroid with the molecular formula c18h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 49sd6g16u5, chemically known as 3.beta.,17.beta.-dihydroxyestr-4-ene but generally known as bolandiol, which bears us nih compound identifier 70691434. european medicines agency schedules bolandiol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05866mig. most nations schedule bolandiol under hs 29061900 and sitc 51231. as of q4 2014, bolandiol remains the us fda preferred term for this commodity. smiles: ccc(=o)oc1ccc2c3ccc4(c(c3ccc2=c1)ccc4oc(=o)cc)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. bolasterone. this classification denotes an anabolic steroid with the molecular formula c21h32o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t7zm08f7fu, chemically known as 17beta-hydroxy-7alpha,17-dimethylandrost-4-en-3-one but generally known as bolasterone, which bears us nih compound identifier 102146. european medicines agency schedules bolasterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05867mig. the term bolasterone is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). bolasterone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bolasterone under hs 29372900 and sitc 54153. as of q4 2014, bolasterone remains the us fda preferred term for this commodity. bolasterone bears us nlm identifiers umls id c0368780 and nci concept code c74111. smiles: oc1(c2(c(c3c(c4(c(=cc(=o)cc4)cc3c)c)cc2)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. clostebol. this classification denotes an anabolic steroid with the molecular formula c19h27clo2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z7d4g976sh, chemically known as testosterone, 4-chloro-, acetate but generally known as clostebol, which bears us nih compound identifier 13327. european medicines agency schedules clostebol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06771mig. the term clostebol is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). clostebol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clostebol under hs 29372900 and sitc 54153. as of q4 2014, clostebol remains the us fda preferred term for this commodity. clostebol bears us nlm identifiers umls id c0172467 and nci concept code c77306. smiles: clc1=c2c(c3c(c4c(cc3)(c(oc(=o)c)cc4)c)cc2)(ccc1=o)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. mebolazine. this classification denotes an anabolic steroid with the molecular formula c42h68n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 69c642i19v, chemically known as 17beta-hydroxy-2alpha,17-dimethyl-5alpha-androstan-3-one azine but generally known as mebolazine, which bears us nih compound identifier 9571069. european medicines agency schedules mebolazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08666mig. the term mebolazine is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). mebolazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mebolazine under hs 29372900 and sitc 54153. as of q4 2014, mebolazine remains the us fda preferred term for this commodity. mebolazine bears us nlm identifiers umls id c0604275 and nci concept code c90641. smiles: oc1(c2(c(c3c(c4(c(cc3)c/c(=n/n=c3/cc5c(c6c(c7c(c(o)(cc7)c)(cc6)c)cc5)(cc3c)c)c(c4)c)c)cc2)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. danazol. this classification denotes a therapeutic androgen, gonadotropin releasing hormone inhibitor, and anabolic steroid with the molecular formula c22h27no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n29qww3buo, chemically known as win 17,757 but generally known as danazol, which bears us nih compound identifier 2949. european medicines agency schedules danazol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06897mig. the term danazol is an international non-proprietary name. world health organization schedules danazol in its anatomical therapeutic chemical (atc) classification. danazol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule danazol under hs 29372900 and sitc 54153. as of q4 2014, danazol remains the us fda preferred term for this commodity. danazol bears us nlm identifiers umls id c0010961 and nci concept code c414. smiles: oc1(c2(c(c3c(c4(c(=cc5oncc5c4)cc3)c)cc2)cc1)c)c#c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. enestebol. this classification denotes an anabolic steroid with the molecular formula c20h28o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lns3mvh7nv, chemically known as 4,17beta-dihydroxy-17-methyl-androsta-1,4-dien-3-one, but generally known as enestebol, which bears us nih compound identifier 208919. european medicines agency schedules enestebol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06528mig. the term enestebol is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). enestebol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule enestebol under hs 29372900 and sitc 54153. as of q4 2014, enestebol remains the us fda preferred term for this commodity. enestebol bears us nlm identifiers umls id c2825600 and nci concept code c81377. smiles: oc1(c2(c(c3c(cc2)c2(c(=c(o)c(=o)c=c2)cc3)c)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. ethylestrenol. this classification denotes an anabolic steroid with the molecular formula c20h32o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier adc79ek5q8, chemically known as 19-norpregn-4-en-17-ol, (17.alpha.)- but generally known as ethylestrenol, which bears us nih compound identifier 3302. european medicines agency schedules ethylestrenol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07291mig. the term ethylestrenol is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules ethylestrenol in its anatomical therapeutic chemical (atc) classification. ethylestrenol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ethylestrenol under hs 29372300 and sitc 54153. as of q4 2014, ethylestrenol remains the us fda preferred term for this commodity. ethylestrenol bears us nlm identifiers umls id c0015099 and nci concept code c65568. smiles: oc1(c2(c(c3c(cc2)c2c(=cccc2)cc3)cc1)c)cc.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. flutamide. this classification denotes an aromatic compound and anti-androgen with the molecular formula c11h11f3n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 76w6j0943e, chemically known as propanamide, 2-methyl-n-(4-nitro-3-(trifluoromethyl)phenyl)- but generally known as flutamide, which bears us nih compound identifier 3397. european medicines agency schedules flutamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07756mig. the term flutamide is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules flutamide in its anatomical therapeutic chemical (atc) classification. flutamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flutamide under hs 29242995 and sitc 51479. as of q4 2014, flutamide remains the us fda preferred term for this commodity. flutamide bears us nlm identifiers umls id c0016384 and nci concept code c509. smiles: cc(c)c(=o)nc1=cc(=c(c=c1)[n+](=o)[o-])c(f)(f)f.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. formebolone. this classification denotes an anabolic steroid with the molecular formula c21h28o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z2mmv08kuq, chemically known as 11alpha,17beta-dihydroxy-17-methyl-3-oxoandrosta-1,4-diene-2-carboxaldehyde but generally known as formebolone, which bears us nih compound identifier 17150. european medicines agency schedules formebolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07783mig. the term formebolone is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). formebolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule formebolone under hs 29372900 and sitc 54153. as of q4 2014, formebolone remains the us fda preferred term for this commodity. formebolone bears us nlm identifiers umls id c0060670 and nci concept code c65751. smiles: oc1(c2(c(c3c(c(o)c2)c2(c(=cc(=o)c(=c2)c=o)cc3)c)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. furazabol. this classification denotes an anabolic steroid with the molecular formula c20h30n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2w07hsp5px, chemically known as 17-methyl-5alpha-androstano(2,3-c)furazan-17beta-ol but generally known as furazabol, which bears us nih compound identifier 14708. european medicines agency schedules furazabol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07833mig. the term furazabol is an international non-proprietary name. furazabol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule furazabol under hs 29349990 and sitc 51579. as of q4 2014, furazabol remains the us fda preferred term for this commodity. furazabol bears us nlm identifiers umls id c0060855 and nci concept code c65782. smiles: oc1(c2(c(c3c(c4(c(cc3)cc3nonc3c4)c)cc2)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. norboletone or norbolethone. this classification denotes an anabolic steroid with the molecular formula c21h32o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u3bzu2241a, chemically known as 18,19-dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17-alpha)- (9ci) but generally known as norbolethone, which bears us nih compound identifier 13108. european medicines agency schedules norboletone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09354mig. the term norbolethone is an international non-proprietary name. norboletone or norbolethone bears us nlm identifiers umls id c1142715 and nci concept code c90642. smiles: ccc12ccc3c(c1ccc2(cc)o)ccc4=cc(=o)ccc34.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. mesterolone. this classification denotes a therapeutic androgen with the molecular formula c20h32o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0srq75x9i9, chemically known as 5alpha-androstan-3-one, 17beta-hydroxy-1alpha-methyl- but generally known as mesterolone, which bears us nih compound identifier 15020. european medicines agency schedules mesterolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08790mig. the term mesterolone is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules mesterolone in its anatomical therapeutic chemical (atc) classification. mesterolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mesterolone under hs 29372900 and sitc 54153. as of q4 2014, mesterolone remains the us fda preferred term for this commodity. mesterolone bears us nlm identifiers umls id c0025503 and nci concept code c87227. smiles: oc1c2(c(c3c(c4(c(cc3)cc(=o)cc4c)c)cc2)cc1)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. metandienone or methandrostenolone or methandienone. this classification denotes an anabolic steroid with the molecular formula c20h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier coz1r7eocc, chemically known as 17-beta-hydroxy-17-methyl-androsta-1,4-dien-3-one (9ci) but generally known as metandienone, which bears us nih compound identifier 6300. european medicines agency schedules metandienone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08812mig. the term metandienone is an international non-proprietary name. world health organization schedules metandienone in its anatomical therapeutic chemical (atc) classification. metandienone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: oc1(c2(c(c3c(cc2)c2(c(=cc(=o)c=c2)cc3)c)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. metenolone. this classification denotes an anabolic agent with the molecular formula c20h30o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9062zt8q5c, chemically known as androst-1-en-3-one, 17-hydroxy-1-methyl-, (5alpha,17beta)- but generally known as metenolone, which bears us nih compound identifier 9054. european medicines agency schedules metenolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08823mig. world health organization schedules metenolone in its anatomical therapeutic chemical (atc) classification. metenolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule metenolone under hs 29372900 and sitc 54153. smiles: oc1c2(c(c3c(c4(c(cc3)cc(=o)c=c4c)c)cc2)cc1)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. mibolerone. this classification denotes a therapeutic androgen with the molecular formula c20h30o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9ogy4bor8d, chemically known as 19-nortestosterone, 7alpha,17-dimethyl- but generally known as mibolerone, which bears us nih compound identifier 19454. european medicines agency schedules mibolerone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08941mig. the term mibolerone is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). mibolerone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mibolerone under hs 29372900 and sitc 54153. as of q4 2014, mibolerone remains the us fda preferred term for this commodity. mibolerone bears us nlm identifiers umls id c0066502 and nci concept code c72100. smiles: oc1(c2(c(c3c(cc2)c2c(=cc(=o)cc2)cc3c)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. nilutamide. this classification denotes an anti-androgen with the molecular formula c12h10f3n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 51g6i8b902, chemically known as 5,5-dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin but generally known as nilutamide, which bears us nih compound identifier 4493. european medicines agency schedules nilutamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09291mig. the term nilutamide is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules nilutamide in its anatomical therapeutic chemical (atc) classification. nilutamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nilutamide under hs 29332100 and sitc 51572. as of q4 2014, nilutamide remains the us fda preferred term for this commodity. nilutamide bears us nlm identifiers umls id c0722107 and nci concept code c1173. smiles: cc1(c(=o)n(c(=o)n1)c2=cc(=c(c=c2)[n+](=o)[o-])c(f)(f)f)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. oxymetholone. this classification denotes a therapeutic androgen and anabolic steroid with the molecular formula c21h32o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l76t0zca8k, chemically known as androstan-3-one, 17-hydroxy-2-(hydroxymethylene)-17methyl-, (5.alpha.,17.beta.) but generally known as oxymetholone, which bears us nih compound identifier 9902. european medicines agency schedules oxymetholone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09568mig. the term oxymetholone is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules oxymetholone in its anatomical therapeutic chemical (atc) classification. oxymetholone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxymetholone under hs 29372900 and sitc 54153. as of q4 2014, oxymetholone remains the us fda preferred term for this commodity. oxymetholone bears us nlm identifiers umls id c0030072 and nci concept code c723. smiles: oc1(c2(c(c3c(c4(c(cc3)cc(=o)c(=c\\o)/c4)c)cc2)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. norclostebol. this classification denotes an anabolic steroid, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vi1001o2di. european medicines agency schedules norclostebol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09356mig. norclostebol generally arises in the molecular formula c18h25clo2. the term norclostebol is an international non-proprietary name or inn. norclostebol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule norclostebol under hs 29372900 and sitc 54153. as of q4 2014, norclostebol remains the us fda preferred term for this commodity. norclostebol bears us nlm identifiers umls id c2698495 and nci concept code c77307. smiles: clc1=c2c(c3c(c4c(cc3)(c(o)cc4)c)cc2)ccc1=o.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. norethandrolone. this classification denotes a therapeutic androgen with the molecular formula c20h30o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p7w01638w6, chemically known as 19-nortestosterone, 17-ethyl- but generally known as norethandrolone, which bears us nih compound identifier 5858. european medicines agency schedules norethandrolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09361mig. the term norethandrolone is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules norethandrolone in its anatomical therapeutic chemical (atc) classification. norethandrolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule norethandrolone under hs 29372900 and sitc 54153. as of q4 2014, norethandrolone remains the us fda preferred term for this commodity. norethandrolone bears us nlm identifiers umls id c0028355 and nci concept code c80802. smiles: oc1(c2(c(c3c(cc2)c2c(=cc(=o)cc2)cc3)cc1)c)cc.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. normethandrone. this classification denotes a therapeutic progestin with the molecular formula c19h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 743f1z557a, chemically known as 19-nortestosterone, 17-methyl- but generally known as normethandrone, which bears us nih compound identifier 10576. european medicines agency schedules normethandrone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14667mig. as of q4 2014, normethandrone remains the us fda preferred term for this commodity. normethandrone bears us nlm identifiers umls id c0650248 and nci concept code c95970. smiles: oc1(c2(c(c3c(cc2)c2c(=cc(=o)cc2)cc3)cc1)c)c. .. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. oxabolone. this classification denotes an anabolic steroid with the molecular formula c26h38o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 51rpf719we, chemically known as 4-hydroxy-19-nortestosterone but generally known as oxabolone, which bears us nih compound identifier 68952. european medicines agency schedules oxabolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09481mig. the term oxabolone is an international non-proprietary name. world health organization schedules oxabolone in its anatomical therapeutic chemical (atc) classification. as of q4 2014, oxabolone remains the us fda preferred term for this commodity. smiles: cc12ccc3c(c1ccc2o)ccc4=c(c(=o)ccc34)o.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. oxandrolone. this classification denotes a therapeutic androgen and anabolic steroid with the molecular formula c19h30o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7h6tm3ct4l, chemically known as 2-oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5-alpha,17-beta)- (9ci) but generally known as oxandrolone, which bears us nih compound identifier 5878. european medicines agency schedules oxandrolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09496mig. the term oxandrolone is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules oxandrolone in its anatomical therapeutic chemical (atc) classification. oxandrolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxandrolone under hs 29372900 and sitc 54153. as of q4 2014, oxandrolone remains the us fda preferred term for this commodity. oxandrolone bears us nlm identifiers umls id c0029995 and nci concept code c29306. smiles: oc1(c2(c(c3c(c4(c(cc3)cc(=o)oc4)c)cc2)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. oxymesterone. this classification denotes an anabolic steroid with the molecular formula c20h30o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4r73k9mrmx, chemically known as 4,17beta-dihydroxy-17-methylandrost-4-en-3-one but generally known as oxymesterone, which bears us nih compound identifier 72061. european medicines agency schedules oxymesterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09566mig. the term oxymesterone is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). oxymesterone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxymesterone under hs 29372900 and sitc 54153. as of q4 2014, oxymesterone remains the us fda preferred term for this commodity. oxymesterone bears us nlm identifiers umls id c0369772 and nci concept code c74112. smiles: oc1(c2(c(c3c(c4(c(=c(o)c(=o)cc4)cc3)c)cc2)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. propetandrol. this classification denotes an anabolic steroid, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k0h1j6311w. european medicines agency schedules propetandrol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10105mig. propetandrol generally arises in the molecular formula c23h36o3. the term propetandrol is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5.) propetandrol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule propetandrol under hs 29372900 and sitc 54153. as of q4 2014, propetandrol remains the us fda preferred term for this commodity. propetandrol bears us nlm identifiers umls id c2826061 and nci concept code c82225. smiles: oc1(c2(c(c3c(cc2)c2c(=cc(oc(=o)cc)cc2)cc3)cc1)c)cc.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. quinbolone. this classification denotes an anabolic steroid with the molecular formula c24h32o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w59598kwlx, chemically known as 17beta-(1-cyclopentenyloxy)-1,4-androstadien-3-on but generally known as quinbolone, which bears us nih compound identifier 17214. european medicines agency schedules quinbolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10204mig. the term quinbolone is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules quinbolone in its anatomical therapeutic chemical (atc) classification. quinbolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule quinbolone under hs 29372900 and sitc 54153. as of q4 2014, quinbolone remains the us fda preferred term for this commodity. quinbolone bears us nlm identifiers umls id c0072862 and nci concept code c82226. smiles: o(c1c2(c(c3c(cc2)c2(c(=cc(=o)c=c2)cc3)c)cc1)c)c1=cccc1.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. rosterolone. this classification denotes a therapeutic androgen, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3l5c5c8zng. european medicines agency schedules rosterolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10390mig. rosterolone generally arises in the molecular formula c23h38o2. the term rosterolone is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29.) rosterolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rosterolone under hs 29372900 and sitc 54153. as of q4 2014, rosterolone remains the us fda preferred term for this commodity. rosterolone bears us nlm identifiers umls id c2347981 and nci concept code c72099. smiles: oc1(c2(c(c3c(c4(c(cc3)cc(=o)cc4c)c)cc2)cc1)c)ccc.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. roxibolone. this classification denotes an anabolic steroid with the molecular formula c21h28o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3r7nlp419c, chemically known as 11beta,17beta-dihydroxy-17-methyl-3-oxoandrosta-1,4-diene-2-carboxylic acid but generally known as roxibolone, which bears us nih compound identifier 68795. european medicines agency schedules roxibolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10397mig. the term roxibolone is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). roxibolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule roxibolone under hs 29372900 and sitc 54153. as of q4 2014, roxibolone remains the us fda preferred term for this commodity. roxibolone bears us nlm identifiers umls id c0073602 and nci concept code c74110. smiles: oc1(c2(c(c3c(c(o)c2)c2(c(=cc(=o)c(=c2)c(=o)o)cc3)c)cc1)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. tibolone. this classification denotes an anabolic steroid with the molecular formula c21h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ff9x0205v2, chemically known as 19-norpregn-5(10)-en-20-yn-3-one, 17-hydroxy-7-methyl-, (7alpha,17alpha)- but generally known as tibolone, which bears us nih compound identifier 21844. european medicines agency schedules tibolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11022mig. the term tibolone is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules tibolone in its anatomical therapeutic chemical (atc) classification. tibolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tibolone under hs 29372300 and sitc 54153. as of q4 2014, tibolone remains the us fda preferred term for this commodity. tibolone bears us nlm identifiers umls id c0076660 and nci concept code c66955. smiles: oc1(c2(c(c3c(cc2)c2=c(cc3c)cc(=o)cc2)cc1)c)c#c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. bolandiol dipropionate. this classification denotes an anabolic steroid with the molecular formula c24h36o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 595cne7rhb, chemically known as 4-estrene-3-beta,17-beta-diol 3,17-dipropionate but more generally known as bolandiol dipropionate, which bears us nih compound identifier 16141. most nations, for tariff and trade purposes, schedule bolandiol dipropionate under hs 29061900 and sitc 51231. as of q4 2014, bolandiol dipropionate remains us fdas preferred term for this commodity. bolandiol dipropionate bears us nlm identifiers umls id c3266850 and nci concept code c87452. smiles: ccc(=o)o[c@h]1cc[c@@h]2[c@h]3cc[c@]4([c@h]([c@@h]3ccc2=c1)cc[c@@h]4oc(=o)cc)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. clostebol propionate. this classification denotes an anabolic steroid c22h31clo3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7jj3052nou, chemically known as androst-4-en-3-one, 4-chloro-17-(1-oxopropoxy)-, (17.beta.)-, but more generally known as clostebol propionate, which bears us nih compound identifier 71586790. most nations, for tariff and trade purposes, schedule clostebol propionate under hs 29372900 and sitc 54153. as of q4 2014, clostebol propionate remains us fdas preferred term for this commodity. smiles: ccc(=o)o[c@h]1cc[c@@h]2[c@@]1(cc[c@h]3[c@h]2ccc4=c(c(=o)cc[c@]34c)cl)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. metenolone acetate. this classification denotes an anabolic agent with the molecular formula c22h32o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w75590vpkq, chemically known as androst-1-en-3-one, 17-(acetyloxy)-1-methyl-, (5.alpha.,17.beta.)-, but more generally known as metenolone acetate, which bears us nih compound identifier 4088. european medicines agency schedules metenolone acetate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08823mig. most nations, for tariff purposes, schedule metenolone acetate under hs 29372900. smiles: cc1=cc(=o)c[c@h]2[c@]1([c@h]3cc[c@]4([c@h]([c@@h]3cc2)cc[c@@h]4oc(=o)c)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. metenolone enantate. this classification denotes an anabolic agent with the molecular formula c27h42o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0spd480wfh, chemically known as androst-1-en-3-one, 1-methyl-17-((1-oxoheptyl)oxy)-, (5.alpha.,17.beta.)-, but more generally known as metenolone enantate, which bears us nih compound identifier 4089. european medicines agency schedules metenolone enantate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08823mig. most nations, for tariff purposes, schedule metenolone enantate under hs 29372900. smiles: ccccccc(=o)o[c@h]1cc[c@@h]2[c@@]1(cc[c@h]3[c@h]2cc[c@@h]4[c@@]3(c(=cc(=o)c4)c)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. methandriol diacetate. this classification denotes an anabolic steroid with the molecular formula c24h36o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z142sx9228, chemically known as androst-5-ene-3,17-diol, 17-methyl-, 3,17-diacetate, (3.beta.,17.beta.)-, but more generally known as methandriol diacetate, which bears us nih compound identifier 102203. european medicines agency schedules methandriol diacetate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08835mig. most nations, for tariff purposes, schedule methandriol diacetate under hs 29372900. smiles: cc(=o)o[c@h]1cc[c@@]2([c@h]3cc[c@]4([c@h]([c@@h]3cc=c2c1)cc[c@]4(c)oc(=o)c)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. methandriol dipropionate. this classification denotes an anabolic steroid with the molecular formula c26h40o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8xiw70q5i3. most nations, for tariff and trade purposes, schedule methandriol dipropionate under hs 29372900 and sitc 54153. as of q4 2014, methandriol dipropionate remains us fdas preferred term for this commodity. methandriol dipropionate bears us nlm identifiers umls id c0770345 and nci concept code c95962. smiles: ccc(=o)o[c@h]1cc[c@@]2([c@h]3cc[c@]4([c@h]([c@@h]3cc=c2c1)cc[c@]4(c)oc(=o)cc)c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. nandrolone benzoate. this classification denotes a therapeutic androgen and anabolic steroid with the molecular formula c25h30o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1665a8i95w, chemically known as estr-4-en-3-one, 17-(benzoyloxy)-, (17.beta.)-, but more generally known as nandrolone benzoate, which bears us nih compound identifier 227796. european medicines agency schedules nandrolone benzoate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09148mig. most nations, for tariff purposes, schedule nandrolone benzoate under hs 29372900. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)c4ccccc4)ccc5=cc(=o)cc[c@h]35.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. nandrolone cyclohexanecarboxylate. this classification denotes a therapeutic androgen and anabolic steroid with the molecular formula c25h36o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 45fah33fmm, chemically known as estr-4-en-3-one, 17-((cyclohexylcarbonyl)oxy)-, (17.beta.)-, but more generally known as nandrolone cyclohexanecarboxylate, which bears us nih compound identifier 86744. european medicines agency schedules nandrolone cyclohexanecarboxylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09148mig. most nations, for tariff purposes, schedule nandrolone cyclohexanecarboxylate under hs 29372900. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)c4ccccc4)ccc5=cc(=o)cc[c@h]35.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. nandrolone cyclohexylpropionate. this classification denotes a therapeutic androgen and anabolic steroid c27h40o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k4ne48gg1y, chemically known as estr-4-en-3-one, 17-(3-cyclohexyl-1-oxopropoxy)-, (17.beta.)-, but more generally known as nandrolone cyclohexylpropionate, which bears us nih compound identifier 101905. european medicines agency schedules nandrolone cyclohexylpropionate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub23549. most nations, for tariff and trade purposes, schedule nandrolone cyclohexylpropionate under hs 29372900 and sitc 54153. as of q4 2014, nandrolone cyclohexylpropionate remains us fdas preferred term for this commodity. nandrolone cyclohexylpropionate bears us nlm identifiers umls id c0626162 and nci concept code c95976. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)ccc4ccccc4)ccc5=cc(=o)cc[c@h]35.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. nandrolone cyclotate. this classification denotes a therapeutic androgen and anabolic steroid c28h38o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1mg9gw4zh8, chemically known as estr-4-en-3-one, 17-(((4-methylbicyclo(2.2.2)oct-2-en-1-yl)carbonyl)oxy)-, (17.beta.)-, but more generally known as nandrolone cyclotate, which bears us nih compound identifier 164526. most nations, for tariff and trade purposes, schedule nandrolone cyclotate under hs 29372900 and sitc 54153. as of q4 2014, nandrolone cyclotate remains us fdas preferred term for this commodity. nandrolone cyclotate bears us nlm identifiers umls id c2828223 and nci concept code c87228. smiles: c[c@@]12c=c[c@@](cc1)(cc2)c(=o)o[c@@h]3[c@@]4([c@h]([c@h]5[c@@h]([c@@h]6c(=cc(=o)cc6)cc5)cc4)cc3)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. nandrolone decanoate. this classification denotes a therapeutic androgen with the molecular formula c28h44o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h45187t098, chemically known as estr-4-en-3-one, 17-beta-hydroxy-, decanoate but more generally known as nandrolone decanoate, which bears us nih compound identifier 9677. european medicines agency schedules nandrolone decanoate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03384mig. most nations, for tariff and trade purposes, schedule nandrolone decanoate under hs 29372900 and sitc 54153. as of q4 2014, nandrolone decanoate remains us fdas preferred term for this commodity. nandrolone decanoate bears us nlm identifiers umls id c0068395 and nci concept code c1172. smiles: cccccccccc(=o)o[c@h]1cc[c@@h]2[c@@]1(cc[c@h]3[c@h]2ccc4=cc(=o)cc[c@h]34)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. nandrolone furylpropionate. this classification denotes a therapeutic androgen and anabolic steroid with the molecular formula c25h32o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w1309sny8u, chemically known as estr-4-en-3-one, 17-(3-(2-furanyl)-1-oxopropoxy)-, (17.beta.)-, but more generally known as nandrolone furylpropionate, which bears us nih compound identifier 111318. european medicines agency schedules nandrolone furylpropionate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09148mig. most nations, for tariff purposes, schedule nandrolone furylpropionate under hs 29372900. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)ccc4ccco4)ccc5=cc(=o)cc[c@h]35.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. nandrolone phenpropionate. this classification denotes a therapeutic androgen with the molecular formula c27h34o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kf7z9k2t3w, chemically known as 19-nortestosterone, hydrocinnamate but more generally known as nandrolone phenpropionate, which bears us nih compound identifier 4435. european medicines agency schedules nandrolone phenpropionate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03385mig. most nations, for tariff and trade purposes, schedule nandrolone phenpropionate under hs 29372900 and sitc 54153. as of q4 2014, nandrolone phenpropionate remains us fdas preferred term for this commodity. nandrolone phenpropionate bears us nlm identifiers umls id c0068397 and nci concept code c66218. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)ccc4ccccc4)ccc5=cc(=o)cc[c@h]35.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. nandrolone propionate. this classification denotes a therapeutic androgen and anabolic steroid with the molecular formula c21h30o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m86g89rh16, chemically known as estr-4-en-3-one, 17-(1-oxopropoxy)-, (17.beta.)-, but more generally known as nandrolone propionate, which bears us nih compound identifier 111273. european medicines agency schedules nandrolone propionate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09148mig. most nations, for tariff purposes, schedule nandrolone propionate under hs 29372900. nandrolone propionate bears us nlm identifiers umls id c3272467 and nci concept code c95972. smiles: ccc(=o)o[c@h]1cc[c@@h]2[c@@]1(cc[c@h]3[c@h]2ccc4=cc(=o)cc[c@h]34)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. nandrolone undecylate. this classification denotes a therapeutic androgen and anabolic steroid c29h46o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k64mcf1i9z, chemically known as estr-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17.beta.)-, but more generally known as nandrolone undecylate, which bears us nih compound identifier 94193. european medicines agency schedules nandrolone undecylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03388mig. most nations, for tariff and trade purposes, schedule nandrolone undecylate under hs 29372900 and sitc 54153. as of q4 2014, nandrolone undecylate remains us fdas preferred term for this commodity. nandrolone undecylate bears us nlm identifiers umls id c0068398 and nci concept code c95974. smiles: ccccccccccc(=o)o[c@h]1cc[c@@h]2[c@@]1(cc[c@h]3[c@h]2ccc4=cc(=o)cc[c@h]34)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. oxabolone cipionate. this classification denotes an anabolic steroid with the molecular formula c26h38o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5rxy50q01n, chemically known as 4,17beta-dihydroxyestr-4-en-3-one 17-cyclopentanepropionate but more generally known as oxabolone cipionate, which bears us nih compound identifier 68952. european medicines agency schedules oxabolone cipionate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09481mig. the term oxabolone cipionate is an international non-proprietary name. world health organization schedules oxabolone cipionate in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule oxabolone cipionate under hs 29372900 and sitc 54153. as of q4 2014, oxabolone cipionate remains us fdas preferred term for this commodity. oxabolone cipionate bears us nlm identifiers umls id c2825599 and nci concept code c81376. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)ccc4cccc4)ccc5=c(c(=o)cc[c@h]35)o.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. prasterone sodium sulfate. this classification denotes a therapeutic androgen with the molecular structure c19h27o5s.na.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, e1cr8487en chemically known as androst-5-en-17-one, 3.beta.-hydroxy-, hydrogen sulfate, sodium salt, dihydrate, but more commonly known as prasterone sodium sulfate, which bears us nih compound identifier 14193. european medicines agency schedules prasterone sodium sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04010mig. most nations, for tariff and trade purposes, schedule prasterone sodium sulfate under hs 29372900. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1ccc2=o)cc=c4[c@@]3(cc[c@@h](c4)os(=o)(=o)[o-])c.[na+].. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. prasterone sulfate. this classification denotes a therapeutic androgen c19h28o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 57b09q7fjr, chemically known as androst-5-en-17-one, 3-(sulfooxy)-, (3.beta.)-, but more generally known as prasterone sulfate, which bears us nih compound identifier 12594. european medicines agency schedules prasterone sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub34548. most nations, for tariff and trade purposes, schedule prasterone sulfate under hs 29372900 and sitc 54153. as of q4 2014, prasterone sulfate remains us fdas preferred term for this commodity. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1ccc2=o)cc=c4[c@@]3(cc[c@@h](c4)os(=o)(=o)o)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone benzoate. this classification denotes an androgen with the molecular formula c26h32o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 387187kt3e, chemically known as androst-4-en-3-one, 17-(benzoyloxy)-, (17.beta.)-, but more generally known as testosterone benzoate, which bears us nih compound identifier 101474. european medicines agency schedules testosterone benzoate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10937mig. most nations, for tariff purposes, schedule testosterone benzoate under hs 29372900. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)c4ccccc4)ccc5=cc(=o)cc[c@]35c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone cipionate. this classification denotes a therapeutic testosterone, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m0xw1ubi14. european medicines agency schedules testosterone cipionate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04734mig. testosterone cipionate generally arises in the molecular formula c27h40o3. the term testosterone cipionate is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule testosterone cipionate under hs 29372900 and sitc 54153. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)ccc4cccc4)ccc5=cc(=o)cc[c@]35c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone cyclopentanepropionate. this classification denotes an androgen with the molecular formula c27h40o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m0xw1ubi14, chemically known as androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17.beta.)-, but more generally known as testosterone cyclopentanepropionate, which bears us nih compound identifier 6012. european medicines agency schedules testosterone cyclopentanepropionate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10937mig. most nations, for tariff purposes, schedule testosterone cyclopentanepropionate under hs 29372900. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)ccc4cccc4)ccc5=cc(=o)cc[c@]35c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone cypionate. this classification denotes a therapeutic testosterone, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m0xw1ubi14. european medicines agency schedules testosterone cipionate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04734mig. testosterone cypionate generally arises in the molecular formula c27h40o3. the term testosterone cypionate is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule testosterone cypionate under hs 29372900. as of q4 2014, testosterone cypionate remains us fdas preferred term for this commodity. testosterone cypionate bears us nlm identifiers umls id c0076181 and nci concept code c1246. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)ccc4cccc4)ccc5=cc(=o)cc[c@]35c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone enantate. this classification denotes a therapeutic testosterone with the molecular formula c26h40o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7z6522t8n9, chemically known as 17-hydroxyandrost-4-en-3-one, 17-heptanoate but more generally known as testosterone enantate, which bears us nih compound identifier 9416. european medicines agency schedules testosterone enantate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04736mig. most nations, for tariff and trade purposes, schedule testosterone enantate under hs 29372900. smiles: ccccccc(=o)o[c@h]1cc[c@@h]2[c@@]1(cc[c@h]3[c@h]2ccc4=cc(=o)cc[c@]34c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone enanthate. this classification denotes a therapeutic testosterone with the molecular formula c26h40o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7z6522t8n9, chemically known as 17-hydroxyandrost-4-en-3-one, 17-heptanoate but more generally known as testosterone enantate, which bears us nih compound identifier 9416. european medicines agency schedules testosterone enantate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04736mig. most nations, for tariff and trade purposes, schedule testosterone enanthate under hs 29372900 and sitc 54153. as of q4 2014, testosterone enanthate remains us fdas preferred term for this commodity. testosterone enanthate bears us nlm identifiers umls id c0076189 and nci concept code c1247. smiles: ccccccc(=o)o[c@h]1cc[c@@h]2[c@@]1(cc[c@h]3[c@h]2ccc4=cc(=o)cc[c@]34c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone heptanoate. this classification denotes an androgen with the molecular formula c26h40o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7z6522t8n9, chemically known as androst-4-en-3-one, 17-(1-oxoheptyl)oxy-, (17.beta.)-, but more generally known as testosterone heptanoate, which bears us nih compound identifier 9416. european medicines agency schedules testosterone heptanoate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10937mig. most nations, for tariff purposes, schedule testosterone heptanoate under hs 29372900. smiles: ccccccc(=o)o[c@h]1cc[c@@h]2[c@@]1(cc[c@h]3[c@h]2ccc4=cc(=o)cc[c@]34c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone hexahydrobenzoate. this classification denotes an androgen with the molecular formula c26h38o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t4qox8847z, chemically known as androst-4-en-3-one, 17-((cyclohexylcarbonyl)oxy)-, (17.beta.)-, but more generally known as testosterone hexahydrobenzoate, which bears us nih compound identifier 85694. european medicines agency schedules testosterone hexahydrobenzoate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10937mig. most nations, for tariff purposes, schedule testosterone hexahydrobenzoate under hs 29372900. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)c4ccccc4)ccc5=cc(=o)cc[c@]35c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone phenylacetate. this classification denotes a therapeutic testosterone with the molecular formula c27h34o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wad1qak81d, chemically known as androst-4-en-3-one, 17-((phenylacetyl)oxy)- but more generally known as testosterone phenylacetate, which bears us nih compound identifier 21925. most nations, for tariff and trade purposes, schedule testosterone phenylacetate under hs 29372900 and sitc 54153. as of q4 2014, testosterone phenylacetate remains us fdas preferred term for this commodity. testosterone phenylacetate bears us nlm identifiers umls id c2986926 and nci concept code c95126. smiles: c[c@]12cc[c@h]3[c@h]([c@@h]1cc[c@@h]2oc(=o)cc4ccccc4)ccc5=cc(=o)cc[c@]35c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone propionate. this classification denotes a therapeutic testosterone with the molecular formula c22h32o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wi93z9138a, chemically known as testosterone, propionate but more generally known as testosterone propionate, which bears us nih compound identifier 5995. european medicines agency schedules testosterone propionate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04743mig. most nations, for tariff and trade purposes, schedule testosterone propionate under hs 29372900 and sitc 54153. as of q4 2014, testosterone propionate remains us fdas preferred term for this commodity. testosterone propionate bears us nlm identifiers umls id c0039607 and nci concept code c863. smiles: ccc(=o)o[c@h]1cc[c@@h]2[c@@]1(cc[c@h]3[c@h]2ccc4=cc(=o)cc[c@]34c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone undecanoate. this classification denotes a therapeutic testosterone with the molecular formula c30h48o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h16a5vct9c, chemically known as 5-alpha-androstan-3-one, 17-beta-hydroxy-, undecanoate but more generally known as testosterone undecanoate, which bears us nih compound identifier 65157. european medicines agency schedules testosterone undecanoate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04744mig. most nations, for tariff and trade purposes, schedule testosterone undecanoate under hs 29372900 and sitc 54153. as of q4 2014, testosterone undecanoate remains us fdas preferred term for this commodity. testosterone undecanoate bears us nlm identifiers umls id c0076195 and nci concept code c1249. smiles: ccccccccccc(=o)o[c@h]1cc[c@@h]2[c@@]1(cc[c@h]3[c@h]2ccc4=cc(=o)cc[c@]34c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. testosterone undecylate. this classification denotes a therapeutic testosterone with the molecular formula c30h48o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h16a5vct9c, chemically known as 5-alpha-androstan-3-one, 17-beta-hydroxy-, undecanoate but more generally known as testosterone undecanoate, which bears us nih compound identifier 65157. european medicines agency schedules testosterone undecanoate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04744mig. most nations, for tariff and trade purposes, schedule testosterone undecylate under hs 29372900. smiles: ccccccccccc(=o)o[c@h]1cc[c@@h]2[c@@]1(cc[c@h]3[c@h]2ccc4=cc(=o)cc[c@]34c)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. trenbolone acetate. this classification denotes an anabolic steroid with the molecular formula c20h24o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rud5y4sv0s, chemically known as 17beta-hydroxyestra-4,9,11-trien-3-one, acetate but more generally known as trenbolone acetate, which bears us nih compound identifier 66359. european medicines agency schedules trenbolone acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32683. most nations, for tariff and trade purposes, schedule trenbolone acetate under hs 29372900 and sitc 54153. as of q4 2014, trenbolone acetate remains us fdas preferred term for this commodity. trenbolone acetate bears us nlm identifiers umls id c0076958 and nci concept code c61982. smiles: cc(=o)o[c@h]1cc[c@@h]2[c@@]1(c=cc3=c4ccc(=o)c=c4cc[c@@h]23)c.. "
"androgens and androgen inhibitors. this classification denotes compounds that interact with, amplify, or inhibit androgen receptors in target tissues to bring about the effects similar to those of testosterone. depending on the target tissues, androgenic effects can be on sex differentiation, male reproductive organs, spermatogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power.. trenbolone cyclohexylmethylcarbonate. this classification denotes an anabolic steroid with the molecular formula c26h34o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bnj7y3jff2, chemically known as estra-4,9,11-trien-3-one, 17-(((cyclohexylmethoxy)carbonyl)oxy)-, (17.beta.)-, but more generally known as trenbolone cyclohexylmethylcarbonate, which bears us nih compound identifier 90930. european medicines agency schedules trenbolone cyclohexylmethylcarbonate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11232mig. most nations, for tariff purposes, schedule trenbolone cyclohexylmethylcarbonate under hs 29372900. smiles: c[c@]12c=cc3=c4ccc(=o)c=c4cc[c@h]3[c@@h]1cc[c@@h]2oc(=o)occ5ccccc5.. "
"posterior pituitary hormones. this classification denotes hormones released from the neurohypophysis (pituitary gland, posterior). they include a number of peptides which are formed in the neurons in the hypothalamus, bound to neurophysins, and stored in the nerve terminals in the posterior pituitary. upon stimulation, these peptides are released into the hypophysial portal vessel blood.. . "
"posterior pituitary hormones. this classification denotes hormones released from the neurohypophysis (pituitary gland, posterior). they include a number of peptides which are formed in the neurons in the hypothalamus, bound to neurophysins, and stored in the nerve terminals in the posterior pituitary. upon stimulation, these peptides are released into the hypophysial portal vessel blood.. desmopressin. this classification denotes an antidiurectic hormone analogue with the molecular formula c46h64n14o12s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier enr1llb0fp, chemically known as vasopressin, 1-(3-mercaptopropanoic acid)-8-d-arginine- but generally known as desmopressin, which bears us nih compound identifier 27991. european medicines agency schedules desmopressin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07001mig. the term desmopressin is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules desmopressin in its anatomical therapeutic chemical (atc) classification. desmopressin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule desmopressin under hs 29371900 and sitc 54154. as of q4 2014, desmopressin remains the us fda preferred term for this commodity. desmopressin bears us nlm identifiers umls id c0011701 and nci concept code c61701. smiles: s1sccc(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n2c(ccc2)c(=o)nc(ccc/n=c(/n)n)c(=o)ncc(=o)n)c1)cc(=o)n)ccc(=o)n)cc1ccccc1)cc1ccc(o)cc1.. "
"posterior pituitary hormones. this classification denotes hormones released from the neurohypophysis (pituitary gland, posterior). they include a number of peptides which are formed in the neurons in the hypothalamus, bound to neurophysins, and stored in the nerve terminals in the posterior pituitary. upon stimulation, these peptides are released into the hypophysial portal vessel blood.. argipressin or vasopressin. this classification denotes antidiuretic hormones released by the neurohypophysis of all vertebrates (structure varies with species) to regulate water balance and osmolarity, most especially arginine vasopressin, which typically arises in the molecular formula c46h65n15o12s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y87y826h08, chemically known as 1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-n-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide but generally known as vasopressin, which bears us nih compound identifier 8230. european medicines agency schedules vasopressin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20776. the term vasopressin is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7.). world health organization schedules vasopressin in its anatomical therapeutic chemical (atc) classification. argipressin or vasopressin bears us nlm identifiers umls id c0003779 and nci concept code c926. smiles: c1cc(n(c1)c(=o)c2csscc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n2)cc(=o)n)ccc(=o)n)cc3=cc=cc=c3)cc4=cc=c(c=c4)o)n)c(=o)nc(cccn=c(n)n)c(=o)ncc(=o)n.. "
"posterior pituitary hormones. this classification denotes hormones released from the neurohypophysis (pituitary gland, posterior). they include a number of peptides which are formed in the neurons in the hypothalamus, bound to neurophysins, and stored in the nerve terminals in the posterior pituitary. upon stimulation, these peptides are released into the hypophysial portal vessel blood.. conivaptan. this classification denotes a vasopressin antagonist with the molecular formula c32h26n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0nj98y462x, chemically known as (1,1-biphenyl)-2-carboxamide, n-(4-(4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)phenyl)- but generally known as conivaptan, which bears us nih compound identifier 151171. european medicines agency schedules conivaptan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32706. the term conivaptan is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44). world health organization schedules conivaptan in its anatomical therapeutic chemical (atc) classification. most nations schedule conivaptan under hs 29339930 and sitc 51577. as of q4 2014, conivaptan remains the us fda preferred term for this commodity. conivaptan bears us nlm identifiers umls id c0966107 and nci concept code c74428. smiles: o=c(n1ccc2[nh]c(nc2c2c1cccc2)c)c1ccc(nc(=o)c2c(c3ccccc3)cccc2)cc1.. "
"posterior pituitary hormones. this classification denotes hormones released from the neurohypophysis (pituitary gland, posterior). they include a number of peptides which are formed in the neurons in the hypothalamus, bound to neurophysins, and stored in the nerve terminals in the posterior pituitary. upon stimulation, these peptides are released into the hypophysial portal vessel blood.. felypressin. this classification denotes an antidiurectic hormone analogue with the molecular formula c46h65n13o11s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 17n2918v6g, chemically known as vasopressin, 2-l-phenylalanine-8-l-lysine- but generally known as felypressin, which bears us nih compound identifier 5956. european medicines agency schedules felypressin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07529mig. the term felypressin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). felypressin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule felypressin under hs 29371900 and sitc 54154. as of q4 2014, felypressin remains the us fda preferred term for this commodity. felypressin bears us nlm identifiers umls id c0015777 and nci concept code c81496. smiles: s1scc(n)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n2c(ccc2)c(=o)nc(ccccn)c(=o)ncc(=o)n)c1)cc(=o)n)ccc(=o)n)cc1ccccc1)cc1ccccc1.. "
"posterior pituitary hormones. this classification denotes hormones released from the neurohypophysis (pituitary gland, posterior). they include a number of peptides which are formed in the neurons in the hypothalamus, bound to neurophysins, and stored in the nerve terminals in the posterior pituitary. upon stimulation, these peptides are released into the hypophysial portal vessel blood.. lypressin. this classification denotes an antidiurectic hormone analogue with the molecular formula c46h65n13o12s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7czf3l922y, chemically known as vasopressin, 8-l-lysine- but generally known as lypressin, which bears us nih compound identifier 5772. european medicines agency schedules lypressin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08627mig. the term lypressin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules lypressin in its anatomical therapeutic chemical (atc) classification. lypressin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lypressin under hs 29371900 and sitc 54154. as of q4 2014, lypressin remains the us fda preferred term for this commodity. lypressin bears us nlm identifiers umls id c0024328 and nci concept code c66044. smiles: s1scc(n)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n2c(ccc2)c(=o)nc(ccccn)c(=o)ncc(=o)n)c1)cc(=o)n)ccc(=o)n)cc1ccccc1)cc1ccc(o)cc1.. "
"posterior pituitary hormones. this classification denotes hormones released from the neurohypophysis (pituitary gland, posterior). they include a number of peptides which are formed in the neurons in the hypothalamus, bound to neurophysins, and stored in the nerve terminals in the posterior pituitary. upon stimulation, these peptides are released into the hypophysial portal vessel blood.. terlipressin. this classification denotes an antidiurectic hormone analogue, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7z5x49w53p. european medicines agency schedules terlipressin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10927mig. terlipressin generally arises in the molecular formula c52h74n16o15s2. the term terlipressin is an international non-proprietary name or inn. terlipressin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule terlipressin under hs 29371900 and sitc 54154. as of q4 2014, terlipressin remains the us fda preferred term for this commodity. terlipressin bears us nlm identifiers umls id c0145185 and nci concept code c77387. smiles: s1scc(nc(=o)cnc(=o)cnc(=o)cn)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n2c(ccc2)c(=o)nc(ccccn)c(=o)ncc(=o)n)c1)cc(=o)n)ccc(=o)n)cc1ccccc1)cc1ccc(o)cc1.. "
"posterior pituitary hormones. this classification denotes hormones released from the neurohypophysis (pituitary gland, posterior). they include a number of peptides which are formed in the neurons in the hypothalamus, bound to neurophysins, and stored in the nerve terminals in the posterior pituitary. upon stimulation, these peptides are released into the hypophysial portal vessel blood.. conivaptan hydrochloride. this classification denotes a vasopressin antagonist with the molecular formula c32h26n4o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 75l57r6x36, chemically known as (1,1-biphenyl)-2-carboxamide, n-(4-(4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)phenyl)- but more generally known as conivaptan hydrochloride, which bears us nih compound identifier 151171. most nations, for tariff and trade purposes, schedule conivaptan hydrochloride under hs 29339930 and sitc 51577. as of q4 2014, conivaptan hydrochloride remains us fdas preferred term for this commodity. conivaptan hydrochloride bears us nlm identifiers umls id c1700196 and nci concept code c65351. smiles: cc1[nh]c-2c(n1)ccn(c3c2cccc3)c(=o)c4ccc(cc4)nc(=o)c5ccccc5c6ccccc6.cl.. "
"posterior pituitary hormones. this classification denotes hormones released from the neurohypophysis (pituitary gland, posterior). they include a number of peptides which are formed in the neurons in the hypothalamus, bound to neurophysins, and stored in the nerve terminals in the posterior pituitary. upon stimulation, these peptides are released into the hypophysial portal vessel blood.. desmopressin acetate. this classification denotes an antidiurectic hormone analogue with the molecular formula c46h64n14o12s2.c2h4o2.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xb13hyu18u, chemically known as vasopressin, 1-(3-mercaptopropanoic acid)-8-d-arginine- but more generally known as desmopressin acetate, which bears us nih compound identifier 27991. european medicines agency schedules desmopressin acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01597mig. most nations, for tariff and trade purposes, schedule desmopressin acetate under hs 29371900 and sitc 54154. as of q4 2014, desmopressin acetate remains us fdas preferred term for this commodity. desmopressin acetate bears us nlm identifiers umls id c0701195 and nci concept code c47475. smiles: cc(=o)o.c1ccc(cc1)c[c@h]2c(=o)n[c@h](c(=o)n[c@h](c(=o)n[c@@h](cssccc(=o)n[c@h](c(=o)n2)cc3ccc(cc3)o)c(=o)n4ccc[c@h]4c(=o)n[c@h](cccnc(=n)n)c(=o)ncc(=o)n)cc(=o)n)ccc(=o)n.o.o.o.. "
"posterior pituitary hormones. this classification denotes hormones released from the neurohypophysis (pituitary gland, posterior). they include a number of peptides which are formed in the neurons in the hypothalamus, bound to neurophysins, and stored in the nerve terminals in the posterior pituitary. upon stimulation, these peptides are released into the hypophysial portal vessel blood.. desmopressin acetate anhydrous. this classification denotes an antidiurectic hormone analogue with the molecular formula c46h64n14o12s2.c2h4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1k12647sfc, chemically known as 1-(3-mercaptopropionic acid)-8-d-arginine-vasopressin monoacetate (salt), but more generally known as desmopressin acetate anhydrous, which bears us nih compound identifier 64758. european medicines agency schedules desmopressin acetate anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07001mig. most nations, for tariff purposes, schedule desmopressin acetate anhydrous under hs 29371900. smiles: cc(=o)o.c1ccc(cc1)c[c@h]2c(=o)n[c@h](c(=o)n[c@h](c(=o)n[c@@h](cssccc(=o)n[c@h](c(=o)n2)cc3ccc(cc3)o)c(=o)n4ccc[c@h]4c(=o)n[c@h](cccnc(=n)n)c(=o)ncc(=o)n)cc(=o)n)ccc(=o)n.. "
"posterior pituitary hormones. this classification denotes hormones released from the neurohypophysis (pituitary gland, posterior). they include a number of peptides which are formed in the neurons in the hypothalamus, bound to neurophysins, and stored in the nerve terminals in the posterior pituitary. upon stimulation, these peptides are released into the hypophysial portal vessel blood.. desmopressin acetate trihydrate. this classification denotes an antidiurectic hormone analogue with the molecular formula c46h64n14o12s2.c2h4o2.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xb13hyu18u, chemically known as vasopressin, 1-(3-mercaptopropanoic acid)-8-d-arginine-, monoacetate (salt), trihydrate, but more generally known as desmopressin acetate trihydrate, which bears us nih compound identifier 64759. european medicines agency schedules desmopressin acetate trihydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07001mig. most nations, for tariff purposes, schedule desmopressin acetate trihydrate under hs 29371900. smiles: cc(=o)o.c1ccc(cc1)c[c@h]2c(=o)n[c@h](c(=o)n[c@h](c(=o)n[c@@h](cssccc(=o)n[c@h](c(=o)n2)cc3ccc(cc3)o)c(=o)n4ccc[c@h]4c(=o)n[c@h](cccnc(=n)n)c(=o)ncc(=o)n)cc(=o)n)ccc(=o)n.o.o.o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. . "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. dinoprostone. this classification denotes a prostaglandin analogue with the molecular formula c20h32o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k7q1jqr04m, chemically known as u,12, 062 but generally known as dinoprostone, which bears us nih compound identifier 158. european medicines agency schedules dinoprostone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07195mig. the term dinoprostone is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules dinoprostone in its anatomical therapeutic chemical (atc) classification. dinoprostone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dinoprostone under hs 29375000 and sitc 54156. as of q4 2014, dinoprostone remains the us fda preferred term for this commodity. dinoprostone bears us nlm identifiers umls id c0012472 and nci concept code c61727. smiles: oc1c(c(c(=o)c1)c/c=c/cccc(=o)o)/c=c/c(o)ccccc.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. methylergometrine or methylergonovine. this classification denotes a cns stimulant with the molecular formula c20h25n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w53l6fe61v, chemically known as 9,10-didehydro-n-(alpha-(hydroxymethyl)propyl)-6-methyl-ergoline-8-beta-carboxamide but generally known as methylergometrine, which bears us nih compound identifier 8226. european medicines agency schedules methylergometrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08868mig. the term methylergometrine is an international non-proprietary name. world health organization schedules methylergometrine in its anatomical therapeutic chemical (atc) classification. methylergometrine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, methylergonovine remains the us fda preferred term for this commodity. methylergonovine bears us nlm identifiers umls id c0025760 and nci concept code c74105. smiles: o=c(nc(cc)co)c1cn(c2c(=c1)c1c3c(c2)c[nh]c3ccc1)c.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. oxytocin. this classification denotes a pituitary hormone with the molecular formula c43h66n12o12s2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1jqs135eyn, chemically known as vasopressin, 3-l-isoleucine-8-l-leucine- but more generally known as oxytocin, which bears u.s. national institutes of health compound identifier 5771. the european medicines agency schedules oxytocin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09580mig. the term oxytocin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules oxytocin in its anatomical therapeutic chemical (atc) classification. oxytocin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1scc(n)c(=o)nc(c(=o)nc(c(cc)c)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n2c(ccc2)c(=o)nc(cc(c)c)c(=o)ncc(=o)n)c1)cc(=o)n)ccc(=o)n)cc1ccc(o)cc1.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. ergometrine or ergonovine. this classification denotes a serotonin antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ymh3d0zjwv. european medicines agency schedules ergometrine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01931mig. ergonovine maleate generally arises in the molecular formula c23h27n3o6. the term ergonovine maleate is a european pharmacopoeia designation. ergometrine or ergonovine bears us nlm identifiers umls id c0014704 and nci concept code c75040. smiles: o=c(nc(c)c)c1cn(c2c(=c1)c1c3c(c2)c[nh]c3ccc1)c.oc(=o)/c=c\\c(=o)o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. doxaprost. this classification denotes a prostaglandin analogue with the molecular formula c21h36o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w3g873mk03, chemically known as prost-13-en-1-oic acid, 15-hydroxy-15-methyl-9-oxo-, (13e) but generally known as doxaprost, which bears us nih compound identifier 6441612. european medicines agency schedules doxaprost in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06383mig. the term doxaprost is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). doxaprost is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule doxaprost under hs 29375000 and sitc 54156. as of q4 2014, doxaprost remains the us fda preferred term for this commodity. doxaprost bears us nlm identifiers umls id c2699807 and nci concept code c74370. smiles: o=c1c(c(cc1)/c=c/c(o)(ccccc)c)ccccccc(=o)o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. atosiban. this classification denotes a hormone antagonist with the molecular formula c43h67n11o12s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 081d12si0z, chemically known as oxytocin, 1-(3-mercaptopropanoic acid)-2-(o-ethyl-d-tyrosine)-4-l-threonine-8-l-ornithine- but generally known as atosiban, which bears us nih compound identifier 68613. european medicines agency schedules atosiban in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05601mig. the term atosiban is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules atosiban in its anatomical therapeutic chemical (atc) classification. atosiban is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule atosiban under hs 29349990 and sitc 51579. as of q4 2014, atosiban remains the us fda preferred term for this commodity. atosiban bears us nlm identifiers umls id c0164398 and nci concept code c84815. smiles: s1sccc(=o)nc(c(=o)nc(c(cc)c)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n2c(ccc2)c(=o)nc(cccn)c(=o)ncc(=o)n)c1)cc(=o)n)c(o)c)cc1ccc(occ)cc1.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. carbetocin. this classification denotes an oxytocic and uterine stimulant with the molecular formula c45h69n11o12s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 88twf8015y, chemically known as 1-carboxytocin, 1-butanoic acid-2-(o-methyl-l-tyrosine)- but generally known as carbetocin, which bears us nih compound identifier 71715. european medicines agency schedules carbetocin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06125mig. world health organization schedules carbetocin in its anatomical therapeutic chemical (atc) classification. carbetocin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carbetocin under hs 29371900 and sitc 54154. as of q4 2014, carbetocin remains the us fda preferred term for this commodity. carbetocin bears us nlm identifiers umls id c0054670 and nci concept code c96858. smiles: s1cc(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(n(c(=o)ccc1)c)cc1ccc(o)cc1)c(cc)c)ccc(=o)n)cc(=o)n)c(=o)n1c(ccc1)c(=o)nc(cc(c)c)c(=o)ncc(=o)n.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. carboprost. this classification denotes a prostaglandin analogue with the molecular formula c21h36o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7b5032xt6o, chemically known as 9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oic acid (5z,9alpha,11alpha,13e,15s)- but generally known as carboprost, which bears us nih compound identifier 5281005. carboprost most often comes in base, methyl, methyl ester, and tromethamine forms. european medicines agency schedules carboprost in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06615mig. the term carboprost is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules carboprost in its anatomical therapeutic chemical (atc) classification. carboprost is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carboprost under hs 29375000 and sitc 54156. as of q4 2014, carboprost remains the us fda preferred term for this commodity. carboprost bears us nlm identifiers umls id c0007047 and nci concept code c61662. smiles: oc1c(c(c(o)c1)/c=c/c(o)(ccccc)c)c/c=c\\cccc(=o)o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. deaminooxytocin or demoxytocin. this classification denotes an oxytocin analog, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2n9hm3x95f. european medicines agency schedules demoxytocin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06971mig. demoxytocin generally arises in the molecular formula c43h65n11o12s2. the term demoxytocin is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10.) demoxytocin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. deaminooxytocin or demoxytocin bears us nlm identifiers umls id c0057218 and nci concept code c96860. smiles: ccc(c)c1c(=o)nc(c(=o)nc(c(=o)nc(cssccc(=o)nc(c(=o)n1)cc2=cc=c(c=c2)o)c(=o)n3cccc3c(=o)nc(cc(c)c)c(=o)ncc(=o)n)cc(=o)n)ccc(=o)n.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. dinoprost. this classification denotes a prostaglandin analogue with the molecular formula c20h34o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b7in85g1hy, chemically known as (5z,13e)-(15s)-9-alpha,11-alpha,15-trihydroxyprosta-5,13-dienoate but generally known as dinoprost, which bears us nih compound identifier 160. european medicines agency schedules dinoprost in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07194mig. the term dinoprost is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules dinoprost in its anatomical therapeutic chemical (atc) classification. dinoprost is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dinoprost under hs 29375000 and sitc 54156. as of q4 2014, dinoprost remains the us fda preferred term for this commodity. dinoprost bears us nlm identifiers umls id c0012471 and nci concept code c65413. smiles: oc1c(c(c(o)c1)/c=c/c(o)ccccc)c/c=c/cccc(=o)o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. epostane. this classification denotes an anti-progestin with the molecular formula c22h31no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6375t36951, chemically known as 4,17-dimethyltrilostane but generally known as epostane, which bears us nih compound identifier 51331. european medicines agency schedules epostane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06582mig. the term epostane is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). epostane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule epostane under hs 29372300 and sitc 54153. as of q4 2014, epostane remains the us fda preferred term for this commodity. epostane bears us nlm identifiers umls id c0059461 and nci concept code c80687. smiles: o1c23c(c4c(c5c(cc4)(c(o)(cc5)c)c)cc3)(cc(c(=o)c12c)c#n)c.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. mepitiostane. this classification denotes an antiestrogen with the molecular formula c25h40o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o00404969k, chemically known as 5-alpha-androstane, 2-alpha,3-alpha-epithio-17-beta-(1-methoxycyclopentyloxy)- but generally known as mepitiostane, which bears us nih compound identifier 30605. european medicines agency schedules mepitiostane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08753mig. the term mepitiostane is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). mepitiostane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mepitiostane under hs 29372900 and sitc 54153. as of q4 2014, mepitiostane remains the us fda preferred term for this commodity. mepitiostane bears us nlm identifiers umls id c0065964 and nci concept code c1158. smiles: s1c2cc3(c4c(c5c(cc4)(c(oc4(oc)cccc4)cc5)c)ccc3cc12)c.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. meteneprost. this classification denotes a prostaglandin analogue with the molecular formula c23h38o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 269eb4r1tv, chemically known as 9-methylene-11r,15s-dihydroxy-16,16-dimethyl-5z,13e-prostadienoic acid but generally known as meteneprost, which bears us nih compound identifier 5283060. european medicines agency schedules meteneprost in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08822mig. the term meteneprost is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). meteneprost is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule meteneprost under hs 29375000 and sitc 54156. as of q4 2014, meteneprost remains the us fda preferred term for this commodity. meteneprost bears us nlm identifiers umls id c0127783 and nci concept code c90926. smiles: oc1c(c(c(=c)c1)c/c=c\\cccc(=o)o)/c=c/c(o)c(cccc)(c)c.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. misoprostol. this classification denotes a prostaglandin analogue and cytoprotective agent and anti-ulcer agent with the molecular formula c22h38o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0e43v0bb57, chemically known as prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13e)-(+-)- but generally known as misoprostol, which bears us nih compound identifier 5282381. european medicines agency schedules misoprostol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08998mig. the term misoprostol is an international non-proprietary name. world health organization schedules misoprostol in its anatomical therapeutic chemical (atc) classification. misoprostol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule misoprostol under hs 29375000 and sitc 54156. as of q4 2014, misoprostol remains the us fda preferred term for this commodity. misoprostol bears us nlm identifiers umls id c0085174 and nci concept code c1313. smiles: oc1c(c(ccccccc(=o)oc)c(=o)c1)/c=c/cc(o)(cccc)c.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. atosiban acetate. this classification denotes the acetate form of a hormone antagonist with the molecular formula c43h67n11o12s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 081d12si0z, chemically known as oxytocin, 1-(3-mercaptopropanoic acid)-2-(o-ethyl-d-tyrosine)-4-l-threonine-8-l-ornithine- but generally known as atosiban, which bears us nih compound identifier 68613. european medicines agency schedules atosiban in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05601mig. the term atosiban is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules atosiban in its anatomical therapeutic chemical (atc) classification. atosiban is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. the base compound, atosiban, is a hormone antagonist with the molecular formula c43h67n11o12s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 081d12si0z, chemically known as oxytocin, 1-(3-mercaptopropanoic acid)-2-(o-ethyl-d-tyrosine)-4-l-threonine-8-l-ornithine- but generally known as atosiban, which bears us nih compound identifier 68613. european medicines agency schedules atosiban in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05601mig. the term atosiban is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules atosiban in its anatomical therapeutic chemical (atc) classification. atosiban is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule atosiban acetate under hs 29349990 and sitc 51579. as of q4 2014, atosiban acetate remains the us fda preferred term for this commodity. atosiban acetate bears us nlm identifiers umls id c0873206 and nci concept code c97706. smiles: s1sccc(=o)nc(c(=o)nc(c(cc)c)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n2c(ccc2)c(=o)nc(cccn)c(=o)ncc(=o)n)c1)cc(=o)n)c(o)c)cc1ccc(occ)cc1.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. carboprost methyl. this classification denotes a prostaglandin analogue c22h38o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uvv9bu3089, chemically known as prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, methyl ester, (5z,9.alpha.,11.alpha.,13e,15s)-, but more generally known as carboprost methyl, which bears us nih compound identifier 5283105. most nations, for tariff and trade purposes, schedule carboprost methyl under hs 29375000 and sitc 54156. as of q4 2014, carboprost methyl remains us fdas preferred term for this commodity. smiles: ccccc[c@@](c)(/c=c/[c@h]1[c@@h](c[c@@h]([c@@h]1c/c=c\\cccc(=o)oc)o)o)o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. carboprost methyl ester. this classification denotes a prostaglandin analogue with the molecular formula c22h38o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uvv9bu3089, chemically known as prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, methyl ester, (5z,9.alpha.,11.alpha.,13e,15s)-, but more generally known as carboprost methyl ester, which bears us nih compound identifier 6434195. european medicines agency schedules carboprost methyl ester or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06615mig. most nations, for tariff purposes, schedule carboprost methyl ester under hs 29375000. smiles: ccccc[c@@](c)(/c=c/[c@h]1[c@@h](c[c@@h]([c@@h]1c/c=c\\cccc(=o)oc)o)o)o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. carboprost trometamol. this classification denotes a prostaglandin analogue, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u4526f86fj. european medicines agency schedules carboprost trometamol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01053mig. carboprost trometamol generally arises in the molecular formula c21h36o5.c4h11no3. the term carboprost trometamol is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule carboprost trometamol under hs 29375000 and sitc 54156. smiles: ccccc[c@@](c)(/c=c/[c@h]1[c@@h](c[c@@h]([c@@h]1c/c=c\\cccc(=o)o)o)o)o.c(c(co)(co)n)o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. carboprost tromethamine. this classification denotes a prostaglandin analogue with the molecular formula c21h36o5.c4h11no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u4526f86fj, chemically known as prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5z,9.alpha.,11.alpha.,13e,15s)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), but more generally known as carboprost tromethamine, which bears us nih compound identifier 5281074. european medicines agency schedules carboprost tromethamine or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06615mig. most nations, for tariff purposes, schedule carboprost tromethamine under hs 29375000. as of q4 2014, carboprost tromethamine remains us fdas preferred term for this commodity. carboprost tromethamine bears us nlm identifiers umls id c0054721 and nci concept code c47433. smiles: ccccc[c@@](c)(/c=c/[c@h]1[c@@h](c[c@@h]([c@@h]1c/c=c\\cccc(=o)o)o)o)o.c(c(co)(co)n)o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. dinoprost trometamol. this classification denotes a prostaglandin analogue, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ct6bbq5a68. european medicines agency schedules dinoprost trometamol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01758mig. dinoprost trometamol generally arises in the molecular formula c20h34o5.c4h11no3. the term dinoprost trometamol is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule dinoprost trometamol under hs 29375000 and sitc 54156. smiles: ccccc[c@@h](/c=c/[c@h]1[c@@h](c[c@@h]([c@@h]1c/c=c\\cccc(=o)o)o)o)o.c(c(co)(co)n)o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. dinoprost tromethamine. this classification denotes a prostaglandin analogue with the molecular formula c20h34o5.c4h11no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ct6bbq5a68, chemically known as (e,z)-(1r,2r,3r,5s)-7-(3,5-dihydroxy-2-((3s)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), but more generally known as dinoprost tromethamine, which bears us nih compound identifier 5282415. european medicines agency schedules dinoprost tromethamine or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07194mig. most nations, for tariff purposes, schedule dinoprost tromethamine under hs 29375000. as of q4 2014, dinoprost tromethamine remains us fdas preferred term for this commodity. dinoprost tromethamine bears us nlm identifiers umls id c0058310 and nci concept code c1074. smiles: ccccc[c@@h](/c=c/[c@h]1[c@@h](c[c@@h]([c@@h]1c/c=c\\cccc(=o)o)o)o)o.c(c(co)(co)n)o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. ergometrine maleate. this classification denotes a serotonin antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ymh3d0zjwv. european medicines agency schedules ergometrine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01931mig. ergonovine maleate generally arises in the molecular formula c23h27n3o6. the term ergonovine maleate is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule ergometrine maleate under hs 29396100. smiles: c[c@@h](co)nc(=o)[c@h]1cn([c@@h]2cc3c[nh]c4c3c(ccc4)c2=c1)c.c(=c\\c(=o)o)\\c(=o)o.. "
"drugs for inducing labor. this classification denotes drugs that stimulate contraction of the myometrium. they are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. they may also be used alone or with other drugs to induce abortions (abortifacients). oxytocics used clinically include the neurohypophyseal hormone oxytocin and certain prostaglandins and ergot alkaloids.. oxytocin citrate. this classification denotes a pituitary hormone c43h66n12o12s2.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1573l6wj8u, chemically known as oxytocin, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt), but more generally known as oxytocin citrate, which bears us nih compound identifier 72941595. european medicines agency schedules oxytocin citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub23136. most nations, for tariff and trade purposes, schedule oxytocin citrate under hs 29371900 and sitc 54154. as of q4 2014, oxytocin citrate remains us fdas preferred term for this commodity. smiles: cc[c@h](c)[c@h]1c(=o)n[c@h](c(=o)n[c@h](c(=o)n[c@@h](cssc[c@@h](c(=o)n[c@h](c(=o)n1)cc2ccc(cc2)o)n)c(=o)n3ccc[c@h]3c(=o)n[c@@h](cc(c)c)c(=o)ncc(=o)n)cc(=o)n)ccc(=o)n.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"growth hormones and their inhibitors. this classification denotes a polypeptide that is secreted by the adenohypophysis (pituitary gland, anterior). growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. species-specific growth hormones have been synthesized.. . "
"growth hormones and their inhibitors. this classification denotes a polypeptide that is secreted by the adenohypophysis (pituitary gland, anterior). growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. species-specific growth hormones have been synthesized.. somatrem. this classification denotes a pituitary agent with the molecular formula c995h1537n263o301s8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cu8d464edw, more generally known as somatrem. european medicines agency schedules somatrem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10583mig. the term somatrem is an international non-proprietary name or inn. somatrem is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule somatrem under hs 29371100 and sitc 54154. as of q4 2014, somatrem remains the us fda preferred term for this commodity. somatrem bears us nlm identifiers umls id c0143083 and nci concept code c66556. smiles: none.. "
"growth hormones and their inhibitors. this classification denotes a polypeptide that is secreted by the adenohypophysis (pituitary gland, anterior). growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. species-specific growth hormones have been synthesized.. human growth hormone or somatotropin or somatropin. this classification denotes a pituitary agent with the molecular formula c990h1528n262o300s7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nqx9kb6pcl, more generally known as somatropin. european medicines agency schedules somatropin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10584mig. the term somatropin is an international non-proprietary name or inn. see who inn reference publication, volume 1, no. 4, 1987, list 27. somatropin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: none.. "
"growth hormones and their inhibitors. this classification denotes a polypeptide that is secreted by the adenohypophysis (pituitary gland, anterior). growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. species-specific growth hormones have been synthesized.. somatostatin. this classification denotes a hypothalmic hormone, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6e20216q0l. european medicines agency schedules somatostatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12320mig. somatostatin generally arises in the molecular formula c76h104n18o19s2. the term somatostatin is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20.) somatostatin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule somatostatin under hs 29371900 and sitc 54154. as of q4 2014, somatostatin remains the us fda preferred term for this commodity. somatostatin bears us nlm identifiers umls id c0037659 and nci concept code c28418. smiles: s1scc(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)cnc(=o)c(n)c)c1)ccccn)cc(=o)n)cc1ccccc1)cc1ccccc1)cc1c2c([nh]c1)cccc2)ccccn)c(o)c)cc1ccccc1)c(o)c)co)c(=o)o.. "
"growth hormones and their inhibitors. this classification denotes a polypeptide that is secreted by the adenohypophysis (pituitary gland, anterior). growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. species-specific growth hormones have been synthesized.. egrifta or tesamorelin. this classification denotes a growth hormone-releasing hormone analogue with the molecular formula c221h366n72o67s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mqg94m5eeo, chemically known as (3e)-hex-3-enoylsomatoliberin, which bears us nih compound identifier 16137828. european medicines agency schedules tesamorelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32399. egrifta or tesamorelin bears us nlm identifiers umls id c1876200 and nci concept code c77425. smiles: ccc=ccc(=o)nc(cc1=cc=c(c=c1)o)c(=o)nc(c)c(=o)nc(cc(=o)o)c(=o)nc(c)c(=o)nc(c(c)cc)c(=o)nc(cc2=cc=cc=c2)c(=o)nc(c(c)o)c(=o)nc(cc(=o)n)c(=o)nc(co)c(=o)nc(cc3=cc=c(c=c3)o)c(=o)nc(cccnc(=n)n)c(=o)nc(ccccn)c(=o)nc(c(c)c)c(=o)nc(cc(c)c)c(=o)ncc(=o)nc(ccc(=o)n)c(=o)nc(cc(c)c)c(=o)nc(co)c(=o)nc(c)c(=o)nc(cccnc(=n)n)c(=o)nc(ccccn)c(=o)nc(cc(c)c)c(=o)nc(cc(c)c)c(=o)nc(ccc(=o)n)c(=o)nc(cc(=o)o)c(=o)nc(c(c)cc)c(=o)nc(ccsc)c(=o)nc(co)c(=o)nc(cccnc(=n)n)c(=o)nc(ccc(=o)n)c(=o)nc(ccc(=o)n)c(=o)ncc(=o)nc(ccc(=o)o)c(=o)nc(co)c(=o)nc(cc(=o)n)c(=o)nc(ccc(=o)n)c(=o)nc(ccc(=o)o)c(=o)nc(cccnc(=n)n)c(=o)ncc(=o)nc(c)c(=o)nc(cccnc(=n)n)c(=o)nc(c)c(=o)nc(cccnc(=n)n)c(=o)nc(cc(c)c)c(=o)n.. "
"growth hormones and their inhibitors. this classification denotes a polypeptide that is secreted by the adenohypophysis (pituitary gland, anterior). growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. species-specific growth hormones have been synthesized.. tesamorelin acetate. this classification denotes a growth hormone-releasing hormone analogue with the molecular formula c221h366n72o67s.c2h4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lgw5h38ve3. the term tesamorelin acetate is a united states adopted name designation. as of q4 2014, tesamorelin acetate remains the us fda preferred term for this commodity. tesamorelin acetate bears us nlm identifiers umls id c2955463 and nci concept code c90852. smiles: ccc=ccc(=o)nc(cc1=cc=c(c=c1)o)c(=o)nc(c)c(=o)nc(cc(=o)o)c(=o)nc(c)c(=o)nc(c(c)cc)c(=o)nc(cc2=cc=cc=c2)c(=o)nc(c(c)o)c(=o)nc(cc(=o)n)c(=o)nc(co)c(=o)nc(cc3=cc=c(c=c3)o)c(=o)nc(cccnc(=n)n)c(=o)nc(ccccn)c(=o)nc(c(c)c)c(=o)nc(cc(c)c)c(=o)ncc(=o)nc(ccc(=o)n)c(=o)nc(cc(c)c)c(=o)nc(co)c(=o)nc(c)c(=o)nc(cccnc(=n)n)c(=o)nc(ccccn)c(=o)nc(cc(c)c)c(=o)nc(cc(c)c)c(=o)nc(ccc(=o)n)c(=o)nc(cc(=o)o)c(=o)nc(c(c)cc)c(=o)nc(ccsc)c(=o)nc(co)c(=o)nc(cccnc(=n)n)c(=o)nc(ccc(=o)n)c(=o)nc(ccc(=o)n)c(=o)ncc(=o)nc(ccc(=o)o)c(=o)nc(co)c(=o)nc(cc(=o)n)c(=o)nc(ccc(=o)n)c(=o)nc(ccc(=o)o)c(=o)nc(cccnc(=n)n)c(=o)ncc(=o)nc(c)c(=o)nc(cccnc(=n)n)c(=o)nc(c)c(=o)nc(cccnc(=n)n)c(=o)nc(cc(c)c)c(=o)n.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. . "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. calcium chloride. this classification denotes a nutritional supplement and electrolyte replacement agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m4i0d6vv5m. european medicines agency schedules calcium chloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11767mig. calcium chloride generally arises in the molecular formula cacl2. the term calcium chloride is a united states homeopathic pharmacopoeia name designation. as of q4 2014, calcium chloride remains the us fda preferred term for this commodity. calcium chloride bears us nlm identifiers umls id c0006686 and nci concept code c28901. smiles: [cl-].[ca+2].. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. dibase calcium phosphate. this classification denotes a calcium phosphate and calcium supplement with the molecular formula ca.ho4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l11k75p92j, chemically known as phosphoric acid, calcium salt (1:1) but generally known as calcium phosphate, dibasic, which bears us nih compound identifier 24441. european medicines agency schedules calcium phosphate, dibasic in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13192mig. smiles: op(=o)([o-])[o-].[ca+2].. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. alendronic acid or alendronate sodium. this classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula c4h13no7p2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x1j18r4w8p, chemically known as 4-amino-1-hydroxybutylidene-1,1-bis(phosphonic acid) but generally known as alendronate, which bears us nih compound identifier 2088. alendronate comes in forms hydrate, sodium, and trihydrate. european medicines agency schedules alendronic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05307mig. the term alendronic acid is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules alendronate in its anatomical therapeutic chemical (atc) classification. alendronic acid or alendronate sodium bears us nlm identifiers umls id c0700482 and nci concept code c973. smiles: c(cc(o)(p(=o)(o)o)p(=o)(o)o)cn.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. cellulose sodium phosphate. this classification denotes a cation exchange resins and column chromatography, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e6s1nj4y5q. european medicines agency schedules sodium cellulose phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15280mig. cellulose sodium phosphate generally arises in the molecular formula (c6h7o5)n.na.o3p.h. the term cellulose sodium phosphate is a united states adopted name designation. as of q4 2014, cellulose sodium phosphate remains the us fda preferred term for this commodity. smiles: none.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. etidronate. this classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula c2h6o7p2.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m16pxg993g, chemically known as 1,1,1-ethanetriol diphosphonate but generally known as etidronate disodium, which bears us nih compound identifier 3305. european medicines agency schedules etidronate disodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13771mig. smiles: p(=o)(o)(o)c(p(=o)(o)o)(o)c.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. tribasic calcium phosphates. this classification denotes a form of tricalcium phosphate are used as bioceramic bone replacement material; see also records for alpha-tricalcium phosphate, beta-tricalcium phosphate, calcium phosphate; apatitic tricalcium phosphate ca9(hpo4)(po4)5(oh) is the calcium orthophosphate leading to beta tricalcium phosphate ca3(po4)2 (b-tcp), with the molecular formula 5ca.3o4p.ho, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 91d9gv0z28. european medicines agency schedules tribasic calcium phosphatein its extended eudravigilance medicinal product dictionary or xevmpd under index sub34727. the term tribasic calcium phosphate is homeopathic pharmacopoeia of the united states designation.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. calcium glycerophosphate or calcium glycero phosphate. this classification denotes a glycerolphosphates and unclear, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xwv9z12c1c. european medicines agency schedules calcium glycerophosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13178mig. calcium glycerophosphate generally arises in the molecular formula c3h7cao6p. the term calcium glycerophosphate is a european pharmacopoeia designation. smiles: c(c(cop(=o)([o-])[o-])o)o.[ca+2].. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. zoledronic acid. this classification denotes a bone density conservation agent with the molecular formula c5h10n2o7p2.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6xc1pad3kf, chemically known as phosphonic acid, (1-hydroxy-2-(1h-imidazol-1-yl)ethylidene)bis- but generally known as zoledronic acid, which bears us nih compound identifier 68740. european medicines agency schedules zoledronic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00176mig. world health organization schedules zoledronic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule zoledronic acid under hs 29332990 and sitc 51573. as of q4 2014, zoledronic acid remains the us fda preferred term for this commodity. zoledronic acid bears us nlm identifiers umls id c0257685 and nci concept code c1699. smiles: p(=o)(o)(o)c(p(=o)(o)o)(o)cn1ccnc1.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. pamidronate disodium or pamidronic acid. this classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula c3h9no7p2.2na.5h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8742t8zqza, chemically known as 3-amino-1-hydroxypropylidene-1,1-diphosphonate but generally known as pamidronate disodium, which bears us nih compound identifier 4674. european medicines agency schedules pamidronate disodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03610mig. pamidronate disodium or pamidronic acid bears us nlm identifiers umls id c0043603 and nci concept code c61875. smiles: p(=o)(o)(o)c(p(=o)(o)o)(o)ccn.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. risedronate sodium or risedronic acid. this classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula c7h11no7p2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier km2z91756z, chemically known as phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis- but generally known as risedronic acid, which bears us nih compound identifier 5245. european medicines agency schedules risedronic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10330mig. the term risedronic acid is an international non-proprietary name. world health organization schedules risedronic acid in its anatomical therapeutic chemical (atc) classification. risedronate sodium or risedronic acid bears us nlm identifiers umls id c0140610 and nci concept code c66517. smiles: p(=o)(o)(o)c(p(=o)(o)o)(o)cc1cccnc1.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. calcium acetate. this classification denotes a nutritional supplement, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y882yxf34x. european medicines agency schedules calcium acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13160mig. calcium acetate generally arises in the molecular formula c4h6cao4. the term calcium acetate is a united states homeopathic pharmacopoeia name designation. most nations schedule calcium acetate under hs 29152900 and sitc 51371. as of q4 2014, calcium acetate remains the us fda preferred term for this commodity. calcium acetate bears us nlm identifiers umls id c0717537 and nci concept code c47429. smiles: cc(=o)[o-].cc(=o)[o-].[ca+2].. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. ibandronate or ibandronic acid. this classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula c9h23no7p2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier umd7g2653w, chemically known as phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis- but generally known as ibandronic acid, which bears us nih compound identifier 60852. european medicines agency schedules ibandronic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08092mig. the term ibandronic acid is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules ibandronic acid in its anatomical therapeutic chemical (atc) classification. ibandronate or ibandronic acid bears us nlm identifiers umls id c0379200 and nci concept code c65874. smiles: p(=o)(o)(o)c(p(=o)(o)o)(o)ccn(ccccc)c.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. butedronic acid. this classification denotes a bone resorption inhibitor and biphosphonate, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 26pb1u68yf. european medicines agency schedules butedronic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06011mig. butedronic acid generally arises in the molecular formula c5h10o10p2. the term butedronic acid is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29.) as of q4 2014, butedronic acid remains the us fda preferred term for this commodity. butedronic acid bears us nlm identifiers umls id c2347239 and nci concept code c72092. smiles: p(=o)(o)(o)c(p(=o)(o)o)c(cc(=o)o)c(=o)o.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. cinacalcet. this classification denotes a malignancy-associated hypercalcemia inhibitor with the molecular formula c22h22f3n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uaz6v7728s, chemically known as 1-naphthalenemethanamine, a-methyl-n-(3-(3-(trifluoromethyl)phenyl)propyl)-, (ar)- but generally known as cinacalcet, which bears us nih compound identifier 156419. european medicines agency schedules cinacalcet in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20068. the term cinacalcet is an international non-proprietary name or inn (see who inn reference publication, volume 17, no. 4, 2003, list 50). world health organization schedules cinacalcet in its anatomical therapeutic chemical (atc) classification. most nations schedule cinacalcet under hs 29214980 and sitc 51454. as of q4 2014, cinacalcet remains the us fda preferred term for this commodity. cinacalcet bears us nlm identifiers umls id c1337242 and nci concept code c74100. smiles: fc(f)(f)c1cc(cccnc(c2c3c(ccc2)cccc3)c)ccc1.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. clodronate or clodronic acid. this classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula ch4cl2o6p2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0813bz6866, chemically known as 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1h-isoindol-1-yl)benzenesulfonamide but generally known as clodronic acid, which bears us nih compound identifier 2732. european medicines agency schedules clodronic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06693mig. the term clodronic acid is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules clodronic acid in its anatomical therapeutic chemical (atc) classification. clodronate or clodronic acid bears us nlm identifiers umls id c0012081 and nci concept code c61685. smiles: clc1c(s(=o)(=o)n)cc(c2(o)nc(=o)c3c2cccc3)cc1.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. denosumab. this classification denotes a monoclonal antibody with the molecular formula c6404h9912n1724o2004s50, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4eqz6yo2hi, more generally known as denosumab. european medicines agency schedules denosumab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub29173. the term denosumab is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 3, 2006, list 56. most nations schedule denosumab under hs 30021020 and sitc 54163. smiles:. as of q4 2014, denosumab remains the us fda preferred term for this commodity. . denosumab bears us nlm identifiers umls id c1690432 and nci concept code c61313.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. strontium ranelate. this classification denotes a bone resorption inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 04nq160fru. european medicines agency schedules strontium ranelate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20045. strontium ranelate generally arises in the molecular formula c12h6n2o8s.2sr. the term strontium ranelate is a european medicines agency european public assessment report system designation. as of q4 2014, strontium ranelate remains the us fda preferred term for this commodity. strontium ranelate bears us nlm identifiers umls id c0936139 and nci concept code c93265. smiles: [sr].[sr].s1c(n(cc(=o)o)cc(=o)o)c(c(c1c(=o)o)cc(=o)o)c#n.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. etidronic acid. this classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula c2h8o7p2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m2f465roxu, chemically known as 1,1,1-ethanetriol diphosphonate but generally known as etidronic acid, which bears us nih compound identifier 3305. european medicines agency schedules etidronic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07299mig. the term etidronic acid is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules etidronic acid in its anatomical therapeutic chemical (atc) classification. as of q4 2014, etidronic acid remains the us fda preferred term for this commodity. etidronic acid bears us nlm identifiers umls id c0015121 and nci concept code c1332. smiles: p(=o)(o)(o)c(p(=o)(o)o)(o)c.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. ipriflavone. this classification denotes a nutritional supplement and flavonoid with the molecular formula c18h16o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 80bj7wn25z, chemically known as 4h-1-benzopyran-4-one, 7-(1-methylethoxy)-3-phenyl- but generally known as ipriflavone, which bears us nih compound identifier 3747. european medicines agency schedules ipriflavone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08278mig. the term ipriflavone is an international non-proprietary name. world health organization schedules ipriflavone in its anatomical therapeutic chemical (atc) classification. ipriflavone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ipriflavone under hs 29329985 and sitc 51569. as of q4 2014, ipriflavone remains the us fda preferred term for this commodity. ipriflavone bears us nlm identifiers umls id c0123903 and nci concept code c63694. smiles: o(c(c)c)c1cc2occ(c(=o)c2cc1)c1ccccc1.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. minodronic acid. this classification denotes a bone resorption inhibitor with the molecular formula c9h12n2o7p2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 40sgr63tgl, chemically known as 1-hydroxy-2-(imidazo(1,2-a)pyridin-3-yl)ethane-1,1-bisphosphonic acid monohydrate but generally known as minodronic acid, which bears us nih compound identifier 130956. european medicines agency schedules minodronic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08981mig. the term minodronic acid is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). most nations schedule minodronic acid under hs 29339990 and sitc 51577. as of q4 2014, minodronic acid remains the us fda preferred term for this commodity. minodronic acid bears us nlm identifiers umls id c0256218 and nci concept code c81673. smiles: p(=o)(o)(o)c(p(=o)(o)o)(o)cc1n2c(nc1)cccc2.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. neridronic acid. this classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula c6h17no7p2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8u27u3rin4, chemically known as 6-amino-1-hydroxyhexane-1,1-diphosphonate but generally known as neridronic acid, which bears us nih compound identifier 71237. european medicines agency schedules neridronic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09205mig. the term neridronic acid is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). as of q4 2014, neridronic acid remains the us fda preferred term for this commodity. neridronic acid bears us nlm identifiers umls id c1882065 and nci concept code c66230. smiles: p(=o)(o)(o)c(p(=o)(o)o)(o)cccccn.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. olpadronic acid. this classification denotes a bone resorption inhibitor with the molecular formula c5h15no7p2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 874hhb2v3s, chemically known as phosphonic acid, (3-(dimethylamino)-1-hydroxypropylidene)bis- but generally known as olpadronic acid, which bears us nih compound identifier 198716. european medicines agency schedules olpadronic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09432mig. the term olpadronic acid is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). as of q4 2014, olpadronic acid remains the us fda preferred term for this commodity. olpadronic acid bears us nlm identifiers umls id c0285779 and nci concept code c79878. smiles: p(=o)(o)(o)c(p(=o)(o)o)(o)ccn(c)c.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. teriparatide. this classification denotes a recombinant parathyroid hormone with the molecular formula c181h291n55o51s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 10t9csu89i, chemically known as l-phenylalanine, l-seryl-l-valyl-l-seryl-l-alpha-glutamyl-l-isoleucyl-l-glutaminyl-l-leucyl-l-methionyl-l-histidyl-l-asparaginyl-l-leucylglycyl-l-lysyl-l-histidyl-l-leucyl-l-asparaginyl-l-seryl-l-methionyl-l-alpha-glutamyl-l-arginyl-l-valyl-l-alpha-glutamyl-l-tryptophyl-l-leucyl-l-arginyl-l-lysyl-l-lysyl-l-leucyl-l-glutaminyl-l-alpha-aspartyl-l-valyl-l-histidyl-l-asparaginyl- but generally known as teriparatide, which bears us nih compound identifier 16129682. european medicines agency schedules teriparatide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10925mig. the term teriparatide is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules teriparatide in its anatomical therapeutic chemical (atc) classification. teriparatide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule teriparatide under hs 29371900 and sitc 54154. as of q4 2014, teriparatide remains the us fda preferred term for this commodity. teriparatide bears us nlm identifiers umls id c0070093 and nci concept code c61966. smiles: s(ccc(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(n)co)c(c)c)co)ccc(=o)o)c(cc)c)ccc(=o)n)cc(c)c)c(=o)nc(cc1nc[nh]c1)c(=o)nc(c(=o)nc(cc(c)c)c(=o)ncc(=o)nc(ccccn)c(=o)nc(c(=o)nc(cc(c)c)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(c)c)c(=o)n.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. tiludronic acid. this classification denotes a bone resorption inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6pns59hp4y. european medicines agency schedules tiludronic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11060mig. tiludronic acid generally arises in the molecular formula c7h9clo6p2s. the term tiludronic acid is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29.) most nations schedule tiludronic acid under hs 29309085 and sitc 51549. as of q4 2014, tiludronic acid remains the us fda preferred term for this commodity. tiludronic acid bears us nlm identifiers umls id c0043611 and nci concept code c72091. smiles: clc1ccc(sc(p(=o)(o)o)p(=o)(o)o)cc1.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. cinacalcet hydrochloride. this classification denotes a malignancy-associated hypercalcemia inhibitor with the molecular formula c22h22f3n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1k860wsg25, chemically known as 1-naphthalenemethanamine, a-methyl-n-(3-(3-(trifluoromethyl)phenyl)propyl)-, (ar)-, hydrochloride but more generally known as cinacalcet hydrochloride, which bears us nih compound identifier 156418. european medicines agency schedules cinacalcet hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20068. most nations, for tariff and trade purposes, schedule cinacalcet hydrochloride under hs 29214980 and sitc 51454. as of q4 2014, cinacalcet hydrochloride remains us fdas preferred term for this commodity. cinacalcet hydrochloride bears us nlm identifiers umls id c1260199 and nci concept code c47450. smiles: c[c@h](c1cccc2c1cccc2)ncccc3cccc(c3)c(f)(f)f.cl.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. teriparatide acetate. this classification denotes a recombinant parathyroid hormone with the molecular formula c181h291n55o51s2.c2h4o2.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9959p4v12n. european medicines agency schedules teriparatide acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04726mig. the term teriparatide acetate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule teriparatide acetate under hs 29371900 and sitc 54154. as of q4 2014, teriparatide acetate remains us fdas preferred term for this commodity. teriparatide acetate bears us nlm identifiers umls id c1170286 and nci concept code c66588. smiles: cc(=o)o.o.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. teriparatide recombinant human. this classification denotes a recombinant parathyroid hormone with the molecular formula c181h291n55o51s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 10t9csu89i, chemically known as l-phenylalanine, l-seryl-l-valyl-l-seryl-l-alpha-glutamyl-l-isoleucyl-l-glutaminyl-l-leucyl-l-methionyl-l-histidyl-l-asparaginyl-l-leucylglycyl-l-lysyl-l-histidyl-l-leucyl-l-asparaginyl-l-seryl-l-methionyl-l-alpha-glutamyl-l-arginyl-l-valyl-l-alpha-glutamyl-l-tryptophyl-l-leucyl-l-arginyl-l-lysyl-l-lysyl-l-leucyl-l-glutaminyl-l-alpha-aspartyl-l-valyl-l-histidyl-l-asparaginyl- but more generally known as teriparatide, which bears us nih compound identifier 16129682. european medicines agency schedules teriparatide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10925mig. the term teriparatide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules teriparatide in its anatomical therapeutic chemical (atc) classification. teriparatide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule teriparatide recombinant human under hs 29371900. smiles:.. "
"calcium regulators and calcium salts. this classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.. sodium cellulose phosphate. this classification denotes a cation exchange resins and column chromatography, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier e6s1nj4y5q. european medicines agency schedules sodium cellulose phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15280mig. sodium cellulose phosphate generally arises in the molecular formula (c6h7o5)n.na.o3p.h. the term sodium cellulose phosphate is a united states adopted name designation.. "
"combination antithyroid agents and supplements. this classification denotes combination drugs used to treat hyperthyroidism by reducing the excessive production of thyroid hormones, hence the term antithyroid agents. typical combination antithyroid agent and supplement constituents are iodine and levothyroxine.. . "
"combination antithyroid agents and supplements. this classification denotes combination drugs used to treat hyperthyroidism by reducing the excessive production of thyroid hormones, hence the term antithyroid agents. typical combination antithyroid agent and supplement constituents are iodine and levothyroxine.. levothyroxine/liothyronine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs851. this va drug class (hs851) classifies this compound as belonging to the group thyroid supplements.. "
"combination hormones/synthetics/modifiers. this classification denotes combination drugs and preparations that consist in whole or part of chemical substances which originate in human glands, or are synthesized from secretions therefrom, having a specific regulatory effect on the activity of a certain organ or organs, and which bear the name hormones, or otherwise, additional preparations that amplify. inhibit, or alter affects of the same. typical combination hormone/synthetic/modifier constituents are cholecalciferol, fluoxymesterone, hydroxyprogesterone, medroxyprogesterone, methyltestosterone, norethindrone, norgestimate, progesterone, risedronate, and testosterone.. . "
"combination hormones/synthetics/modifiers. this classification denotes combination drugs and preparations that consist in whole or part of chemical substances which originate in human glands, or are synthesized from secretions therefrom, having a specific regulatory effect on the activity of a certain organ or organs, and which bear the name hormones, or otherwise, additional preparations that amplify. inhibit, or alter affects of the same. typical combination hormone/synthetic/modifier constituents are cholecalciferol, fluoxymesterone, hydroxyprogesterone, medroxyprogesterone, methyltestosterone, norethindrone, norgestimate, progesterone, risedronate, and testosterone.. diethylstilbestrol/methyltestosterone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs900. this va drug class (hs900) classifies this compound as belonging to the group hormones/synthetics/modifiers, other.. "
"combination oral hypoglycemic agents. this classification denotes combination drugs and preparations which lower blood glucose levels, which patients can swallow by pill or liquid, and which therefore bear the term oral hypoglycemic agents. practitioners deploy these agents against diabetes. typical constituents are glimepiride, glipizide, glyburide, metformin, etc. typical combination oral hypoglycemic agent constituents are glimepiride, glipizide, glyburide, and metformin.. . "
"combination oral hypoglycemic agents. this classification denotes combination drugs and preparations which lower blood glucose levels, which patients can swallow by pill or liquid, and which therefore bear the term oral hypoglycemic agents. practitioners deploy these agents against diabetes. typical constituents are glimepiride, glipizide, glyburide, metformin, etc. typical combination oral hypoglycemic agent constituents are glimepiride, glipizide, glyburide, and metformin.. glimepiride/pioglitazone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs502. this va drug class (hs502) classifies this compound as belonging to the group oral hypoglycemic agents, oral.. "
"combination oral hypoglycemic agents. this classification denotes combination drugs and preparations which lower blood glucose levels, which patients can swallow by pill or liquid, and which therefore bear the term oral hypoglycemic agents. practitioners deploy these agents against diabetes. typical constituents are glimepiride, glipizide, glyburide, metformin, etc. typical combination oral hypoglycemic agent constituents are glimepiride, glipizide, glyburide, and metformin.. glimepiride/rosiglitazone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs502. this va drug class (hs502) classifies this compound as belonging to the group oral hypoglycemic agents, oral.. "
"combination oral hypoglycemic agents. this classification denotes combination drugs and preparations which lower blood glucose levels, which patients can swallow by pill or liquid, and which therefore bear the term oral hypoglycemic agents. practitioners deploy these agents against diabetes. typical constituents are glimepiride, glipizide, glyburide, metformin, etc. typical combination oral hypoglycemic agent constituents are glimepiride, glipizide, glyburide, and metformin.. glipizide/metformin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs502. this va drug class (hs502) classifies this compound as belonging to the group oral hypoglycemic agents, oral.. "
"combination oral hypoglycemic agents. this classification denotes combination drugs and preparations which lower blood glucose levels, which patients can swallow by pill or liquid, and which therefore bear the term oral hypoglycemic agents. practitioners deploy these agents against diabetes. typical constituents are glimepiride, glipizide, glyburide, metformin, etc. typical combination oral hypoglycemic agent constituents are glimepiride, glipizide, glyburide, and metformin.. glyburide/metformin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs502. this va drug class (hs502) classifies this compound as belonging to the group oral hypoglycemic agents, oral.. "
"combination oral hypoglycemic agents. this classification denotes combination drugs and preparations which lower blood glucose levels, which patients can swallow by pill or liquid, and which therefore bear the term oral hypoglycemic agents. practitioners deploy these agents against diabetes. typical constituents are glimepiride, glipizide, glyburide, metformin, etc. typical combination oral hypoglycemic agent constituents are glimepiride, glipizide, glyburide, and metformin.. metformin/pioglitazone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs502. this va drug class (hs502) classifies this compound as belonging to the group oral hypoglycemic agents, oral.. "
"combination oral hypoglycemic agents. this classification denotes combination drugs and preparations which lower blood glucose levels, which patients can swallow by pill or liquid, and which therefore bear the term oral hypoglycemic agents. practitioners deploy these agents against diabetes. typical constituents are glimepiride, glipizide, glyburide, metformin, etc. typical combination oral hypoglycemic agent constituents are glimepiride, glipizide, glyburide, and metformin.. metformin/repaglinide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs502. this va drug class (hs502) classifies this compound as belonging to the group oral hypoglycemic agents, oral.. "
"combination oral hypoglycemic agents. this classification denotes combination drugs and preparations which lower blood glucose levels, which patients can swallow by pill or liquid, and which therefore bear the term oral hypoglycemic agents. practitioners deploy these agents against diabetes. typical constituents are glimepiride, glipizide, glyburide, metformin, etc. typical combination oral hypoglycemic agent constituents are glimepiride, glipizide, glyburide, and metformin.. metformin/rosiglitazone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs502. this va drug class (hs502) classifies this compound as belonging to the group oral hypoglycemic agents, oral.. "
"combination oral hypoglycemic agents. this classification denotes combination drugs and preparations which lower blood glucose levels, which patients can swallow by pill or liquid, and which therefore bear the term oral hypoglycemic agents. practitioners deploy these agents against diabetes. typical constituents are glimepiride, glipizide, glyburide, metformin, etc. typical combination oral hypoglycemic agent constituents are glimepiride, glipizide, glyburide, and metformin.. metformin/saxagliptin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs502. this va drug class (hs502) classifies this compound as belonging to the group oral hypoglycemic agents, oral.. "
"combination oral hypoglycemic agents. this classification denotes combination drugs and preparations which lower blood glucose levels, which patients can swallow by pill or liquid, and which therefore bear the term oral hypoglycemic agents. practitioners deploy these agents against diabetes. typical constituents are glimepiride, glipizide, glyburide, metformin, etc. typical combination oral hypoglycemic agent constituents are glimepiride, glipizide, glyburide, and metformin.. metformin/sitagliptin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs502. this va drug class (hs502) classifies this compound as belonging to the group oral hypoglycemic agents, oral.. "
"combination oxytocics. this classification denotes combination drugs and preparations that stimulate contraction of the myometrium, medically used to, for example, induce labor, or control postpartum or postabortion hemorrhage, or, in some cases, to induce abortion, which derive from the nonapeptide hormone oxytocin, and which therefore bear the term oxytocics. typical combination oxytocic constituents are dextrose and oxytocin.. . "
"combination oxytocics. this classification denotes combination drugs and preparations that stimulate contraction of the myometrium, medically used to, for example, induce labor, or control postpartum or postabortion hemorrhage, or, in some cases, to induce abortion, which derive from the nonapeptide hormone oxytocin, and which therefore bear the term oxytocics. typical combination oxytocic constituents are dextrose and oxytocin.. dextrose/oxytocin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu600. this va drug class (gu600) classifies this compound as belonging to the group oxytocics.. "
"combination phosphorus. this classification denotes combination drugs and preparations that contain a bio-chemically-active, non-metal element that bears atomic symbol p, atomic number 15, and atomic weight 31, known as phosphorus. typical combination phosphorus constituents are phosphoric acid, sodium biphosphate, sodium phosphate, etc.. . "
"combination phosphorus. this classification denotes combination drugs and preparations that contain a bio-chemically-active, non-metal element that bears atomic symbol p, atomic number 15, and atomic weight 31, known as phosphorus. typical combination phosphorus constituents are phosphoric acid, sodium biphosphate, sodium phosphate, etc.. calcium glycerophosphate/phosphoric acid/sodium glycerophosphate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn475. this va drug class (tn475) classifies this compound as belonging to the group phosphorus.. "
"combination anterior pituitary. this classification denotes combination drugs that consist of various combined compounds that deal with the adenohypophysis, or the anterior glandular lobe of the pituitary gland, hence the term anterior pituitary. typical combination anterior pituitary constituients are corticotropin and zinc hydroxide.. . "
"combination anterior pituitary. this classification denotes combination drugs that consist of various combined compounds that deal with the adenohypophysis, or the anterior glandular lobe of the pituitary gland, hence the term anterior pituitary. typical combination anterior pituitary constituients are corticotropin and zinc hydroxide.. corticotropin/zinc hydroxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs701. this va drug class (hs701) classifies this compound as belonging to the group anterior pituitary.. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. . "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. alrestatin. this classification denotes an aldose reductase inhibitor with the molecular formula c14h9no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 515dhk15lg, chemically known as 2,3-dihydro-1,3-dioxo-1h-benz(de)isochiolin-2-essigsaeure but more generally known as alrestatin, which bears us nih compound identifier 2120. alrestatin most often comes in natrium and sodium forms. european medicines agency schedules alrestatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05373mig. the term alrestatin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). alrestatin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule alrestatin under hs 29251995 and sitc 51482. as of q4 2014, alrestatin remains us fdas preferred term for this commodity. alrestatin bears us nlm identifiers umls id c0051486 and nci concept code c72917. smiles: o=c1n(c(=o)c2c3c1cccc3ccc2)cc(=o)o.. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. alrestatin sodium. this classification denotes an aldose reductase inhibitor with the molecular structure c14h8no4.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 018xnu6812 chemically known as 1h-benz(de)isoquinoline-2(3h)acetic acid, 1,3-dioxo-, sodium salt, but more commonly known as alrestatin sodium, which bears us nih compound identifier 40158. european medicines agency schedules alrestatin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00380mig. most nations, for tariff and trade purposes, schedule alrestatin sodium under hs 29251995 and sitc 51482. as of q4 2014, alrestatin sodium remains us fdas preferred term for this commodity. alrestatin sodium bears us nlm identifiers umls id c2346724 and nci concept code c72691. smiles: c1cc2cccc3c2c(c1)c(=o)n(c3=o)cc(=o)[o-].[na+].. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. benfluorex. this classification denotes an anti-lipidemic agent and anorexiant with the molecular formula c19h20f3no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 403fo0nqg3, chemically known as phenethylamine, n-(2-hydroxyethyl)-alpha-methyl-m-trifluoromethyl-, benzoate but more generally known as benfluorex, which bears us nih compound identifier 2318. benfluorex most often comes in base and hydrochloride forms. european medicines agency schedules benfluorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05714mig. the term benfluorex is an international non-proprietary name who schedules benfluorex in its anatomical therapeutic chemical (atc) classification. benfluorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule benfluorex under hs 29221980 and sitc 51461. as of q4 2014, benfluorex remains us fdas preferred term for this commodity. benfluorex bears us nlm identifiers umls id c0053105 and nci concept code c72936. smiles: fc(f)(f)c1cc(cc(nccoc(=o)c2ccccc2)c)ccc1.. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. benfluorex hydrochloride. this classification denotes an anti-lipidemic agent and anorexiant with the molecular formula c19h20f3no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x7o165xz00, chemically known as phenethylamine, n-(2-hydroxyethyl)-alpha-methyl-m-trifluoromethyl-, benzoate but more generally known as benfluorex hydrochloride, which bears us nih compound identifier 2318. european medicines agency schedules benfluorex hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00701mig. most nations, for tariff and trade purposes, schedule benfluorex hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, benfluorex hydrochloride remains us fdas preferred term for this commodity. smiles: cc(cc1cccc(c1)c(f)(f)f)nccoc(=o)c2ccccc2.cl.. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. gliflumide. this classification denotes an anti-diabetic agent with the molecular formula c25h29fn4o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) use67b01yn, chemically known as benzeneacetamide, n-((1s)-1-(5-fluoro-2-methoxyphenyl)ethyl)-4-(((5-(2-methylpropyl)-2-pyrimidinyl)amino)sulfonyl)- but more generally known as gliflumide, which bears us nih compound identifier 197722. european medicines agency schedules gliflumide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07924mig. the term gliflumide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 29, no. 10 1975, list 15). gliflumide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule gliflumide under hs 29350090 and sitc 51580. as of q4 2014, gliflumide remains us fdas preferred term for this commodity. gliflumide bears us nlm identifiers umls id c0061322 and nci concept code c72947. smiles: s(=o)(=o)(nc1ncc(cc(c)c)cn1)c1ccc(cc(=o)nc(c2c(oc)ccc(f)c2)c)cc1.. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. glycodiazine or glymidine. this classification denotes an antimuscarinic agent with the molecular formula c19h28no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a14fb57v1d, chemically known as 3-hydroxy-1,1-dimethylpyrrolidinium bromide .alpha.-cyclopentylmandelate but generally known as glycopyrrolate, which bears us nih compound identifier 3494. european medicines agency schedules glycopyrronium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02381mig. the term glycopyrronium bromide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules glycopyrrolate in its anatomical therapeutic chemical (atc) classification. as of q4 2014, glycopyrrolate remains the us fda preferred term for this commodity. glycopyrrolate bears us nlm identifiers umls id c0017970 and nci concept code c29078. smiles: c[n+]1(ccc(c1)oc(=o)c(c2cccc2)(c3=cc=cc=c3)o)c.. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. glymidine sodium. this classification denotes an anti-diabetic agent with the molecular formula c13h14n3o4s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qpy3c057x1, chemically known as benzenesulfonamide, n-(5-(2-methoxyethoxy)-2-pyrimidinyl)-, sodium salt but more generally known as glymidine sodium, which bears us nih compound identifier 18956. european medicines agency schedules glymidine sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07954mig. the term glymidine sodium is an international non-proprietary name or inn (see world health organization inn reference publication, volume 31, no10, 1977, list 17). most nations, for tariff and trade purposes, schedule glymidine sodium under hs 29350090. as of q4 2014, glymidine sodium remains us fdas preferred term for this commodity. smiles: coccoc1cnc(nc1)[n-]s(=o)(=o)c2ccccc2.[na+].. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. glypinamide. this classification denotes an anti-diabetic agent with the molecular formula c13h18cln3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) ore084u8ip, chemically known as urea, 1-((p-chlorophenyl)sulfonyl)-3-(hexahydro-1h-azepin-1-yl)- but more generally known as glypinamide, which bears us nih compound identifier 219111. european medicines agency schedules glypinamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07956mig. the term glypinamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). glypinamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule glypinamide under hs 29350090 and sitc 51580. as of q4 2014, glypinamide remains us fdas preferred term for this commodity. glypinamide bears us nlm identifiers umls id c1880993 and nci concept code c65811. smiles: clc1ccc(s(=o)(=o)nc(=o)nn2cccccc2)cc1.. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. glyprothiazol. this classification denotes an anti-diabetic agent with the molecular formula c11h14n4o2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 1804fjn4mo, chemically known as 4-amino-n-(5-(1-methylethyl)-1,3,4-thiadiazol-2-yl)benzenesulfonamide but more generally known as glyprothiazol, which bears us nih compound identifier 66458. european medicines agency schedules glyprothiazol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07957mig. the term glyprothiazol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). glyprothiazol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule glyprothiazol under hs 29350090 and sitc 51580. as of q4 2014, glyprothiazol remains us fdas preferred term for this commodity. glyprothiazol bears us nlm identifiers umls id c1880994 and nci concept code c65812. smiles: cc(c)c1=nn=c(s1)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. ingliforib. this classification denotes an anti-diabetic agent with the molecular formula c23h24cln3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) uii7156wlu, chemically known as 1h-indole-2-carboxamide, 5-chloro-n-((1s,2r)-3-((3r,4s)-3,4-dihydroxy-1-pyrrolidinyl)-2-hydroxy-3-oxo-1-(phenylmethyl)propyl)- but more generally known as ingliforib, which bears us nih compound identifier 6451325. the term ingliforib is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16., no. 1.2002, list 47). most nations, for tariff and trade purposes, schedule ingliforib under hs 29339990 and sitc 51577. as of q4 2014, ingliforib remains us fdas preferred term for this commodity. ingliforib bears us nlm identifiers umls id c1436456 and nci concept code c75982. smiles: c1c(c(cn1c(=o)c(c(cc2=cc=cc=c2)nc(=o)c3=cc4=c(n3)c=cc(=c4)cl)o)o)o.. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. meglitinide. this classification denotes an anti-diabetic agent with the molecular formula c17h16clno4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 8v6ok1i088, chemically known as benzoic acid, 4-(2-((5-chloro-2-methoxybenzoyl)amino)ethyl)- but more generally known as meglitinide, which bears us nih compound identifier 41214. european medicines agency schedules meglitinide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08713mig. the term meglitinide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). meglitinide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule meglitinide under hs 29242995 and sitc 51479. as of q4 2014, meglitinide remains us fdas preferred term for this commodity. meglitinide bears us nlm identifiers umls id c0065880 and nci concept code c66075. smiles: clc1cc(c(=o)nccc2ccc(cc2)c(=o)o)c(oc)cc1.. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. thiohexamide. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 6m8cv4tkxl. european medicines agency schedules thiohexamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10979mig. thiohexamide generally arises in the molecular formula c14h20n2o3s2. the term thiohexamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5.) thiohexamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule thiohexamide under hs 29350090 and sitc 51580. as of q4 2014, thiohexamide remains us fdas preferred term for this commodity. thiohexamide bears us nlm identifiers umls id c2348771 and nci concept code c72861. smiles: s(=o)(=o)(nc(=o)nc1ccccc1)c1ccc(sc)cc1.. "
"antidiabetic and hyperglycemic amides. this classification organic compounds containing the -co-nh2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amides.. tolpyrramide. this classification denotes an anti-diabetic agent with the molecular formula c12h16n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) w68dd2c7vg, chemically known as 1-pyrrolidinecarboxamide, n- (p-tolylsulfonyl)- but more generally known as tolpyrramide, which bears us nih compound identifier 267368. european medicines agency schedules tolpyrramide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11177mig. the term tolpyrramide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). tolpyrramide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule tolpyrramide under hs 29350090 and sitc 51580. as of q4 2014, tolpyrramide remains us fdas preferred term for this commodity. tolpyrramide bears us nlm identifiers umls id c2348802 and nci concept code c72872. smiles: cc1=cc=c(c=c1)s(=o)(=o)nc(=o)n2cccc2.. "
"antidiabetic and hyperglycemic amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amines.. . "
"antidiabetic and hyperglycemic amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amines.. alogliptin. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) jhc049lo86. european medicines agency schedules alogliptin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32564. alogliptin generally arises in the molecular formula c18h21n5o2. the term alogliptin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21, no. 3, 2007, list 58.) most nations, for tariff and trade purposes, schedule alogliptin under hs 29335990 and sitc 51576. as of q4 2014, alogliptin remains us fdas preferred term for this commodity. alogliptin bears us nlm identifiers umls id c1958126 and nci concept code c76906. smiles: cn1c(=o)c=c(n(c1=o)cc2=cc=cc=c2c#n)n3cccc(c3)n.. "
"antidiabetic and hyperglycemic amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amines.. alogliptin benzoate. this classification denotes an anti-diabetic agent c18h21n5o2.c7h6o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier een99869sc, chemically known as benzonitrile, 2-((6-((3r)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl)methyl)-, monobenzoate, but more generally known as alogliptin benzoate, which bears us nih compound identifier 16088021. european medicines agency schedules alogliptin benzoate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32165. most nations, for tariff and trade purposes, schedule alogliptin benzoate under hs 29335990 and sitc 51576. as of q4 2014, alogliptin benzoate remains us fdas preferred term for this commodity. alogliptin benzoate bears us nlm identifiers umls id c1958127 and nci concept code c75186. smiles: cn1c(=o)cc(n(c1=o)cc2ccccc2c#n)n3ccc[c@h](c3)n.c1ccc(cc1)c(=o)o.. "
"antidiabetic and hyperglycemic amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amines.. isaglidole. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) b51uc955kq. european medicines agency schedules isaglidole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08301mig. isaglidole generally arises in the molecular formula c11h13fn4. the term isaglidole is an international non-proprietary name or inn (see world health organization inn reference publication, volume 4, no. 3 1990, list 30.) isaglidole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule isaglidole under hs 29332990 and sitc 51573. as of q4 2014, isaglidole remains us fdas preferred term for this commodity. isaglidole bears us nlm identifiers umls id c1881270 and nci concept code c65966. smiles: c1cn=c(n1)nn2cc3=c(c2)c(=cc=c3)f.. "
"antidiabetic and hyperglycemic amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term antidiabetic and hyperglycemic amines.. tolrestat. this classification denotes an aldose reductase inhibitor with the molecular formula c16h14f3no3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 0t93lg5nmk, chemically known as glycine, n-((6-methoxy-5-(trifluoromethyl)-1-naphthalenyl)thioxomethyl)-n-methyl- but more generally known as tolrestat, which bears us nih compound identifier 53359. european medicines agency schedules tolrestat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11179mig. the term tolrestat is an international non-proprietary name or inn (see world health organization inn reference publication, volume 38, no. 6, 1984, list 24) who schedules tolrestat in its anatomical therapeutic chemical (atc) classification. tolrestat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule tolrestat under hs 29309085 and sitc 51549. as of q4 2014, tolrestat remains us fdas preferred term for this commodity. tolrestat bears us nlm identifiers umls id c0076808 and nci concept code c96310. smiles: s=c(n(cc(=o)o)c)c1c2c(c(c(oc)cc2)c(f)(f)f)ccc1.. "
"antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors. this classification denotes compounds that suppress incretins degradation by blocking dipeptidyl-peptidase iv action, thus correcting defective insulin and glucagon secretion, thus the term antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.. . "
"antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors. this classification denotes compounds that suppress incretins degradation by blocking dipeptidyl-peptidase iv action, thus correcting defective insulin and glucagon secretion, thus the term antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.. linagliptin. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3x29zej4r2. european medicines agency schedules linagliptin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31340. linagliptin generally arises in the molecular formula c25h28n8o2. the term linagliptin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 23, no. 1, 2009, list 61.) as of q4 2014, linagliptin remains us fdas preferred term for this commodity. linagliptin bears us nlm identifiers umls id c2746078 and nci concept code c83887. smiles: cc#ccn1c2=c(n=c1n3cccc(c3)n)n(c(=o)n(c2=o)cc4=nc5=cc=cc=c5c(=n4)c)c.. "
"antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors. this classification denotes compounds that suppress incretins degradation by blocking dipeptidyl-peptidase iv action, thus correcting defective insulin and glucagon secretion, thus the term antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.. saxagliptin. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 8i7io46ivq. european medicines agency schedules saxagliptin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25220. saxagliptin generally arises in the molecular formula c18h25n3o2. the term saxagliptin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19, no. 3, 2005, list 54.) most nations, for tariff and trade purposes, schedule saxagliptin under hs 29339990 and sitc 51577. saxagliptin bears us nlm identifiers umls id c1611934 and nci concept code c75983. smiles: oc12c3cc(cc(c1)(cc3)c(n)c(=o)n1c3c(c3)cc1c#n)c2.. "
"antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors. this classification denotes compounds that suppress incretins degradation by blocking dipeptidyl-peptidase iv action, thus correcting defective insulin and glucagon secretion, thus the term antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.. sitagliptin. this classification denotes a protease inhibitor with the molecular formula c16h15f6n5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) qfp0p1dv7z, chemically known as 4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8h)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate but more generally known as sitagliptin, which bears us nih compound identifier 6451150. european medicines agency schedules sitagliptin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25227 who schedules sitagliptin in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule sitagliptin under hs 29335990 and sitc 51576. as of q4 2014, sitagliptin remains us fdas preferred term for this commodity. sitagliptin bears us nlm identifiers umls id c1565750 and nci concept code c73838. smiles: p(=o)(o)(o)o.fc(f)(f)c1n2ccn(cc2nn1)c(=o)cc(n)cc1c(f)cc(f)c(f)c1.. "
"antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors. this classification denotes compounds that suppress incretins degradation by blocking dipeptidyl-peptidase iv action, thus correcting defective insulin and glucagon secretion, thus the term antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.. vildagliptin. this classification denotes a protease inhibitor and anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) i6b4b2u96p. european medicines agency schedules vildagliptin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25199. vildagliptin generally arises in the molecular formula c17h25n3o2. the term vildagliptin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 18, no. 3, 2004, list 52.) most nations, for tariff and trade purposes, schedule vildagliptin under hs 29339990 and sitc 51577. as of q4 2014, vildagliptin remains us fdas preferred term for this commodity. vildagliptin bears us nlm identifiers umls id c1570906 and nci concept code c66653. smiles: oc12cc3(ncc(=o)n4c(ccc4)c#n)cc(c1)cc(c3)c2.. "
"antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors. this classification denotes compounds that suppress incretins degradation by blocking dipeptidyl-peptidase iv action, thus correcting defective insulin and glucagon secretion, thus the term antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.. saxagliptin anhydrous. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8i7io46ivq. european medicines agency schedules saxagliptin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25220. saxagliptin generally arises in the molecular formula c18h25n3o2. the term saxagliptin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19, no. 3, 2005, list 54.) most nations, for tariff and trade purposes, schedule saxagliptin anhydrous under hs 29339990. as of q4 2014, saxagliptin anhydrous remains us fdas preferred term for this commodity. saxagliptin anhydrous bears us nlm identifiers umls id c2699273 and nci concept code c75984. smiles: c1[c@@h]2c[c@@h]2n([c@@h]1c#n)c(=o)[c@h]([c@]34c[c@@h]5cc(c3)c[c@@](c5)(c4)o)n.. "
"antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors. this classification denotes compounds that suppress incretins degradation by blocking dipeptidyl-peptidase iv action, thus correcting defective insulin and glucagon secretion, thus the term antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.. sitagliptin phosphate. this classification denotes a protease inhibitor and anti-diabetic agent with the molecular structure c16h15f6n5o.h2o.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, ts63ew8x6f chemically known as 1,2,4-triazolo(4,3-a)pyrazine, 7-((3r)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl)-5,6,7,8-tetrahydro-3-(trifluoromethyl), phosphate (1:1) monohydrate, but more commonly known as sitagliptin phosphate, which bears us nih compound identifier 11591741. european medicines agency schedules sitagliptin phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25200. most nations, for tariff and trade purposes, schedule sitagliptin phosphate under hs 29335990 and sitc 51576. as of q4 2014, sitagliptin phosphate remains us fdas preferred term for this commodity. sitagliptin phosphate bears us nlm identifiers umls id c1667080 and nci concept code c73811. smiles: c1c(c(cc(c1f)f)f)c[c@h](cc(=o)n2ccn3c(nnc3c(f)(f)f)c2)n.o.op(=o)(o)o.. "
"antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors. this classification denotes compounds that suppress incretins degradation by blocking dipeptidyl-peptidase iv action, thus correcting defective insulin and glucagon secretion, thus the term antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.. saxagliptin hydrochloride. this classification denotes a protease inhibitor and anti-diabetic agent with the molecular formula c18h25n3o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z8j84yix6l. european medicines agency schedules saxagliptin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub30804. the term saxagliptin hydrochloride is a u.s. fda designation. most nations, for tariff and trade purposes, schedule saxagliptin hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, saxagliptin hydrochloride remains us fdas preferred term for this commodity. saxagliptin hydrochloride bears us nlm identifiers umls id c2719771 and nci concept code c81702. smiles: c1[c@@h]2c[c@@h]2n([c@@h]1c#n)c(=o)[c@h]([c@]34c[c@@h]5cc(c3)c[c@@](c5)(c4)o)n.cl.. "
"antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors. this classification denotes compounds that suppress incretins degradation by blocking dipeptidyl-peptidase iv action, thus correcting defective insulin and glucagon secretion, thus the term antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.. sitagliptin phosphate hydrate. this classification denotes a protease inhibitor and anti-diabetic agent with the molecular structure c16h15f6n5o.h2o.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, ts63ew8x6f chemically known as 1,2,4-triazolo(4,3-a)pyrazine, 7-((3r)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl)-5,6,7,8-tetrahydro-3-(trifluoromethyl), phosphate (1:1) monohydrate, but more commonly known as sitagliptin phosphate, which bears us nih compound identifier 11591741. european medicines agency schedules sitagliptin phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25200. most nations, for tariff and trade purposes, schedule sitagliptin phosphate hydrate under hs 29335990. smiles: c1c(c(cc(c1f)f)f)c[c@h](cc(=o)n2ccn3c(nnc3c(f)(f)f)c2)n.o.op(=o)(o)o.. "
"antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors. this classification denotes compounds that suppress incretins degradation by blocking dipeptidyl-peptidase iv action, thus correcting defective insulin and glucagon secretion, thus the term antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.. saxagliptin monohydrate. this classification denotes an anti-diabetic agent c18h25n3o2.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9gb927lajw, chemically known as (1s,3s,5s)-2-((2s)-amino(3-hydroxytricyclo(3.3.1.1(sup 3,7))dec-1-yl)acetyl)2-azabicyclo(3.1.0)hexane-3-carbonitrile monohydrate, but more generally known as saxagliptin monohydrate, which bears us nih compound identifier 53297473. most nations, for tariff and trade purposes, schedule saxagliptin monohydrate under hs 29339990 and sitc 51577. as of q4 2014, saxagliptin monohydrate remains us fdas preferred term for this commodity. smiles: c1[c@@h]2c[c@@h]2n([c@@h]1c#n)c(=o)[c@h]([c@]34c[c@@h]5cc(c3)c[c@@](c5)(c4)o)n.o.. "
"antidiabetic and hyperglycemic glinides. this classification denotes benzoic-acid-based compounds that increased pro-insulin secretion, substances called glinides (after 4-(2-(5-chloro-2-methoxybenzamido)ethyl)benzoic acid, or meglitinide), thus the term antidiabetic and hyperglycemic glinides.. . "
"antidiabetic and hyperglycemic glinides. this classification denotes benzoic-acid-based compounds that increased pro-insulin secretion, substances called glinides (after 4-(2-(5-chloro-2-methoxybenzamido)ethyl)benzoic acid, or meglitinide), thus the term antidiabetic and hyperglycemic glinides.. aminoguanidine or pimagedine. this classification denotes a nitric oxide synthetase inhibitor with the molecular formula ch6n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier scq4ezq113, chemically known as guanidine, amino- but more generally known as aminoguanidine, which bears us nih compound identifier 2146. aminoguanidine comes in various forms, including bicarbonate, hemisulfate, hydrocarbonate, hydrochloride, hydrogencarbonate, monohydrochloride, nitrate, and sulfate. european medicines agency schedules pimagedine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09835mig. the term pimagedine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 8 no. 3 1994, list 34). aminoguanidine or pimagedine bears us nlm identifiers umls id c0282774 and nci concept code c84059. smiles: c(=nn)(n)n.. "
"antidiabetic and hyperglycemic glinides. this classification denotes benzoic-acid-based compounds that increased pro-insulin secretion, substances called glinides (after 4-(2-(5-chloro-2-methoxybenzamido)ethyl)benzoic acid, or meglitinide), thus the term antidiabetic and hyperglycemic glinides.. mitiglinide. this classification denotes an anti-diabetic agent with the molecular formula c19h25no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) d86i0xlb13, chemically known as (-)-(2s,3a,7a-cis)-alpha-benzylhexahydro-gamma-oxo-2-isoindolinebutyric acid but more generally known as mitiglinide, which bears us nih compound identifier 3047758. european medicines agency schedules mitiglinide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08999mig. the term mitiglinide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 12 no. 2 1999, list 40) who schedules mitiglinide in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule mitiglinide under hs 29339990 and sitc 51577. as of q4 2014, mitiglinide remains us fdas preferred term for this commodity. mitiglinide bears us nlm identifiers umls id c0906166 and nci concept code c81699. smiles: o=c(n1cc2c(c1)cccc2)cc(cc1ccccc1)c(=o)o.. "
"antidiabetic and hyperglycemic glinides. this classification denotes benzoic-acid-based compounds that increased pro-insulin secretion, substances called glinides (after 4-(2-(5-chloro-2-methoxybenzamido)ethyl)benzoic acid, or meglitinide), thus the term antidiabetic and hyperglycemic glinides.. nateglinide. this classification denotes an anti-diabetic agent with the molecular formula c19h27no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 41x3pwk4o2, chemically known as d-phenylalanine, n-((4-(1-methylethyl)cyclohexyl)carbonyl)-, trans- but more generally known as nateglinide, which bears us nih compound identifier 60026. european medicines agency schedules nateglinide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09170mig. the term nateglinide is an international non-proprietary name who schedules nateglinide in its anatomical therapeutic chemical (atc) classification. nateglinide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nateglinide under hs 29242995 and sitc 51479. as of q4 2014, nateglinide remains us fdas preferred term for this commodity. nateglinide bears us nlm identifiers umls id c1323198 and nci concept code c61858. smiles: o=c(nc(cc1ccccc1)c(=o)o)c1ccc(cc1)c(c)c.. "
"antidiabetic and hyperglycemic glinides. this classification denotes benzoic-acid-based compounds that increased pro-insulin secretion, substances called glinides (after 4-(2-(5-chloro-2-methoxybenzamido)ethyl)benzoic acid, or meglitinide), thus the term antidiabetic and hyperglycemic glinides.. repaglinide. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 668z8c33lu. european medicines agency schedules repaglinide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10280mig. repaglinide generally arises in the molecular formula c27h36n2o4. the term repaglinide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 6, no, 3 1992, list 32.) repaglinide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule repaglinide under hs 29333999 and sitc 51574. as of q4 2014, repaglinide remains us fdas preferred term for this commodity. repaglinide bears us nlm identifiers umls id c0246689 and nci concept code c47703. smiles: o=c(nc(c1c(n2ccccc2)cccc1)cc(c)c)cc1cc(occ)c(cc1)c(=o)o.. "
"antidiabetic and hyperglycemic glinides. this classification denotes benzoic-acid-based compounds that increased pro-insulin secretion, substances called glinides (after 4-(2-(5-chloro-2-methoxybenzamido)ethyl)benzoic acid, or meglitinide), thus the term antidiabetic and hyperglycemic glinides.. mitiglinide calcium. this classification denotes an anti-diabetic agent with the molecular formula 2c19h24no3.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p5wor98g68, chemically known as (s)-2-benzyl-4-oxo-4-(cis-perhydroisoindol-2-yl)butyric acid calcium salt, but more generally known as mitiglinide calcium, which bears us nih compound identifier 5478927. european medicines agency schedules mitiglinide calcium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08999mig. most nations, for tariff purposes, schedule mitiglinide calcium under hs 29339990. smiles: c1ccc(cc1)c[c@@h](cc(=o)n2c[c@h]3cccc[c@h]3c2)c(=o)[o-].c1ccc(cc1)c[c@@h](cc(=o)n2c[c@h]3cccc[c@h]3c2)c(=o)[o-].[ca+2].. "
"antidiabetic and hyperglycemic glinides. this classification denotes benzoic-acid-based compounds that increased pro-insulin secretion, substances called glinides (after 4-(2-(5-chloro-2-methoxybenzamido)ethyl)benzoic acid, or meglitinide), thus the term antidiabetic and hyperglycemic glinides.. mitiglinide calcium dihydrate. this classification denotes an anti-diabetic agent 2c19h24no3.ca.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9651c21w3z, chemically known as bis((2s)-2-benzyl-3-(cis-hexahydroisoindolin-2-ylcarbonyl)propionate) calcium dihydrate, d-, but more generally known as mitiglinide calcium dihydrate, which bears us nih compound identifier 6918235. european medicines agency schedules mitiglinide calcium dihydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21788. most nations, for tariff and trade purposes, schedule mitiglinide calcium dihydrate under hs 29339990 and sitc 51577. as of q4 2014, mitiglinide calcium dihydrate remains us fdas preferred term for this commodity. smiles: c1ccc(cc1)c[c@@h](cc(=o)n2c[c@h]3cccc[c@h]3c2)c(=o)[o-].c1ccc(cc1)c[c@@h](cc(=o)n2c[c@h]3cccc[c@h]3c2)c(=o)[o-].o.o.[ca+2].. "
"antidiabetic and hyperglycemic glinides. this classification denotes benzoic-acid-based compounds that increased pro-insulin secretion, substances called glinides (after 4-(2-(5-chloro-2-methoxybenzamido)ethyl)benzoic acid, or meglitinide), thus the term antidiabetic and hyperglycemic glinides.. mitiglinide calcium hydrate. this classification denotes an anti-diabetic agent with the molecular formula 2c19h24no3.ca.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9651c21w3z, chemically known as bis((2s)-2-benzyl-3-(cis-hexahydroisoindolin-2-ylcarbonyl)propionate) calcium dihydrate, d-, but more generally known as mitiglinide calcium hydrate, which bears us nih compound identifier 6918235. european medicines agency schedules mitiglinide calcium hydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08999mig. most nations, for tariff purposes, schedule mitiglinide calcium hydrate under hs 29339990. smiles: c1ccc(cc1)c[c@@h](cc(=o)n2c[c@h]3cccc[c@h]3c2)c(=o)[o-].c1ccc(cc1)c[c@@h](cc(=o)n2c[c@h]3cccc[c@h]3c2)c(=o)[o-].o.o.[ca+2].. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. . "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. benfosformin. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 49030p3c8s. european medicines agency schedules benfosformin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05715mig. benfosformin generally arises in the molecular formula c9h12n5o3p.2na.h2o. the term benfosformin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 27, no. 10 1973, list 13.) benfosformin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule benfosformin under hs 29299000 and sitc 51489. as of q4 2014, benfosformin remains us fdas preferred term for this commodity. benfosformin bears us nlm identifiers umls id c2346994 and nci concept code c72721. smiles: p(=o)(o)(o)/n=c(/n/c(=n/cc1ccccc1)n)n.[na].[na].o.. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. buformin. this classification denotes an anti-diabetic agent with the molecular formula c6h15n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) w2115e9c7b, chemically known as imidodicarbonimidic diamide, n-butyl- but more generally known as buformin, which bears us nih compound identifier 2468. buformin most often comes in base and hydrochloride forms. european medicines agency schedules buformin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05965mig. the term buformin is an international non-proprietary name who schedules buformin in its anatomical therapeutic chemical (atc) classification. buformin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule buformin under hs 29252900 and sitc 51482. as of q4 2014, buformin remains us fdas preferred term for this commodity. buformin bears us nlm identifiers umls id c0006359 and nci concept code c95328. smiles: n(=c(\\n=c(\\n)n)n)/cccc.. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. etoformin. this classification denotes an anti-diabetic agent with the molecular formula c8h19n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 630f8m4q1d, chemically known as 1-butyl-2-ethylbiguanide but more generally known as etoformin, which bears us nih compound identifier 170347. european medicines agency schedules etoformin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07322mig. most nations, for tariff and trade purposes, schedule etoformin under hs 29252900 and sitc 51482. as of q4 2014, etoformin remains us fdas preferred term for this commodity. etoformin bears us nlm identifiers umls id c1880583 and nci concept code c65589. smiles: ccccn=c(ncc)n=c(n)n.. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. linogliride. this classification denotes an anti-diabetic agent with the molecular formula c16h22n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 7e521jyj4x, chemically known as 4-morpholinecarboximidamide, n-(1-methyl-2-pyrrolidinylidene)-n-phenyl- but more generally known as linogliride, which bears us nih compound identifier 6536869. european medicines agency schedules linogliride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08521mig. the term linogliride is an international non-proprietary name or inn (see world health organization inn reference publication, volume 37, no. 6, 1983, list 23). linogliride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule linogliride under hs 29349990 and sitc 51579. as of q4 2014, linogliride remains us fdas preferred term for this commodity. linogliride bears us nlm identifiers umls id c0065013 and nci concept code c66015. smiles: o1ccn(cc1)/c(=n\\c1ccccc1)/n=c1/n(ccc1)c.. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. metformin. this classification denotes an anti-diabetic agent with the molecular formula c4h11n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 9100l32l2n, chemically known as 1,1-dimethylbiguanide but more generally known as metformin, which bears us nih compound identifier 4091. european medicines agency schedules metformin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08831mig. the term metformin is an international non-proprietary name who schedules metformin in its anatomical therapeutic chemical (atc) classification. metformin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule metformin under hs 29252900 and sitc 51482. as of q4 2014, metformin remains us fdas preferred term for this commodity. metformin bears us nlm identifiers umls id c0025598 and nci concept code c61612. smiles: n(c)(c)c(=n)/n=c(/n)n.. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. benfosformin anhydrous. this classification denotes the anhydrous form of an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 49030p3c8s. european medicines agency schedules benfosformin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05715mig. benfosformin generally arises in the molecular formula c9h12n5o3p.2na.h2o. the term benfosformin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 27, no. 10 1973, list 13.) benfosformin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule benfosformin anhydrous under hs 29299000. as of q4 2014, benfosformin anhydrous remains us fdas preferred term for this commodity. benfosformin anhydrous bears us nlm identifiers umls id c2698357 and nci concept code c79537. smiles: c1ccc(cc1)cnc(=n)nc(=n)np(=o)([o-])[o-].[na+].[na+].. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. buformin hydrochloride. this classification denotes an anti-diabetic agent with the molecular formula c6h15n5.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d947sxo87p, chemically known as imidodicarbonimidic diamide, n-butyl- but more generally known as buformin hydrochloride, which bears us nih compound identifier 2468. european medicines agency schedules buformin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00892mig. most nations, for tariff and trade purposes, schedule buformin hydrochloride under hs 29252900 and sitc 51482. as of q4 2014, buformin hydrochloride remains us fdas preferred term for this commodity. buformin hydrochloride bears us nlm identifiers umls id c2987056 and nci concept code c95329. smiles: ccccnc(=n)nc(=n)n.cl.. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. metformin embonate. this classification denotes an anti-diabetic agent with the molecular formula c23h16o6.2c4h11n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v9azj7gjz1, chemically known as 2-naphthalenecarboxylic acid, 4,4-methylenebis(3-hydroxy-, compd. with n,n-dimethylimidodicarbonimidic diamide (1:2), but more generally known as metformin embonate, which bears us nih compound identifier 62987. european medicines agency schedules metformin embonate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08831mig. most nations, for tariff purposes, schedule metformin embonate under hs 29252900. smiles: cn(c)c(=n)nc(=n)n.cn(c)c(=n)nc(=n)n.c1ccc2c(c1)cc(c(c2cc3c4ccccc4cc(c3o)c(=o)o)o)c(=o)o.. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. metformin glycinate. this classification denotes an anti-diabetic agent c4h11n5.c2h5no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yei21w005y, chemically known as glycine, compd. with n,n-dimethylimidodicarbonimidic diamide (1:1), but more generally known as metformin glycinate, which bears us nih compound identifier 44520175. most nations, for tariff and trade purposes, schedule metformin glycinate under hs 29252900 and sitc 51482. as of q4 2014, metformin glycinate remains us fdas preferred term for this commodity. smiles: cn(c)c(=n)nc(=n)n.c(c(=o)o)n.. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. metformin hydrochloride. this classification denotes an anti-diabetic agent with the molecular formula c4h11n5.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 786z46389e, chemically known as 1,1-dimethylbiguanide but more generally known as metformin hydrochloride, which bears us nih compound identifier 4091. european medicines agency schedules metformin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03200mig. most nations, for tariff and trade purposes, schedule metformin hydrochloride under hs 29252900 and sitc 51482. as of q4 2014, metformin hydrochloride remains us fdas preferred term for this commodity. metformin hydrochloride bears us nlm identifiers umls id c0770893 and nci concept code c29251. smiles: cn(c)c(=n)nc(=n)n.cl.. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. phenformin. this classification denotes an anti-diabetic agent with the molecular formula c10h15n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) dd5k7529ce, chemically known as imidodicarbonimidic diamide, n- (2-phenylethyl)-, monohydrochloride but more generally known as phenformin, which bears us nih compound identifier 8249. european medicines agency schedules phenformin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09761mig. the term phenformin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4) who schedules phenformin in its anatomical therapeutic chemical (atc) classification. phenformin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule phenformin under hs 29252900 and sitc 51482. as of q4 2014, phenformin remains us fdas preferred term for this commodity. phenformin bears us nlm identifiers umls id c0031404 and nci concept code c81700. smiles: c1=cc=c(c=c1)ccn=c(n)n=c(n)n.. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. metformin orotate. this classification denotes an anti-diabetic agent with the molecular formula c5h4n2o4.c4h11n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ke1d8ap3j5, chemically known as 4-pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, compd. with n,n-dimethylimidodicarbonimidic diamide (1:1), but more generally known as metformin orotate, which bears us nih compound identifier 124097. european medicines agency schedules metformin orotate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08831mig. most nations, for tariff purposes, schedule metformin orotate under hs 29252900. smiles: cn(c)c(=n)nc(=n)n.c1c([nh]c(=o)[nh]c1=o)c(=o)o.. "
"antidiabetic and hyperglycemic guanidines. this classification denotes iminourea derivatives based in whole or part on guanidine or ch5n3, substances called guanidines, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic guanidines.. phenformin hydrochloride. this classification denotes an anti-diabetic agent with the molecular formula c10h15n5.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 91xc93eu03, chemically known as imidodicarbonimidic diamide, n- (2-phenylethyl)-, monohydrochloride but more generally known as phenformin hydrochloride, which bears us nih compound identifier 8249. european medicines agency schedules phenformin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03743mig. most nations, for tariff and trade purposes, schedule phenformin hydrochloride under hs 29252900 and sitc 51482. as of q4 2014, phenformin hydrochloride remains us fdas preferred term for this commodity. phenformin hydrochloride bears us nlm identifiers umls id c0770237 and nci concept code c81696. smiles: c1ccc(cc1)ccnc(=n)nc(=n)n.cl.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. . "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. exenatide. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 9p1872d4ol. european medicines agency schedules exenatide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21818. exenatide generally arises in the molecular formula c184h282n50o60s. the term exenatide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 18, no. 1, 2004, list 51.) most nations, for tariff and trade purposes, schedule exenatide under hs 29332990 and sitc 51573. as of q4 2014, exenatide remains us fdas preferred term for this commodity. exenatide bears us nlm identifiers umls id c0167117 and nci concept code c65611. smiles: none.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. glucagon. this classification denotes a peptide hormone, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 76la80ig2g. european medicines agency schedules glucagon in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02347mig. glucagon generally arises in the molecular formula c153h225n43o49s. the term glucagon is a european pharmacopoeia designation. glucagon is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule glucagon under hs 29371900 and sitc 54154. as of q4 2014, glucagon remains us fdas preferred term for this commodity. glucagon bears us nlm identifiers umls id c0017687 and nci concept code c2268. smiles: s(ccc(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)cnc(=o)c(nc(=o)c(nc(=o)c(n)cc1nc[nh]c1)co)ccc(=o)n)c(o)c)cc1ccccc1).. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin. this classification denotes a therapeutic insulin with the molecular formula c256h381n65o79s6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) d933668qvx, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears us nih compound identifier 16129672. european medicines agency schedules insulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02689mig. the term insulin aspart is an international non-proprietary name or inn (see world health organization inn reference publication, volume 11, no. 3 1997, list 38) who schedules insulin in its anatomical therapeutic chemical (atc) classification. insulin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule insulin under hs 29371200 and sitc 54154. insulin bears us nlm identifiers umls id cl026873 and nci concept code c2271. smiles: scc(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)cnc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(n)cc1ccccc1)c(c)c)cc(=o)n)ccc(=o)n)cc1[nh]cnc1)cc(c)c)cs)co)cc1[nh]cnc1)cc(c)c)c(c)c)ccc(=o)o)c)cc(c)c)cc1ccc(o)cc1)cc(c)c)c(c)c)c(=o)ncc(=o)nc(ccc(=o)o)c(=o)nc(cccnc(=n)n)c(=o)ncc(=o)nc(cc1ccccc1)c(=o)nc(cc1ccccc1)c(=o)nc(cc1ccc(o)cc1)c(=o)nc(c(o)c)c(=o)nc(c(=o)nc(ccccn)c(=o)nc(c(o)c)c(=o)o)cc(=o)o.scc(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)cn)c(cc)c)c(c)c)ccc(=o)o)ccc(=o)n)cs)cs)c(o)c)co)c(cc)c)c(=o)nc(c(=o)nc(cc(c)c)c(=o)nc(cc1ccc(o)cc1)c(=o)nc(c(=o)nc(cc(c)c)c(=o)nc(ccc(=o)o)c(=o)nc(cc(=o)n)c(=o)nc(cc1ccc(o)cc1)c(=o)nc(cs)c(=o)nc(cc(=o)n)c(=o)o)ccc(=o)n)co.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. exenatide synthetic. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9p1872d4ol. european medicines agency schedules exenatide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21818. exenatide synthetic generally arises in the molecular formula c184h282n50o60s. the term exenatide synthetic is a u.s. fda orange book designation. most nations, for tariff and trade purposes, schedule exenatide synthetic under hs 29332990. smiles:.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. glucagon hydrochloride. this classification denotes a therapeutic hormone, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1h87nvf4db. european medicines agency schedules glucagon hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02349mig. glucagon hydrochloride generally arises in the molecular formula c153h225n43o49s.clh. the term glucagon hydrochloride is a u.s. fda orange book designation. most nations, for tariff and trade purposes, schedule glucagon hydrochloride under hs 29371900 and sitc 54154. glucagon hydrochloride bears us nlm identifiers umls id c0795614 and nci concept code c87236. smiles: as of q4 2014, glucagon hydrochloride remains us fdas preferred term for this commodity.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin argine. this classification denotes a peptide hormone , a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 785p1qwq1n, chemically known as insulin (human), 30ba-l-arginine-30bb-l-arginine-, but more generally known as insulin argine, which bears us nih compound identifier 16132322. european medicines agency schedules insulin argine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08194mig. most nations, for tariff and trade purposes, schedule insulin argine under hs 29371200 and sitc 54154. smiles: as of q4 2014, insulin argine remains us fdas preferred term for this commodity.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin aspart. this classification denotes a therapeutic insulin with the molecular formula c256h381n65o79s6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) d933668qvx, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears us nih compound identifier 16129672. european medicines agency schedules insulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02689mig. the term insulin aspart is an international non-proprietary name or inn (see world health organization inn reference publication, volume 11, no. 3 1997, list 38) who schedules insulin in its anatomical therapeutic chemical (atc) classification. insulin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule insulin aspart under hs 29371900 and sitc 54154. as of q4 2014, insulin aspart remains us fdas preferred term for this commodity. insulin aspart bears us nlm identifiers umls id c0123677 and nci concept code c47563. smiles: scc(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)cnc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(n)cc1ccccc1)c(c)c)cc(=o)n)ccc(=o)n)cc1[nh]cnc1)cc(c)c)cs)co)cc1[nh]cnc1)cc(c)c)c(c)c)ccc(=o)o)c)cc(c)c)cc1ccc(o)cc1)cc(c)c)c(c)c)c(=o)ncc(=o)nc(ccc(=o)o)c(=o)nc(cccnc(=n)n)c(=o)ncc(=o)nc(cc1ccccc1)c(=o)nc(cc1ccccc1)c(=o)nc(cc1ccc(o)cc1)c(=o)nc(c(o)c)c(=o)nc(c(=o)nc(ccccn)c(=o)nc(c(o)c)c(=o)o)cc(=o)o.scc(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)cn)c(cc)c)c(c)c)ccc(=o)o)ccc(=o)n)cs)cs)c(o)c)co)c(cc)c)c(=o)nc(c(=o)nc(cc(c)c)c(=o)nc(cc1ccc(o)cc1)c(=o)nc(c(=o)nc(cc(c)c)c(=o)nc(ccc(=o)o)c(=o)nc(cc(=o)n)c(=o)nc(cc1ccc(o)cc1)c(=o)nc(cs)c(=o)nc(cc(=o)n)c(=o)o)ccc(=o)n)co.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin beef. this classification denotes a peptide hormone with the molecular formula c254h377n65o75s6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 576o9iz534, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears us nih compound identifier 16129672. european medicines agency schedules insulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02689mig. the term insulin is an international non-proprietary name. insulin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, insulin beef remains us fdas preferred term for this commodity.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin detemir. this classification denotes a therapeutic insulin with the molecular formula c267h402n64o76s6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4ft78t86xv, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears us nih compound identifier 16129672. european medicines agency schedules insulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02689mig. the term insulin detemir is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13 no. 3, 1999, list 42) who schedules insulin in its anatomical therapeutic chemical (atc) classification. insulin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule insulin detemir under hs 29349990 and sitc 51579. insulin detemir bears us nlm identifiers umls id c0537270 and nci concept code c65920. smiles: as of q4 2014, insulin detemir remains us fdas preferred term for this commodity.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin glargine. this classification denotes a therapeutic insulin with the molecular formula c267h404n72o78s6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2zm8cx04rz, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears us nih compound identifier 16129672. european medicines agency schedules insulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02689mig. the term insulin glargine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 11, no. 3 1997, list 38) who schedules insulin in its anatomical therapeutic chemical (atc) classification. insulin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule insulin glargine under hs 29371900 and sitc 54154. smiles:. as of q4 2014, insulin glargine remains us fdas preferred term for this commodity. . insulin glargine bears us nlm identifiers umls id c0907402 and nci concept code c47564.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. liraglutide. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 839i73s42a. european medicines agency schedules liraglutide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25238. liraglutide generally arises in the molecular formula c172h265n43o51. the term liraglutide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 17, no. 2uy, 2003, list 49.) most nations, for tariff and trade purposes, schedule liraglutide under hs 29371900 and sitc 54154. as of q4 2014, liraglutide remains us fdas preferred term for this commodity. liraglutide bears us nlm identifiers umls id c1456408 and nci concept code c82239. smiles: cccccccccccccccc(=o)nc(ccc(=o)o)c(=o)nccccc(c(=o)nc(ccc(=o)o)c(=o)nc(cc1=cc=cc=c1)c(=o)nc(c(c)cc)c(=o)nc(c)c(=o)nc(cc2=cnc3=cc=cc=c32)c(=o)nc(cc(c)c)c(=o)nc(c(c)c)c(=o)nc(cccnc(=n)n)c(=o)ncc(=o)nc(cccnc(=n)n)c(=o)ncc(=o)o)nc(=o)c(c)nc(=o)c(c)nc(=o)c(ccc(=o)n)nc(=o)cnc(=o)c(ccc(=o)o)nc(=o)c(cc(c)c)nc(=o)c(cc4=cc=c(c=c4)o)nc(=o)c(co)nc(=o)c(co)nc(=o)c(c(c)c)nc(=o)c(cc(=o)o)nc(=o)c(co)nc(=o)c(c(c)o)nc(=o)c(cc5=cc=cc=c5)nc(=o)c(c(c)o)nc(=o)cnc(=o)c(ccc(=o)o)nc(=o)c(c)nc(=o)c(cc6=cn=cn6)n.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. pancreatic extract. this classification denotes extracts prepared from pancreatic tissue that may contain the pancreatic enzymes or other specific uncharacterized factors or proteins with specific activities.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin glulisine. this classification denotes a therapeutic insulin with the molecular formula c258h384n64o78s6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7xiy785azd, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears us nih compound identifier 16129672. european medicines agency schedules insulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02689mig. the term insulin glulisine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 15 no. 3-4, 2001, list 46) who schedules insulin in its anatomical therapeutic chemical (atc) classification. insulin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule insulin glulisine under hs 29371900 and sitc 54154. smiles:. as of q4 2014, insulin glulisine remains us fdas preferred term for this commodity. . insulin glulisine bears us nlm identifiers umls id c1313386 and nci concept code c65921.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin human. this classification denotes a therapeutic insulin with the molecular formula c257h383n65o77s6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 1y17cti5sr, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears us nih compound identifier 16129672. european medicines agency schedules insulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02689mig. the term insulin human is an international non-proprietary name or inn (see world health organization inn reference publication, volume 37, no. 6, 1983, list 23). insulin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule insulin human under hs 29371200 and sitc 54154. as of q4 2014, insulin human remains us fdas preferred term for this commodity. insulin human bears us nlm identifiers umls id c0795635 and nci concept code c65922. smiles: ccc(c)c1c(=o)nc2csscc(c(=o)nc(csscc(c(=o)ncc(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(csscc(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc2=o)co)cc(c)c)cc3=cc=c(c=c3)o)ccc(=o)n)cc(c)c)ccc(=o)o)cc(=o)n)cc4=cc=c(c=c4)o)c(=o)nc(cc(=o)n)c(=o)o)c(=o)ncc(=o)nc(ccc(=o)o)c(=o)nc(cccnc(=n)n)c(=o)ncc(=o)nc(cc5=cc=cc=c5)c(=o)nc(cc6=cc=cc=c6)c(=o)nc(cc7=cc=c(c=c7)o)c(=o)nc(c(c)o)c(=o)n8cccc8c(=o)nc(ccccn)c(=o)nc(c(c)o)c(=o)o)c(c)c)cc(c)c)cc9=cc=c(c=c9)o)cc(c)c)c)ccc(=o)o)c(c)c)cc(c)c)cc2=cn=cn2)co)nc(=o)c(cc(c)c)nc(=o)c(cc2=cn=cn2)nc(=o)c(ccc(=o)n)nc(=o)c(cc(=o)n)nc(=o)c(c(c)c)nc(=o)c(cc2=cc=cc=c2)n)c(=o)nc(c(=o)nc(c(=o)n1)co)c(c)o)nc(=o)c(ccc(=o)n)nc(=o)c(ccc(=o)o)nc(=o)c(c(c)c)nc(=o)c(c(c)cc)nc(=o)cn.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin lispro. this classification denotes a therapeutic insulin with the molecular formula c257h383n65o77s6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gfx7qis1ii, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears us nih compound identifier 16129672. european medicines agency schedules insulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02689mig. the term insulin is an international non-proprietary name who schedules insulin in its anatomical therapeutic chemical (atc) classification. insulin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule insulin lispro under hs 29349990 and sitc 51579. insulin lispro bears us nlm identifiers umls id c0293359 and nci concept code c29123. smiles: as of q4 2014, insulin lispro remains us fdas preferred term for this commodity.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin peglispro. this classification denotes a peptide hormone c8h16n2o4(c2h4o)n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6y83i5f10i, chemically known as poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-methoxy-, 28b-ester with 28b-(n6-carboxy-l-lysine)-29b-l-prolineinsulin (human), but more generally known as insulin peglispro, which bears us nih compound identifier 71301236. most nations, for tariff and trade purposes, schedule insulin peglispro under hs 29371200 and sitc 54154. smiles: as of q4 2014, insulin peglispro remains us fdas preferred term for this commodity.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin porcine. this classification denotes a therapeutic insulin with the molecular formula c256h381n65o76s6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier avt680jb39, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-, but more generally known as insulin porcine, which bears us nih compound identifier 16131098. european medicines agency schedules insulin porcine or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02689mig. most nations, for tariff purposes, schedule insulin porcine under hs 29371200. smiles:.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. insulin pork. this classification denotes a peptide hormone with the molecular formula c256h381n65o76s6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) avt680jb39, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears us nih compound identifier 16129672. european medicines agency schedules insulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02689mig. the term insulin is an international non-proprietary name. insulin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule insulin pork under hs 29371200 and sitc 54154. as of q4 2014, insulin pork remains us fdas preferred term for this commodity. insulin pork bears us nlm identifiers umls id c0770206 and nci concept code c65923. smiles: ccc(c)c1c(=o)nc2csscc(c(=o)nc(csscc(c(=o)ncc(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(csscc(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc2=o)co)cc(c)c)cc3=cc=c(c=c3)o)ccc(=o)n)cc(c)c)ccc(=o)o)cc(=o)n)cc4=cc=c(c=c4)o)c(=o)nc(cc(=o)n)c(=o)o)c(=o)ncc(=o)nc(ccc(=o)o)c(=o)nc(cccnc(=n)n)c(=o)ncc(=o)nc(cc5=cc=cc=c5)c(=o)nc(cc6=cc=cc=c6)c(=o)nc(cc7=cc=c(c=c7)o)c(=o)nc(c(c)o)c(=o)n8cccc8c(=o)nc(ccccn)c(=o)nc(c)c(=o)o)c(c)c)cc(c)c)cc9=cc=c(c=c9)o)cc(c)c)c)ccc(=o)o)c(c)c)cc(c)c)cc2=cn=cn2)co)nc(=o)c(cc(c)c)nc(=o)c(cc2=cn=cn2)nc(=o)c(ccc(=o)n)nc(=o)c(cc(=o)n)nc(=o)c(c(c)c)nc(=o)c(cc2=cc=cc=c2)n)c(=o)nc(c(=o)nc(c(=o)n1)co)c(c)o)nc(=o)c(ccc(=o)n)nc(=o)c(ccc(=o)o)nc(=o)c(c(c)c)nc(=o)c(c(c)cc)nc(=o)cn.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. pramlintide. this classification denotes an anti-diabetic agent with the molecular formula c171h267n51o53s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) d3fm8fa78t, chemically known as l-tyrosinamide, l-lysyl-l-cysteinyl-l-asparaginyl-l-threonyl-l-alanyl-l-threonyl-l-cysteinyl-l-alanyl-l-threonyl-l-glutaminyl-l-arginyl-l-leucyl-l-alanyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-valyl-l-histidyl-l-seryl-l-seryl-l-asparaginyl-l-asparaginyl-l-phenylalanylglycyl-l-prolyl-l-isoleucyl-l-leucyl-l-prolyl-l-prolyl-l-threonyl-l-asparaginyl-l-valylglycyl-l-seryl-l-asparaginyl-l-threonyl-, cyclic (2-7)-disulfide but more generally known as pramlintide, which bears us nih compound identifier 16132446. european medicines agency schedules pramlintide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09993mig. the term pramlintide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 10, no. 3, 1996, list 36) who schedules pramlintide in its anatomical therapeutic chemical (atc) classification. pramlintide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule pramlintide under hs 29349990 and sitc 51579. as of q4 2014, pramlintide remains us fdas preferred term for this commodity. pramlintide bears us nlm identifiers umls id c0537551 and nci concept code c61901. smiles: scc(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(n)ccccn)cs)cc(=o)n)c(o)c)c)c(o)c)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(cccnc(=n)n)c(=o)nc(cc(c)c)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)ncc(=o)n1c(ccc1)c(=.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. pramlintide acetate. this classification denotes an anti-diabetic agent with the molecular formula c171h267n51o53s2.c2h4o2.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 726i6te06g. european medicines agency schedules pramlintide acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12564mig. the term pramlintide acetate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule pramlintide acetate under hs 29349990 and sitc 51579. as of q4 2014, pramlintide acetate remains us fdas preferred term for this commodity. pramlintide acetate bears us nlm identifiers umls id c1174780 and nci concept code c61902. smiles: ccc(c)c(c(=o)nc(cc(c)c)c(=o)n1cccc1c(=o)n2cccc2c(=o)nc(c(c)o)c(=o)nc(cc(=o)n)c(=o)nc(c(c)c)c(=o)ncc(=o)nc(co)c(=o)nc(cc(=o)n)c(=o)nc(c(c)o)c(=o)nc(cc3=cc=c(c=c3)o)c(=o)n)nc(=o)c4cccn4c(=o)cnc(=o)c(cc5=cc=cc=c5)nc(=o)c(cc(=o)n)nc(=o)c(cc(=o)n)nc(=o)c(co)nc(=o)c(co)nc(=o)c(cc6=cn=cn6)nc(=o)c(c(c)c)nc(=o)c(cc(c)c)nc(=o)c(cc7=cc=cc=c7)nc(=o)c(cc(=o)n)nc(=o)c(c)nc(=o)c(cc(c)c)nc(=o)c(cccnc(=n)n)nc(=o)c(ccc(=o)n)nc(=o)c(c(c)o)nc(=o)c(c)nc(=o)c(cs)nc(=o)c(c(c)o)nc(=o)c(c)nc(=o)c(c(c)o)nc(=o)c(cc(=o)n)nc(=o)c(cs)nc(=o)c(ccccn)n.. "
"antidiabetic and hyperglycemic peptide hormones. this classification denotes hormones synthesized from amino acids, substances called peptide hormones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic peptide hormones.. invert sugar. this classification denotes a cariogenic agents and fructose, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier ed959s6acy. european medicines agency schedules invert sugar in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14234mig. invert sugar generally arises in the molecular formula 2c6h12o6. the term invert sugar is a u.s. fda designation.. "
"antidiabetic and hyperglycemic thiazolidinediones. this classification denotes substances that chemically consist of thiazoles with two keto oxygens, substances thus called thiazoli-di-nediones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic thiazolidinediones.. . "
"antidiabetic and hyperglycemic thiazolidinediones. this classification denotes substances that chemically consist of thiazoles with two keto oxygens, substances thus called thiazoli-di-nediones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic thiazolidinediones.. ciglitazone. this classification denotes an anti-diabetic agent with the molecular formula c18h23no3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) u8qxs1wu8g, chemically known as 2,4-thiazolidinedione, 5-((4-((1-methylcyclohexyl)methoxy)phenyl)methyl)-, (+-)- but more generally known as ciglitazone, which bears us nih compound identifier 2750. european medicines agency schedules ciglitazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06260mig. the term ciglitazone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 38, no. 6, 1984, list 24). ciglitazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule ciglitazone under hs 29341000 and sitc 51579. as of q4 2014, ciglitazone remains us fdas preferred term for this commodity. ciglitazone bears us nlm identifiers umls id c0055721 and nci concept code c72726. smiles: s1c(cc2ccc(occ3(ccccc3)c)cc2)c(=o)nc1=o.. "
"antidiabetic and hyperglycemic thiazolidinediones. this classification denotes substances that chemically consist of thiazoles with two keto oxygens, substances thus called thiazoli-di-nediones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic thiazolidinediones.. netoglitazone. this classification denotes an anti-diabetic agent with the molecular formula c21h16fno3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) qov2jz647a, chemically known as 2,4-thiazolidinedione, 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)- but more generally known as netoglitazone, which bears us nih compound identifier 204109. the term netoglitazone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16., no. 1.2002, list 47). most nations, for tariff and trade purposes, schedule netoglitazone under hs 29341000 and sitc 51579. as of q4 2014, netoglitazone remains us fdas preferred term for this commodity. netoglitazone bears us nlm identifiers umls id c1721279 and nci concept code c72822. smiles: c1=cc=c(c(=c1)coc2=cc3=c(c=c2)c=c(c=c3)cc4c(=o)nc(=o)s4)f.. "
"antidiabetic and hyperglycemic thiazolidinediones. this classification denotes substances that chemically consist of thiazoles with two keto oxygens, substances thus called thiazoli-di-nediones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic thiazolidinediones.. pioglitazone. this classification denotes an anti-diabetic agent with the molecular formula c19h20n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) x4ov71u42s, chemically known as 2,4-thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)- but more generally known as pioglitazone, which bears us nih compound identifier 4829. european medicines agency schedules pioglitazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09857mig. the term pioglitazone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29) who schedules pioglitazone in its anatomical therapeutic chemical (atc) classification. pioglitazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule pioglitazone under hs 29341000 and sitc 51579. as of q4 2014, pioglitazone remains us fdas preferred term for this commodity. pioglitazone bears us nlm identifiers umls id c0071097 and nci concept code c71633. smiles: s1c(cc2ccc(occc3ncc(cc)cc3)cc2)c(=o)nc1=o.. "
"antidiabetic and hyperglycemic thiazolidinediones. this classification denotes substances that chemically consist of thiazoles with two keto oxygens, substances thus called thiazoli-di-nediones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic thiazolidinediones.. rivoglitazone. this classification denotes an anti-diabetic agent with the molecular formula c20h19n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 3a3n0634q6, chemically known as 2,4-thiazolidinedione, 5-((4-((6-methoxy-1-methyl-1h-benzimidazol-2-yl)methoxy)phenyl)methyl)-; but more generally known as rivoglitazone, which bears us nih compound identifier 3055168. the term rivoglitazone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 15 no. 3-4, 2001, list 46). most nations, for tariff and trade purposes, schedule rivoglitazone under hs 29341000 and sitc 51579. as of q4 2014, rivoglitazone remains us fdas preferred term for this commodity. rivoglitazone bears us nlm identifiers umls id c1958863 and nci concept code c72841. smiles: cn1c2=c(c=cc(=c2)oc)n=c1coc3=cc=c(c=c3)cc4c(=o)nc(=o)s4.. "
"antidiabetic and hyperglycemic thiazolidinediones. this classification denotes substances that chemically consist of thiazoles with two keto oxygens, substances thus called thiazoli-di-nediones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic thiazolidinediones.. rosiglitazone. this classification denotes a differentiation inducer and anti-diabetic agent with the molecular formula c18h19n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 05v02f2kdg, chemically known as 2,4-thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)- but more generally known as rosiglitazone, which bears us nih compound identifier 77999. european medicines agency schedules rosiglitazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10388mig. the term rosiglitazone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 12 no. 2 1999, list 40) who schedules rosiglitazone in its anatomical therapeutic chemical (atc) classification. rosiglitazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule rosiglitazone under hs 29341000 and sitc 51579. as of q4 2014, rosiglitazone remains us fdas preferred term for this commodity. rosiglitazone bears us nlm identifiers umls id c0289313 and nci concept code c62076. smiles: s1c(cc2ccc(occn(c3ncccc3)c)cc2)c(=o)nc1=o.. "
"antidiabetic and hyperglycemic thiazolidinediones. this classification denotes substances that chemically consist of thiazoles with two keto oxygens, substances thus called thiazoli-di-nediones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic thiazolidinediones.. pioglitazone hydrochloride. this classification denotes a hypoglycemic agent with the molecular formula c19h20n2o3s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jqt35npk6c, chemically known as 2,4-thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)- but more generally known as pioglitazone hydrochloride, which bears us nih compound identifier 4829. european medicines agency schedules pioglitazone hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03834mig. most nations, for tariff and trade purposes, schedule pioglitazone hydrochloride under hs 29341000 and sitc 51579. as of q4 2014, pioglitazone hydrochloride remains us fdas preferred term for this commodity. pioglitazone hydrochloride bears us nlm identifiers umls id c0872972 and nci concept code c29367. smiles: ccc1ccc(nc1)ccoc2ccc(cc2)cc3c(=o)nc(=o)s3.cl.. "
"antidiabetic and hyperglycemic thiazolidinediones. this classification denotes substances that chemically consist of thiazoles with two keto oxygens, substances thus called thiazoli-di-nediones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic thiazolidinediones.. rivoglitazone hydrochloride. this classification denotes an anti-diabetic agent c20h19n3o4s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 60hqu68h8a, chemically known as 2,4-thiazolidinedione, 5-((4-((6-methoxy-1-methyl-1h-benzimidazol-2-yl)methoxy)phenyl)methyl)-, hydrochloride, but more generally known as rivoglitazone hydrochloride, which bears us nih compound identifier 9889104. most nations, for tariff and trade purposes, schedule rivoglitazone hydrochloride under hs 29341000 and sitc 51579. as of q4 2014, rivoglitazone hydrochloride remains us fdas preferred term for this commodity. smiles: cn1c2cc(ccc2nc1coc3ccc(cc3)cc4c(=o)nc(=o)s4)oc.cl.. "
"antidiabetic and hyperglycemic thiazolidinediones. this classification denotes substances that chemically consist of thiazoles with two keto oxygens, substances thus called thiazoli-di-nediones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic thiazolidinediones.. rosiglitazone maleate. this classification denotes a vasodilator agent, fibrinolytic agent, and hypoglycemic agent with the molecular formula c18h19n3o3s.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kx2339dp44, chemically known as 2,4-thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)- but more generally known as rosiglitazone maleate, which bears us nih compound identifier 77999. european medicines agency schedules rosiglitazone maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04274mig. most nations, for tariff and trade purposes, schedule rosiglitazone maleate under hs 29341000 and sitc 51579. as of q4 2014, rosiglitazone maleate remains us fdas preferred term for this commodity. rosiglitazone maleate bears us nlm identifiers umls id c0795660 and nci concept code c2583. smiles: cn(ccoc1ccc(cc1)cc2c(=o)nc(=o)s2)c3ccccn3.c(=c\\c(=o)o)\\c(=o)o.. "
"antidiabetic and hyperglycemic thiazolidinediones. this classification denotes substances that chemically consist of thiazoles with two keto oxygens, substances thus called thiazoli-di-nediones, that help regulate blood glucose levels, thus the term antidiabetic and hyperglycemic thiazolidinediones.. troglitazone. this classification denotes a differentiation inducer and anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) i66zz0zn0e. european medicines agency schedules troglitazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11332mig. troglitazone generally arises in the molecular formula c24h27no5s. the term troglitazone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 7, no3, 1993, list 33.) troglitazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule troglitazone under hs 29341000 and sitc 51579. as of q4 2014, troglitazone remains us fdas preferred term for this commodity. troglitazone bears us nlm identifiers umls id c0245514 and nci concept code c1522. smiles: cc1=c(c(=c2ccc(oc2=c1c)(c)coc3=cc=c(c=c3)cc4c(=o)nc(=o)s4)c)o.. "
"antidiabetic and hyperglycemic alpha-glucosidase inhibitors. this classification denotes substances that consist of saccharides that inhibit human digestive enzymes and which thereby disrupt and markedly reduce carbohydrate absorption, substances called alpha-glucosidase inhibitors, that lower blood glucose levels, thus the term antidiabetic and hyperglycemic alpha-glucosidase inhibitors.. . "
"antidiabetic and hyperglycemic alpha-glucosidase inhibitors. this classification denotes substances that consist of saccharides that inhibit human digestive enzymes and which thereby disrupt and markedly reduce carbohydrate absorption, substances called alpha-glucosidase inhibitors, that lower blood glucose levels, thus the term antidiabetic and hyperglycemic alpha-glucosidase inhibitors.. acarbose. this classification denotes a glucosidase inhibitor and anti-diabetic agent with the molecular formula c25h43no18, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) t58msi464g, chemically known as o-4,6-dideoxy-4-(((1s,4r,5s,6s)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-d-glucopyranosyl-(1->4)-o-alpha-d-glucopyranosyl-(1->4)-d-glucose but more generally known as acarbose, which bears us nih compound identifier 41774. acarbose most often comes in forms base, hexasaccharide, pentasaccharide, and trisaccharide. european medicines agency schedules acarbose in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07368mig. the term acarbose is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19) who schedules acarbose in its anatomical therapeutic chemical (atc) classification. acarbose is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule acarbose under hs 29329970 and sitc 51569. as of q4 2014, acarbose remains us fdas preferred term for this commodity. acarbose bears us nlm identifiers umls id c0591572 and nci concept code c983. smiles: o(c1c(o)c(o)c(oc1co)oc1c(o)c(o)c(oc1co)o)c1oc(c(nc2c(o)c(o)c(o)c(=c2)co)c(o)c1o)c.. "
"antidiabetic and hyperglycemic alpha-glucosidase inhibitors. this classification denotes substances that consist of saccharides that inhibit human digestive enzymes and which thereby disrupt and markedly reduce carbohydrate absorption, substances called alpha-glucosidase inhibitors, that lower blood glucose levels, thus the term antidiabetic and hyperglycemic alpha-glucosidase inhibitors.. miglitol. this classification denotes a glucosidase inhibitor with the molecular formula c8h17no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 0v5436jaqw, chemically known as 3,4,5-piperidinetriol, 1-(2-hydroxyethyl)-2-(hydroxymethyl)-, (2r-(2alpha,3beta,4alpha,5beta))- but more generally known as miglitol, which bears us nih compound identifier 51577. european medicines agency schedules miglitol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08958mig. the term miglitol is an international non-proprietary name who schedules miglitol in its anatomical therapeutic chemical (atc) classification. miglitol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule miglitol under hs 29333999 and sitc 51574. as of q4 2014, miglitol remains us fdas preferred term for this commodity. miglitol bears us nlm identifiers umls id c0066535 and nci concept code c61847. smiles: oc1c(n(cc(o)c1o)cco)co.. "
"antidiabetic and hyperglycemic alpha-glucosidase inhibitors. this classification denotes substances that consist of saccharides that inhibit human digestive enzymes and which thereby disrupt and markedly reduce carbohydrate absorption, substances called alpha-glucosidase inhibitors, that lower blood glucose levels, thus the term antidiabetic and hyperglycemic alpha-glucosidase inhibitors.. voglibose. this classification denotes a glucosidase inhibitor and anti-diabetic agent with the molecular formula c10h21no7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) s77p977ag8, chemically known as 3,4-dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-c-(hydroxymethyl)-d-epi-inositol but more generally known as voglibose, which bears us nih compound identifier 5677. european medicines agency schedules voglibose in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00085mig. the term voglibose is an international non-proprietary name or inn (see world health organization inn reference publication, volume 6, no, 3 1992, list 32) who schedules voglibose in its anatomical therapeutic chemical (atc) classification. voglibose is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule voglibose under hs 29221980 and sitc 51461. as of q4 2014, voglibose remains us fdas preferred term for this commodity. voglibose bears us nlm identifiers umls id c0532578 and nci concept code c95221. smiles: c1c(c(c(c(c1(co)o)o)o)o)nc(co)co.. "
"antidiabetic and hyperglycemic peroxisome proliferator-activated receptors. this classification denotes substances that constitute nuclear receptor proteins, substances which regulate gene expression, substances called peroxisome proliferator-activated receptors, that lower blood glucose levels, thus the term antidiabetic and hyperglycemic peroxisome proliferator-activated receptors.. . "
"antidiabetic and hyperglycemic peroxisome proliferator-activated receptors. this classification denotes substances that constitute nuclear receptor proteins, substances which regulate gene expression, substances called peroxisome proliferator-activated receptors, that lower blood glucose levels, thus the term antidiabetic and hyperglycemic peroxisome proliferator-activated receptors.. farglitazar. this classification denotes an anti-diabetic agent with the molecular formula c34h30n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 3433gy7132, chemically known as l-tyrosine, n-(2-benzoylphenyl)-o-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl) but more generally known as farglitazar, which bears us nih compound identifier 170364. the term farglitazar is an international non-proprietary name or inn (see world health organization inn reference publication, volume 15 no. 3-4, 2001, list 46). most nations, for tariff and trade purposes, schedule farglitazar under hs 29349990 and sitc 51579. as of q4 2014, farglitazar remains us fdas preferred term for this commodity. farglitazar bears us nlm identifiers umls id c1447907 and nci concept code c81693. smiles: cc1=c(n=c(o1)c2=cc=cc=c2)ccoc3=cc=c(c=c3)cc(c(=o)o)nc4=cc=cc=c4c(=o)c5=cc=cc=c5.. "
"antidiabetic and hyperglycemic peroxisome proliferator-activated receptors. this classification denotes substances that constitute nuclear receptor proteins, substances which regulate gene expression, substances called peroxisome proliferator-activated receptors, that lower blood glucose levels, thus the term antidiabetic and hyperglycemic peroxisome proliferator-activated receptors.. ragaglitazar. this classification denotes an anti-diabetic agent with the molecular formula c25h25no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) q5elr5a7y5, chemically known as benzenepropanoic acid, alpha-ethoxy-4-(2-(10h-phenoxazin-10-yl)ethoxy)-, (alphas)- but more generally known as ragaglitazar, which bears us nih compound identifier 128814. the term ragaglitazar is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16., no. 1.2002, list 47). most nations, for tariff and trade purposes, schedule ragaglitazar under hs 29349990 and sitc 51579. as of q4 2014, ragaglitazar remains us fdas preferred term for this commodity. ragaglitazar bears us nlm identifiers umls id c1175029 and nci concept code c75192. smiles: ccoc(cc1=cc=c(c=c1)occn2c3=cc=cc=c3oc4=cc=cc=c42)c(=o)o.. "
"antidiabetic and hyperglycemic peroxisome proliferator-activated receptors. this classification denotes substances that constitute nuclear receptor proteins, substances which regulate gene expression, substances called peroxisome proliferator-activated receptors, that lower blood glucose levels, thus the term antidiabetic and hyperglycemic peroxisome proliferator-activated receptors.. tesaglitazar. this classification denotes an anti-diabetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 6734037o3l. european medicines agency schedules tesaglitazar in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25217. tesaglitazar generally arises in the molecular formula c20h24o7s. the term tesaglitazar is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16., no. 1.2002, list 47.) most nations, for tariff and trade purposes, schedule tesaglitazar under hs 29189900 and sitc 51396. as of q4 2014, tesaglitazar remains us fdas preferred term for this commodity. tesaglitazar bears us nlm identifiers umls id c1570259 and nci concept code c75985. smiles: s(=o)(=o)(oc1ccc(ccoc2ccc(cc(occ)c(=o)o)cc2)cc1)c.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. . "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. acetohexamide. this classification denotes an anti-diabetic agent with the molecular formula c15h20n2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) qgc8w08i6i, chemically known as urea, 1-((p-acetylphenyl)sulfonyl)-3-cyclohexyl- but more generally known as acetohexamide, which bears us nih compound identifier 1989. european medicines agency schedules acetohexamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05223mig. the term acetohexamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5) who schedules acetohexamide in its anatomical therapeutic chemical (atc) classification. acetohexamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule acetohexamide under hs 29350090 and sitc 51580. as of q4 2014, acetohexamide remains us fdas preferred term for this commodity. acetohexamide bears us nlm identifiers umls id c0733364 and nci concept code c47380. smiles: s(=o)(=o)(nc(=o)nc1ccccc1)c1ccc(cc1)c(=o)c.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. carbutamide. this classification denotes an anti-diabetic agent with the molecular formula c11h17n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) e3k8p4869p, chemically known as urea, 1-butyl-3-sulfanilyl- but more generally known as carbutamide, which bears us nih compound identifier 9564. european medicines agency schedules carbutamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06620mig. the term carbutamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 31, no10, 1977, list 17) who schedules carbutamide in its anatomical therapeutic chemical (atc) classification. carbutamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule carbutamide under hs 29350090 and sitc 51580. as of q4 2014, carbutamide remains us fdas preferred term for this commodity. carbutamide bears us nlm identifiers umls id c0007080 and nci concept code c83597. smiles: ccccnc(=o)ns(=o)(=o)c1=cc=c(c=c1)n.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. chlorpropamide. this classification denotes an anti-diabetic agent with the molecular formula c10h13cln2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) wtm2c3il2x, chemically known as urea, 1-((p-chlorophenyl)sulfonyl)-3-propyl- but more generally known as chlorpropamide, which bears us nih compound identifier 2727. european medicines agency schedules chlorpropamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06209mig. the term chlorpropamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4) who schedules chlorpropamide in its anatomical therapeutic chemical (atc) classification. chlorpropamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule chlorpropamide under hs 29350090 and sitc 51580. as of q4 2014, chlorpropamide remains us fdas preferred term for this commodity. chlorpropamide bears us nlm identifiers umls id c0008287 and nci concept code c47447. smiles: cccnc(=o)ns(=o)(=o)c1=cc=c(c=c1)cl.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. glibenclamide or glyburide. this classification denotes a cation channel blocker and anti-diabetic agent with the molecular formula c23h28cln3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sx6k58tvwc, chemically known as urea, 1-((p-(2-(chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl- but more generally known as glibenclamide, which bears us nih compound identifier 3488. european medicines agency schedules glibenclamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07916mig who schedules glibenclamide in its anatomical therapeutic chemical (atc) classification. glibenclamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. glibenclamide or glyburide bears us nlm identifiers umls id c0017628 and nci concept code c29076. smiles: clc1cc(c(=o)nccc2ccc(s(=o)(=o)nc(=o)nc3ccccc3)cc2)c(oc)cc1.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. glibornuride. this classification denotes a hypoglycemic agent with the molecular formula c18h26n2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) vp83e7434r, chemically known as urea, 1-(2-hydroxy-3-bornyl)-3-(p-tolylsulfonyl)-, (1r,2r,3s,4s)- but more generally known as glibornuride, which bears us nih compound identifier 33649. european medicines agency schedules glibornuride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07917mig who schedules glibornuride in its anatomical therapeutic chemical (atc) classification. glibornuride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule glibornuride under hs 29350090 and sitc 51580. as of q4 2014, glibornuride remains us fdas preferred term for this commodity. smiles: s(=o)(=o)(nc(=o)nc1c2c(c(c1o)(cc2)c)(c)c)c1ccc(cc1)c.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. glicaramide. this classification denotes an anti-diabetic agent with the molecular formula c30h42n6o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) uk5sr22c8q, chemically known as 1-cyclohexyl-3-((p-(2-(1-ethyl-4-(isopentyloxy)-3-methyl-1h-pyrazolo(3,4-b)pyridine-5-carboxamido)ethyl)phenyl)sulfonyl)urea but more generally known as glicaramide, which bears us nih compound identifier 65799. european medicines agency schedules glicaramide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07919mig. the term glicaramide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 27, no. 10 1973, list 13). glicaramide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule glicaramide under hs 29350090 and sitc 51580. as of q4 2014, glicaramide remains us fdas preferred term for this commodity. glicaramide bears us nlm identifiers umls id c0603303 and nci concept code c72945. smiles: s(=o)(=o)(nc(=o)nc1ccccc1)c1ccc(ccnc(=o)c2c(occc(c)c)c3c(n(nc3c)cc)nc2)cc1.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. gliclazide. this classification denotes an anti-diabetic agent with the molecular formula c15h21n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) g4px8c4hkv, chemically known as urea, 1-(hexahydrocyclopenta(c)pyrrol-2(1h)-yl)-3-(p-tolylsulfonyl)- but more generally known as gliclazide, which bears us nih compound identifier 3475. european medicines agency schedules gliclazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07921mig. the term gliclazide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11) who schedules gliclazide in its anatomical therapeutic chemical (atc) classification. gliclazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule gliclazide under hs 29350090 and sitc 51580. as of q4 2014, gliclazide remains us fdas preferred term for this commodity. gliclazide bears us nlm identifiers umls id c0017631 and nci concept code c87618. smiles: s(=o)(=o)(nc(=o)nn1cc2c(ccc2)c1)c1ccc(cc1)c.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. glipalamide. this classification denotes an anti-diabetic agent with the molecular formula c12h15n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) w7j490cuhm, chemically known as 4,5-dihydro-5-methyl-n-((4-methylphenyl)sulfonyl)-1h-pyrazole-1-carboxamide but more generally known as glipalamide, which bears us nih compound identifier 65802. european medicines agency schedules glipalamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07926mig. the term glipalamide is an international non-proprietary name. glipalamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule glipalamide under hs 29350090 and sitc 51580. as of q4 2014, glipalamide remains us fdas preferred term for this commodity. glipalamide bears us nlm identifiers umls id c0243356 and nci concept code c72797. smiles: cc1cc=nn1c(=o)ns(=o)(=o)c2=cc=c(c=c2)c.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. glipizide. this classification denotes an anti-diabetic agent with the molecular formula c21h27n5o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) x7wdt95n5c, chemically known as urea, 1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)- but more generally known as glipizide, which bears us nih compound identifier 3478. european medicines agency schedules glipizide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07927mig. the term glipizide is an international non-proprietary name who schedules glipizide in its anatomical therapeutic chemical (atc) classification. glipizide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule glipizide under hs 29350090 and sitc 51580. as of q4 2014, glipizide remains us fdas preferred term for this commodity. glipizide bears us nlm identifiers umls id c0017642 and nci concept code c29074. smiles: s(=o)(=o)(nc(=o)nc1ccccc1)c1ccc(ccnc(=o)c2ncc(nc2)c)cc1.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. gliquidone. this classification denotes an anti-diabetic agent with the molecular formula c27h33n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) c7c2qdd75p, chemically known as 1-cyclohexyl-3-(p-beta-(4,4-dimethyl-2-methoxy-1,3-(2h,4h)-isoquinolinedione-2-yl)phenethyl)sulfonylurea but more generally known as gliquidone, which bears us nih compound identifier 91610. european medicines agency schedules gliquidone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07928mig. the term gliquidone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 27, no. 10 1973, list 13) who schedules gliquidone in its anatomical therapeutic chemical (atc) classification. gliquidone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule gliquidone under hs 29350090 and sitc 51580. as of q4 2014, gliquidone remains us fdas preferred term for this commodity. gliquidone bears us nlm identifiers umls id c0061328 and nci concept code c72798. smiles: s(=o)(=o)(nc(=o)nc1ccccc1)c1ccc(ccn2c(=o)c(c3c(c2=o)cc(oc)cc3)(c)c)cc1.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. glisolamide. this classification denotes an anti-diabetic agent with the molecular formula c20h26n4o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) f83u6t74xr, chemically known as 3-isozazolecarboxamide, n-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl- but more generally known as glisolamide, which bears us nih compound identifier 65713. european medicines agency schedules glisolamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07932mig. the term glisolamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 34, no. 10 1980, list 20). glisolamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule glisolamide under hs 29350090 and sitc 51580. as of q4 2014, glisolamide remains us fdas preferred term for this commodity. glisolamide bears us nlm identifiers umls id c0061329 and nci concept code c72800. smiles: s(=o)(=o)(nc(=o)nc1ccccc1)c1ccc(ccnc(=o)c2noc(c2)c)cc1.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. glisoxepid or glisoxepide. this classification denotes an anti-diabetic agent with the molecular formula c20h27n5o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h7sc0i332i, chemically known as 3-isoxazolecarboxamide, n-(2-(4-(((((hexahydro-1h-azepin-1-yl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl- but more generally known as glisoxepid, which bears us nih compound identifier 32778. european medicines agency schedules glisoxepide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07933mig. the term glisoxepide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11) who schedules glisoxepid in its anatomical therapeutic chemical (atc) classification. glisoxepid or glisoxepide bears us nlm identifiers umls id c0061330 and nci concept code c72801. smiles: cc1=cc(=no1)c(=o)nccc2=cc=c(c=c2)s(=o)(=o)nc(=o)nn3cccccc3.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. glybuthiazol. this classification denotes an anti-diabetic agent with the molecular formula c12h16n4o2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 35421n8e8w, chemically known as sulfanilamide, n(sup 1)-(5-tert-butyl-1,3,4-thiadiazol-2-yl)- but more generally known as glybuthiazol, which bears us nih compound identifier 10811. european medicines agency schedules glybuthiazol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07946mig. the term glybuthiazol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). glybuthiazol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule glybuthiazol under hs 29350090 and sitc 51580. as of q4 2014, glybuthiazol remains us fdas preferred term for this commodity. glybuthiazol bears us nlm identifiers umls id c2348868 and nci concept code c72803. smiles: cc(c)(c)c1=nn=c(s1)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. metahexamide. this classification denotes an anti-diabetic agent with the molecular formula c14h21n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) t3u6f5d722, chemically known as 1,3,5-triazine-2,4-diamine, 6-chloro-n,n,n,n-tetraethyl- but more generally known as metahexamide, which bears us nih compound identifier 11259. european medicines agency schedules metahexamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08803mig. the term metahexamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4) who schedules metahexamide in its anatomical therapeutic chemical (atc) classification. metahexamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule metahexamide under hs 29350090 and sitc 51580. as of q4 2014, metahexamide remains us fdas preferred term for this commodity. metahexamide bears us nlm identifiers umls id c0663351 and nci concept code c91022. smiles: s(=o)(=o)(nc(=o)nc1ccccc1)c1cc(n)c(cc1)c.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. tolazamide. this classification denotes an anti-diabetic agent with the molecular formula c14h21n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 9lt1bro48q, chemically known as 4-(p-tolylsulfonyl)-1,1-hexamethylenesemicarbazide but more generally known as tolazamide, which bears us nih compound identifier 5503. european medicines agency schedules tolazamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11147mig. the term tolazamide is an international non-proprietary name who schedules tolazamide in its anatomical therapeutic chemical (atc) classification. tolazamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule tolazamide under hs 29350090 and sitc 51580. as of q4 2014, tolazamide remains us fdas preferred term for this commodity. tolazamide bears us nlm identifiers umls id c0040372 and nci concept code c29502. smiles: s(=o)(=o)(nc(=o)nn1cccccc1)c1ccc(cc1)c.. "
"antidiabetic and hyperglycemic sulfonylureas. this classification denotes substances composed of substituted arylsulfonylureas that lower blood glucose levels by increasing pancreatic insulin release, thus the term antidiabetic and hyperglycemic sulfonylureas.. tolbutamide. this classification denotes an anti-diabetic agent with the molecular formula c12h18n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 982xcm1foi, chemically known as urea, 1-butyl-3-(p-tolylsulfonyl)- but more generally known as tolbutamide, which bears us nih compound identifier 5505. european medicines agency schedules tolbutamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11150mig. the term tolbutamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3) who schedules tolbutamide in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule tolbutamide under hs 29350090 and sitc 51580. as of q4 2014, tolbutamide remains us fdas preferred term for this commodity. tolbutamide bears us nlm identifiers umls id c0040374 and nci concept code c66610. smiles: ccccnc(=o)ns(=o)(=o)c1=cc=c(c=c1)c.. "
